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F O R E W O R D
Drug misuse is one of the great social ills
of our time. It affects individuals, families
and whole communities. That is why this
review of our current drugs policy is so
important. It is the most comprehensive
analysis and assessment of the drugs
problem ever conducted in Ireland and
outlines the policy framework through
which all those involved in addressing
this problem can work for the next 
seven years. 
A striking feature of the consultations
conducted as part of the re v i e w, part i c u l a r l y
outside of Dublin, was the serious
concern expressed about the widespread
abuse of alcohol by young people and
the perception that such abuse may be a
gateway to illicit drug misuse. I have
made these views known to my
colleague, the Minister for Health and
Children, Micháel Martin T.D., and the
recent launch of an Alcohol Awareness
Campaign, aimed particularly at young
people, is clearly both timely and critical.
In addition, the new strategy contains
recommendations designed to ensure
close liaison between the implementation
of the Drugs and Alcohol Strategies. 
Many Government Departments and
agencies, community and voluntary
organisations and individuals provided
information and assistance and made
submissions during the course of the
review. Their help was greatly
appreciated, particularly for the many 
insights into this complex problem which
they presented from a variety of
perspectives. In particular, I wish to
express my thanks to the members of the
Review Group who gave so generously of
their time and oversaw the work of the
review. I would also like to thank Farrell
Grant Sparks/Dr Michael Farrell/Nexus
Research Co-operative Consultants for 
the assistance they provided. In addition,
I would like to thank the staff of my
Department whose commitment and
dedication was so instrumental in
maintaining the pace and scope of the
review and, ultimately, the production 
of this Report. 
While the review has been taking 
place, progress has also been made in
enhancing the current strategy and a
number of landmark initiatives have
taken place. These include the
publication of the Steering Group Report
on Prison-Based Drug Treatment Services
in June 2000; the establishment of the
National Advisory Committee on Drugs in
July 2000; the establishment of the pilot
Drug Court in the North Inner City of
Dublin in January 2001; and the
substantial increase in the number of
treatment places available (from 4,332 
at the end of 1999 to 5,032 at the end 
of 2000). Meanwhile, preparation of 
new Action Plans by the Local Drugs Task
Forces has continued and the Cabinet
Committee on Social Inclusion has, in the
past few months, approved over £5.5m in
funding for nine updated plans covering
a wide variety of initiatives in the areas
of treatment, rehabilitation, awareness,
prevention and education. 
I believe that with the implementation 
of the recommendations set out in this
Report and the active involvement and
hard work of all those engaged in
tackling drug misuse, we can turn the
tide on one of the greatest threats facing
our young people and society today.
E X E C U T I V E S U M M A RY
In April 2000, the Cabinet Committee on
Social Inclusion requested that a review
of the current national drugs strategy 
be undertaken. The overall objective of
the review was to identify any gaps or
deficiencies in the existing strategy and
to develop revised strategies and, if
necessary, new arrangements through
which to deliver them. A sub-group of
the Inter-Departmental Group on Drugs
and the National Drugs Strategy Team –
known as the Review Group – managed
and oversaw the process. 
As part of the review, a study of the
latest available data on the extent and
nature of drug misuse in Ireland was
undertaken. This revealed that the 
most commonly used drug in Ireland is
cannabis, followed by ecstasy. However,
in terms of harm to the individual and
the community, heroin has the greatest
impact. Both treatment data and data
from An Garda Síochána indicate that
heroin misuse remains, almost exclusively,
a Dublin phenomenon. Research shows
that the majority of those presenting for
treatment are male, are under 30 years of
age and are unemployed while over half
had already left school by the age of 15.
An overview of drug misuse in Ireland is
outlined in Chapter 2.
Ireland’s current approach to tackling 
the drug problem has developed around
the four pillars of supply reduction,
prevention, treatment and research.
Central to the approach has been the
bringing together of key agencies – both
statutory and community/voluntary – in 
a planned and co-ordinated manner, to
develop a range of appropriate responses
to tackle drug misuse, not just in relation
to the supply of drugs but also in
providing treatment and rehabilitation
for those who are addicted, as well as
developing appropriate preventative
strategies. The various elements of the
current national drugs strategy are
outlined in Chapter 3.
As part of the review, the drug strategies
of a number of other countries were
examined. The approach to dealing with
drug misuse in those countries shared
common twin characteristics – a focus on
the needs of the drug misuser, coupled
with attempts through various enforc e m e n t
measures and agencies to cut off the
supply of drugs, with the degree of
emphasis varying according to the country ’s
fundamental philosophy on tackling the
d rugs issue. An overview of the intern a t i o n a l
approaches is set out in Chapter 4. 
An extensive public consultation 
process was undertaken as part of the
review to give individuals and groups an
opportunity to outline their views on the
effectiveness of the current strategy and
how it might be improved/adapted.
Approximately 190 written submissions
were received, 34 different groups made
oral presentations and a series of eight
consultation fora were held throughout
the country at which over 600 people
attended. An overview of the issues that
emerged during the consultation process
is set out in Chapter 5. 
N AT I O N A L D R U G S S T R AT E G Y
2 0 0 1 - 2 0 0 8
In developing a new strategy for the next
seven years, the Review Group recognised
that while much remains to be done,
there are encouraging signs of progress
in recent years which suggests that the
current approach to tackling the drug
problem is proving to be effective. The
G roup believes, there f o re, that the pre s e n t
approach provides a solid foundation
from which all those involved in trying to
tackle the problem should work for the
future. Consequently, it is recommended
that the new strategy should endorse the
existing approach and should expand on
and strengthen the pillars and principles
which underpin it. 
The conclusions of the Review Group in
relation to the individual pillars that
constitute the current strategy are set out
in Chapter 6. In light of these conclusions
and the overall strategic objective and
strategic aims set for the Strategy, the
Review Group has developed 100
individual actions which are designed to
build on the existing approach and drive
the new strategy forward. 
Implementation of the actions will be a
matter for the Departments and agencies
involved in the delivery of drugs policy.
Their implemenation will be overseen by
the Inter-Departmental Group on Drugs,
in consultation with the National Drugs
Strategy Team. Six monthly progress
reports will be made to be Cabinet
Committee on Social Inclusion. 
The 100 individual actions are set out in
detail in Chapter 6. 
FR A M E W O R K F O R T H E NAT I O N A L
DR U G S ST R AT E G Y 2001 – 2008 
Overall Strategic Objective
The overall strategic objective for the
National Drugs Strategy 2001 – 2008 is : 
to significantly reduce the harm caused
to individuals and society by the
misuse of drugs through a concerted
focus on supply reduction, prevention,
treatment and research 
Overall Strategic Aims 
The following are the overall strategic
aims of the Strategy : 
n to reduce the availability of illicit
drugs;
n to promote throughout society a
greater awareness, understanding and
clarity of the dangers of drug misuse;
n to enable people with drug misuse
problems to access treatment and
other supports in order to re-integrate
into society;
n to reduce the risk behaviour associated
with drug misuse;
n to reduce the harm caused by drug
misuse to individuals, families and
communities;
n to have valid, timely and comparable
data on the extent and nature of drug
misuse in Ireland; and
n to strengthen existing partnerships in
and with communities and build new
partnerships to tackle the problems of
drug misuse.
OB J E C T I V E S A N D KE Y
PE R F O R M A N C E IN D I C AT O R S
Supply Reduction
Objectives
n To significantly reduce the volume of
illicit drugs available in Ireland, to
arrest the dynamic of existing markets
and to curtail new markets as they are
identified; and
n To significantly reduce access to all
drugs, particularly those drugs that
cause most harm, amongst young
people especially in those areas where
misuse is most prevalent.
Key Performance Indicators
n Increase the volume of opiates and all
other drugs seized by 25% by end 2004
and by 50% by end 2008 (using 2000
seizures as a base); 
n Establish a co-ordinating framework in
relation to drugs policy in each Garda
District by end 2001; and
n Increase the level of Garda resources in
Local Drugs Task Force areas by end
2001, building on lessons emanating
from the Community Policing Forum
model; 
n Strengthen and consolidate existing
coastal watch and other ports of entry
measures designed to restrict the
importation of illicit drugs;
n Co-operate and collaborate fully, at
every level, with law enforcement and
intelligence agencies, in Europe and
internationally, in reducing the amount
of drugs coming into Ireland. 
P re v e n t i o n
Objective
n To create greater societal awareness
about the dangers and prevalence of
drug misuse; and
n To equip young people and other
vulnerable groups with the skills and
supports necessary to make informed
choices about their health, personal
lives and social development.
Key Performance Indicators
n Bring drug misuse by schools-goers to
below the EU average and, as a first
step, reduce the level of substance
misuse reported to ESPAD by school-
goers by 15% by 2003 and by 25% by
2007 (based on 1999 ESPAD levels as
reported in 2001);
n Develop and launch an ongoing
National Awareness Campaign
highlighting the dangers of drugs, the
first stage to commence by end 2001;
n Develop formal links at local, regional
and national levels with the National
Alcohol Policy, by end 2001 and ensure
complementarity between the different
measures being undertaken;
n Publish and implement a policy
statement specifically relating to
education supports for Local Drugs Task
Force areas, including an audit of the
level of current supports, by end 2001;
n Nominate an official from the
Department of Education and Science
to serve as a member of each of the
Local Drugs Task Forces by end 2001;
n Prioritise Local Drugs Task Force areas
during the establishment and
expansion of the services of the
National Educational Welfare Board;
n Have comprehensive substance misuse
prevention programmes in all schools
and, as a first step, implement the
“Walk Tall” and “On My Own Two
Feet” Programmes in all schools in the
Local Drugs Task Force areas during the
academic year 2001/02;
n Complete the evaluation of the “Walk
Tall” and “On My Own Two Feet”
Programmes by end 2002; and
n Deliver the SPHE Programme (Social,
Personal & Health Education) in all
second level schools nation-wide by
September 2003.
Tre a t m e n t
Objectives
n To encourage and enable those
dependent on drugs to avail of
treatment with the aim of reducing
dependency and improving overall
health and social well-being, with the
ultimate aim of leading a drug-free
lifestyle; and 
n To minimise the harm to those who
continue to engage in drug-taking
activities that put them at risk.
Key Performance Indicators
n Have immediate access for drug
misusers to professional assessment and
counselling by health board services,
followed by commencement of
treatment as deemed appropriate, not
later than one month after assessment;
n Have access for under-18s to treatment
following the development of an
appropriate protocol for dealing with
this age group;
n I n c rease the number of treatment places
to 6,000 places by end 2001 and to a
minimum of 6,500 places by end 2002;
n Continue to implement the
recommendations of the Steering
Group on Prison-Based Drug 
Treatment Services as a priority and
implement proposals designed to end
heroin use in prisons during the period
of the Strategy; 
n Have in place, in each Health Board are a ,
a service user charter by end 2002; 
n Have in place, in each Health Board
area, a range of treatment and
rehabilitation options as part of a
planned programme of progression for
each drug misuser, by end 2002; and
n Provide stabilised drug misusers with
training and employment opport u n i t i e s
and, as a first step, increase the
number of such opportunities by 30%
by end 2004.
R e s e a rc h
Objectives
n To have available valid, timely and
comparable data on the extent of drug
misuse amongst the Irish population
and specifically amongst all
marginalised groups; and
n To gain a greater understanding of the
factors which contribute to Irish
people, particularly young people,
misusing drugs.
Key Performance Indicators
n Eliminate all major research gaps in
drug research by end 2003; and
n Publish an annual report on the nature
and extent of the drug problem in
Ireland and on progress being made 
in achieving the objectives set out in
the Strategy.
C o - o rd i n a t i o n
Objective
n To have in place an efficient and
effective framework for implementing
the National Drugs Strategy.
Key Performance Indicators
n Establish an effective regional
framework to support the measures
outlined in the Report by end 2001; 
n Complete an independent evaluation
the effectiveness of the overall
framework by end 2004.
n Each agency to prepare and publish a
critical implementation path for each
of the actions relevant to their remit by
end 2001; and
n Review the membership, work-load and
s u p p o rts re q u i red by the National Dru g s
Strategy Team to carry out its terms of
reference, by end September 2001.

P a rt I
Review of the Current Strategy


1 . 1 T E R M S O F R E F E R E N C E
1.1.1 The Cabinet Committee on Social
Inclusion, in line with the commitment to
review the current drugs strategy
contained in the Review of the
Government Programme and in the
Programme for Prosperity and Fairness,
1
requested in April 2000 a review to: 
n identify the latest available data on the
extent and nature of problem drug use
in the country as a whole, any
emerging trends in drug misuse and
the areas with the greatest level of
problem drug use;
n outline the current National Drugs
Strategy, including the role of the
statutory agencies and the community
and voluntary sectors, in terms of :
n supply reduction; 
n education, prevention and
awareness; 
n risk reduction, treatment and
rehabilitation; 
n inter-agency co-ordination and
integration; and 
n community/voluntary sector
participation in the design and
delivery of the strategies.
n examine the impact of the current
National Drugs Strategy across the
headings listed in the context of the
objectives set for it and the resources
allocated to date;
n identify any major gaps and deficiencies
presenting across these headings;
n examine international trends,
developments and best practice
models; and
n in the light of the foregoing, consider
how the current National Drugs
Strategy, including the structures
involved in its development and
delivery, can be revised or modified to
meet the gaps and deficiencies
identified. 
1.1.2 The Cabinet Committee on Social
Inclusion was established in 1997. The
Committee has, inter alia, responsibility
for reviewing trends in the area of
problem drug use, assessing progress in
implementing national drugs strategy
and resolving policy or organisational
difficulties which may inhibit effective
responses to the problem. It is chaired by
the Taoiseach and comprises the Tánaiste
and the following Ministers – Tourism,
Sport & Recreation; Education & Science;
Environment & Local Government; Health
& Children; Finance; Justice, Equality &
Law Reform; Social, Community & Family
Affairs; the Minister for Housing and
Urban Renewal at the Department of the
Environment and Local Government; the
Minister of State for Local Development
(with special responsibility for the National
Drugs Strategy) the Minister of State for
Children; the Minister of State for Rural
Development and the Attorney General.
1
1 Action Programme for the Millennium Review, November 1999 and the Programme for Prosperity and Fairness, 2000.
1 . 2 R E V I E W P R O C E S S
1.2.1 Responsibility for conducting of the
review rested with the Inter-
Departmental Group (IDG), which reports
to the Cabinet Committee and oversees
progress on the implementation of the
drugs strategy and overall policy. The
following Departments are represented
on the IDG: Tourism, Sport & Recreation
(Chair); Taoiseach; Finance; Education &
Science; Enterprise, Trade & Employment;
Environment & Local Government; Health
& Children and Justice, Equality & Law
Reform. The IDG established a sub-group,
known as the “Review Group” to manage
the process. The Group comprised
representatives of key departments and
the National Drugs Strategy Team (NDST)
including a re p resentative of the community
and voluntary sectors. A full list of the
members of the IDG and the Review
Group is contained in Appendix I. The
Secretariat to the Review was supplied by
the Drugs Strategy Unit of the Depart m e n t
of Tourism, Sport and Recre a t i o n .
1.2.2 The review included an extensive
consultation process, research of
international examples of best practice
and an examination of various relevant
evaluation reports and other literature.
The Review Group was assisted in its
work by independent consultants 
(Farrell Grant Sparks, Dr Michael Farrell
and NEXUS Research Co-operative) who
reported on the consultation process 
and prepared draft documents for
consideration by the Review Group. 
1.2.3 Advertisements were placed in the
national newspapers in April 2000
inviting any interested individuals or
organisations to make submissions. 
State Agencies such as Health Boards, 
the Gardaí, VECs, the Prisons Service,
Local Authorities etc. were written to
separately, inviting them to make a
submission with a view to assisting the
Review Group to identify any gaps or
deficiencies in the Strategy, develop
revised strategies and, if necessary, new 
arrangements through which to 
deliver them. In total, 189 submissions
2
were received and each submission 
was analysed in light of the terms 
of reference. A small number of
submissions, which related to specific
project proposals or issues which fell
outside the remit of the review, were
referred to relevant agencies for
appropriate consideration. 
1.2.4 Public invitations were subsequently
inserted prominently in all of the
national newspapers inviting interested
parties and members of the public to
attend one of eight regional fora around
the country. The first of these took place
in Cork on Friday 10th June, followed by
Kilkenny on Monday 12th June; Galway
on the 15th; Limerick on the 16th; Dublin
on the 19th; Athlone on the 22nd; Sligo
on the 23rd and Dublin, again, on the
26th. Some 600 people in all participated
in the fora.
1.2.5 The format of the fora was identical
irrespective of location and facilitated
wide-ranging debate in relation to the
drugs strategy. An overview of current
strategy was presented by the Minister of
State followed by presentations by each
of the various interests i.e. the Health
Boards, the Gardaí, the Department of
Education and Science and the voluntary
and community sectors. Following these
presentations, questions were taken from
the floor. Each session was then broken
up into 4 workshops, each with a
separate theme, (a) existing risk
reduction, treatment and rehabilitation
methods; (b) existing supply reduction
measures; (c) existing education,
prevention and awareness strategies and
(d) other issues, including emerg i n g
t rends in drug misuse, drugs in prisons
and gaps in existing strategies to deal
with these issues.
1
2 A full list of submissions is contained in Appendix 3.
1.2.6 Analysis of the attendance sheets
indicates that a broad spectrum of people
attended, including representatives from
the Health Boards, An Garda Síochána,
Local Authorities, Customs and Excise,
youth workers, treatment services,
schools, individual treatment and
rehabilitation centres, community and
voluntary sectors, drug-user groups and
members of the general public. Response
sheets were also provided to all attendees
at each forum, providing them with a
further opportunity to express opinions
in relation to current drugs strategy.
Sixty-six response sheets were returned.
1.2.7 During July and August 2000, following
the fora, a total of 34 different groups
3
representing Government Departments,
Agencies, service providers and other
interested parties were invited to meet
with and make presentations to the
Minister of State, members of the Review
Group and the consultants, on their
respective contributions to overcoming
the drugs problem and to explore how
they might address issues emerging from
the fora. The consultants also met
separately with the NDST to discuss a
range of issues, in particular the Team’s
current responsibilities, both in relation
to Local Drugs Task Forces (LDTFs) and
the broader strategy.
1.2.8 A debate in Seanad Eireann, in June
2000, provided an opportunity for
Senators to make an input to the review.
In addition, towards the end of the
review process, the Minister of State and
officials visited Sweden, Australia and
Switzerland to discuss their experiences
and to look at the range of treatment
and rehabilitation facilities operating in
those countries.
1.2.9 A detailed review of available
epidemiological data was conducted by
the consultants in order to identify, using
the best available information, the extent
and nature of problem drug use in the
country as a whole, any emerging trends
in drug misuse and the areas with the
greatest levels of drug misuse.
Epidemiological data was also sourced 
for groups identified as engaging in drug
misuse. In order to examine international
trends and developments and to identify
models of good practice, the drugs
strategies of Australia, the Netherlands,
Portugal, Spain, Scotland, Sweden,
Switzerland and England were analysed
in detail. The Embassies of the relevant
countries were a key source of
information in this regard.
1
3 A full list of those who made presentations is contained in Appendix 3.
1 . 3 T H E R E P O RT
1.3.1 Once the consultation process was
completed, the Review Group proceeded
to analyse all the views and data
presented, before reaching the
conclusions and recommended actions
outlined in Part 2 of the Report. The
Report was adopted by the Government
in April 2001.
1


2 . 1 N AT I O N A L D ATA C O L L E C T I O N
2.1.1 According to the Health Research Board
(HRB), the term drug use “refers to any
aspect of the drug taking process”;
however, drug misuse or problem drug
use refers to drug use which causes
“social, psychological, physical or legal
difficulties as a result of an excessive
compulsion to continue taking drugs”.
Indirect methods encompassing the use
of numbers of known drug misusers in
the country i.e those registered for
treatment, drug-related arrests and
deaths etc. are currently used to
approximate the numbers of drug
misusers within the Irish population. 
2.1.2 The Drug Misuse Research Division
(DMRD) of the HRB was established in
1989 and is responsible for operating the
National Drug Treatment Reporting
System (NDTRS) which is the main source
of information on drug misuse in Ireland.
The NDTRS is an epidemiological
database, which provides data on people
who avail of treatment services for
problem drug use, on a nationwide basis.
This provides information on the current
patterns and trends of treated drug
misuse and drug addiction in Ireland.
Data are provided to the NDTRS through
centres or service locations where drug
misuse is treated.
2.1.3 From 1990 to 1994, NDTRS data were
collected in relation to the Greater
Dublin area only. In 1995, the data
collected by the NDTRS was extended to
the whole country in response both to
domestic demand for national data on
treated drug misuse and, following the
establishment of the European
Monitoring Centre for Drugs and Drug
Addiction (EMCDDA) in 1993, when the
provision of national information became
a requirement for each Member State. At
present, the NDTRS is the country’s most
developed epidemiological database and
one of the key indicators of drug misuse. 
2.1.4 Drug treatment data collected by the
NDTRS provides a synopsis of the number
of drug misusers availing of drug
treatment services within the country in a
particular year. Although recorded as the
number of cases presenting for treatment
rather than total the number of
individuals,
4
analysing data on drug
misusers receiving treatment for the first
time can allow conclusions to be drawn
from changes in the patterns and trends
of problem drug use over time. The
DMRD publishes an annual report, the
most recent being the Statistical Bulletin
1997 and 1998, with a more up-to-date
data set to be published in mid-2001. The
DMRD and the Irish College of General
Practitioners are now co-operating in
collecting data from GPs working under
the Methadone Treatment Protocol.
5
They
are also examining the possibility of the
inclusion of prison treatment services as
part of their on-going efforts to 
promote more comprehensive data
collection systems.
2
4 The NDTRS re c o rds the number of total treatment contacts i . e . all cases receiving treatment at any time during the calender year. The term c a s e s rather than
individuals is applied, as there is a possibility of double counting of individual patients who may have been treated more than once.
5 D e p a rtment of Health (1993). R e p o rt of the Expert Group on the Establishment of a Protocol for the Prescribing of Methadone. 
Dublin: Department of Health.
2.1.5 Other sources of information on drug
misuse in Ireland which the Review Group
drew on include:
n Department of Health and Children –
statistics on infectious diseases;
n Central Statistics Office (CSO) – Report
on Vital Statistics (Regional Registrars
of Births and Deaths);
n Garda Síochána – annual reports on
drug-related arrests and offences; and
n Forensic Science Laboratory at Garda
HQ – drug seizure data.
As well as these sources of information,
of which the DMRD and the Garda
Síochána are the most developed, many
individual reports and studies carried out
on both a local and national scale by
Health Boards, LDTFs, academic
institutions and by individual
organisations/authors were referred to.
2 . 2 D ATA C O L L E C T I O N AT E U R O P E A N
L E V E L
2.2.1 In addition to the operation of the
NDTRS, the DMRD is the designated Irish
Focal Point for the EMCDDA’s REITOX
Network. In 1993, the EMCDDA was set
up, by the European Commission,
6
in
response to the escalating drug problem
in Europe. With 16 Focal Points operating
within the REITOX Network, one in 
each Member State and the European
Commission, the main responsibility 
of the EMCDDA is to provide valid,
comparable and objective information,
which accurately reflects the rapidly
changing drug patterns and trends in
Europe. In the context of epidemiology,
the EMCDDA has identified 5 key
indicators
7
of drug misuse in Europe.
These indicators, which are listed below,
will be implemented in each Member
State and over time will provide
information on trends and patterns 
of drug misuse. The first two are direct
indicators of drug use/misuse in a
population, while the remainder give 
an indirect indication of drug misuse. 
n Extent and pattern of drug use in the
general population;
n Prevalence of problem drug use;
n Demand for treatment by drug users;
n Drug-related deaths and mortality of
drug users; and
n Drug-related infectious diseases 
(HIV, hepatitis).
With data based on the above indicators,
the EMCDDA publishes an annual report.
The most recent report, published in
2000, is the fifth annual report the
Centre has produced on the state of the
drugs problem in the EU. The EMCDDA is
working closely with the DMRD in Ireland
in an attempt to harmonise data
collection across the EU. By synchronising
data among Member States, comparisons
can be made about emerging trends
across the EU.
2
6 Council Regulation (EEC) no. 302/93.
7 Extended Annual Report on the State of the Drugs Problem in the European Union, 2000. E M C D D A .
2 . 3 D R U G M I S U S E I N I R E L A N D
2.3.1 The DMRD acknowledges the limitations
of current prevalence estimation methods
and the need for on-going investigation
of data availability in order to carry out
accurate prevalence estimation work. As
mentioned in paragraph 2.1.2 above,
figures from the NDTRS relate only to the
persons who present themselves for
treatment nationwide and, may not
include private hospitals and clinics, as all
information submitted to the HRB is done
on a voluntary basis. Drug misuse outside
of treatment is, therefore, not accounted
for in their figures. Accordingly, it should
be noted that numbers presenting for
treatment for problem drug use do not
represent the total number of drug users
in the country. In fact, they may not even
represent all those experiencing problems
with their drug use. 
2.3.2 A number of attempts have been made
to estimate the number of opiate users in
Ireland. Dr Catherine Comiskey estimated
the prevalence figures based on three
1996 data sets – the methadone
treatment list, acute hospital discharges
and Garda data.
8
This exercise was
confined to residents in the Dublin
region. Her results suggested a rough
estimate of the number of opiate users,
in Dublin in 1996, was 13,460, a
prevalence of over 21 per 1,000, aged 15
– 54 years (or 2.1 per cent of the
population). However, concerns have
been expressed about the method used
(“capture/re-capture” model), which state
that this figure could be significantly
lower or higher.
9
The First Report of the
Ministerial Task Force on Measures to
Reduce the Demand for Drugs (1996) also
attempted to estimate the number of
opiate users by extrapolating from the
treatment numbers and arrived at an
estimate of approximately 8,000 heroin
misusers in the Greater Dublin area. 
2.3.3 The number of heroin users on
methadone maintenance programmes at
December 2000 was 5,032 compared to
4,332 at the end of 1999. A further 469
users, in the Eastern Regional Health
Authority (ERHA) area, were on the
waiting lists to receive treatment. 
2
8 C o m i s k e y, C. (1998). P revalence Estimate of Opiate Use in Dublin, Ireland during 1996. Dublin: Institute of Technology Tallaght, 28.
9 Uhl states that “one has to warn seriously against re g a rding capture - re c a p t u re estimates as reliable scientifically based estimates. As we could demonstrate: the
t rue value may easily be 50% less or 100% more than estimated", “The Prevalence of Problematic Opiate Use in Austria Based on a Capture - R e c a p t u re
Estimation", Uhl, Dr Alfred, Ludwig-Boltzmann Institute for Addiction Research at the Anton-Proksch Institute, Vienna, 2000.
2 . 4 N AT I O N A L A N D R E G I O N A L T R E N D S
2.4.1 Surveys carried out on schools and young
people and reports by An Garda Síochána
show clear differences particularly,
between the Greater Dublin area and the
rest of the country, as regards the misuse
of drugs and drug types. This disparity in
the pattern of drug misuse throughout
the country is also indicated in the NDTRS.
Of the clients receiving treatment in
1998, 85 per cent were resident within
the ERHA area, while 4 per cent w e re
t re a t e d in the Southern Health Board
(SHB) area. The small numbers remaining
received treatment in the other 6 Health
Board areas (Table 2.1). Details of the
treatment provided, which includes a
range of medical approaches (including
d e t o x i f i c a t i o n , methadone substitution
and drug-free programmes) and non-
medical therapies (such as addiction
counselling, group therapy and
psychotherapy), is broken down by the
main drug of misuse in each Health
Board area and is given in Table 2.2.
Table 2.1 – Clients (by residence) receiving
treatment for drug misuse by Health Board
Area in 1998*
* NDTRS Statistical Bulletin 1997 and 1998.
1 0
Of clients who received treatment in
1998, the main drug of misuse was heroin
in almost 70 per cent of cases. These were
mainly confined to the Dublin area. 
Table 2.2 – Treatment by main drugs of misuse
in Regional Health Board areas in 1998*
* NDTRS Statistical Bulletin 1997 and 1998 (Note – National  total contains
those clients of no fixed abode and from outside Ire l a n d ) .
**Others include morphine sulphate tablets, medical and non-medical
methadone and other opiates, amphetamines, benzodiazepines, hypnotics,
inhalants and sedatives and non-LSD hallucinogens.
2
1 0 I n f o rmation from the NDTRS is presented according to the Health Board area in which the client is resident. This may be in contrast to the Health Board where
the treatment was received. In most cases, the Health Board of residence and that of treatment are the same.
Treated in Number %
Eastern Health Board 5,076 85%
Southern Health Board 303 5.1%
North Western Health Board 48 0.8%
Midland Health Board 96 1.6%
Western Health Board 14 0.2%
Mid Western Health Board 96 1.6%
North Eastern Health Board 128 2.1%
South Eastern Health Board 201 3.4%
Total (includes residence not known) 6,043 100%
Data Total No. Heroin Cannabis Ecstasy Cocaine LSD Others**
National 6,043 4,297 71.1% 642 10.6% 196 3.3% 88 1.5% 14 0.2% 806 13.3%
EHB 5,076 4,121 81% 211 4.2% 45 0.9% 58 1.1% 4 0.1% 637 12.7%
SHB 303 14 4.6% 120 39.6% 89 29.4% 12 4% 4 1.3% 64 21.1%
NWHB 48 10 20.8% 21 43.8% 10 20.8% 0 0% 1 2.1% 6 12.5%
MHB 96 23 24% 51 53.1% 5 5.2% 0 0% 2 2.1% 15 15.6%
WHB 14 6 42.9% 2 14.3% 1 7.1% 1 7.1% 0 0% 4 28.6%
MWHB 96 7 7.3% 57 59.4% 11 11.5% 3 3.1% 1 1.0% 17 17.7%
NEHB 128 32 25% 52 40.6% 15 11.7% 2 1.6% 2 1.6% 26 19.5%
SEHB 201 22 10.9% 119 59.2% 19 9.5% 9 4.5% 0 0% 32 15.9%
2.4.2 Socio-demographic information, compiled
by the NDTRS and profiles of drug
misusers reporting for drug treatment
indicate that the majority of drug
misusers are male (70 per cent) and in the
20 – 24 year age bracket (36 per cent).
Over three quarters of the drug misusers
reporting for treatment left school by the
age of 16 years and over 70 per cent
were unemployed. As regards drug
misuse behaviours, over half of the clients
reported injecting their main drug, while
34 per cent smoke their main drug.
Almost three quarters of those receiving
treatment for drug misuse were under 19
years of age when they first tried their
main drug and over 30 per cent were
regularly using their main drug for
between 2 to 3 years. 
2.4.3 In January, 2000 an external review of
the drug services for the Eastern Health
Board was published.
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As regards the
provision of services for drug misusers,
urine tests were carried out for opiates,
benzodiazepines and tricyclics in five
ERHA addiction centres. Overall results
are presented in Table 2.3. Although the
positivity rates for both opiates and
tricyclics were low, the high rates of
benzodiazepine positivity indicate a
growing problem of poly-drug misuse.
Table 2.3 – Poly-Drug Misuse – Urinalysis
results from 5 ERHA Addiction Centres*
* F a rrell et al., 2000
2.4.4 Data from An Garda Síochána Annual
Reports relating to drug possession
offences and seizures are one indicator of
the use of non-opiate drugs, such as
cannabis etc., throughout the country.
Table 2.4 demonstrates the regional
breakdown of drug possession offences
in Ireland. However, it should be noted
that seizures may not necessarily be
related to usage in that locality as the
drugs may have been in transit. Table 2.5
shows the number of possession offences
by region and drug type in 1999.
Table 2.4 – An Garda Síochána Regional
breakdown of drug possession offences*
* An Garda Síochána Annual Reports 1996, 1997, 1998 and 1999.
Of the number of people prosecuted for
drugs offences in 1999, the Southern
region accounted for 25 per cent, the
next highest after Dublin which had
decreased significantly to 38 per cent. In
all regions the majority of persons
prosecuted for drugs offences were male
and over 21 years.
12
2
1 1 F a rrell, M., Gerada, C., Marsden, J. (2000). E x t e rnal Review of Drug Services for The Eastern Health Board . National Addiction Centre, Institute of Psychiatry,
London. 
1 2 An Garda Síochána Annual Report 1999.
Drug Type Aggregate Clinic Total  
% Positive
Opiates 30
Benzodiazepines 65
Tricyclics 14
Region Number & percentage of offences
1996 1997 1998 1999
E a s t e rn 1 4 9 5 % 3 4 0 9 % 4 1 6 7 % 8 7 4 1 2 %
D u b l i n 1 , 2 4 3 4 3 % 1 , 8 3 9 4 4 %2 , 9 4 1 5 3 % 2 , 7 1 9 3 8 %
N o rt h e rn 9 9 3 % 1 7 0 4 % 1 9 5 4 % 2 7 5 4 %
South Eastern 2 1 5 8 % 3 6 8 9 % 4 6 8 8 % 6 5 2 9 %
S o u t h e rn 8 8 3 3 1 % 1 , 1 6 9 2 8 %1 , 2 8 9 2 2 % 1 , 7 7 0 2 5 %
We s t e rn 2 9 6 1 0 % 2 6 2 6 % 3 2 2 6 % 8 4 7 1 2 %
To t a l 2 , 8 8 5 1 0 0 % 4 , 1 5 61 0 0 %5 , 6 3 1 1 0 0 % 7 , 1 3 71 0 0 %
Table 2.5 – An Garda Síochána Regional
breakdown of possession offences by drug
type in 1999*
* An Garda Síochána Annual Report 1999.
** Others include morphine sulphate tablets, medical and non-medical
methadone and other opiates, amphetamines, benzodiazepines, hypnotics
and sedatives and non-LSD hallucinogens as well as possession of forg e d
p re s c r i p t i o n s.
2
R e g i o n Number of Off e n c e s / P e rcentage of To t a l
C a n n a b i s Cannabis Resin H e ro i n L S D E c s t a s y A m p h e t s C o c a i n e O t h e r * * To t a l
E a s t e rn 9 8 1 1 % 4 4 5 5 1 % 1 9 2 % 3 < 1 % 2 0 0 2 3 % 8 3 1 0 % 9 1 % 1 7 2 % 8 7 4
D u b l i n 4 7 1 1 7 % 7 3 7 2 7 % 8 5 2 3 2 % 2 < 1 % 2 1 1 8 % 7 0 2 % 1 2 6 5 % 2 5 0 9 % 2 , 7 1 9
N o rt h e rn 8 7 3 2 % 1 0 0 3 7 % 0 0 1 < 1 % 6 0 2 2 % 1 6 6 % 4 1 % 7 2 % 2 7 5
South Eastern 8 6 1 3 % 3 5 1 5 4 % 1 < 1 % 1 1 2 % 8 1 1 2 % 9 2 1 4 % 6 1 % 2 4 4 % 6 5 2
S o u t h e rn 8 0 5 % 1 , 1 4 7 6 5 % 1 2 1 % 5 < 1 % 3 6 8 2 1 % 1 0 8 6 % 1 0 < 1 % 4 0 2 % 1 , 7 7 0
We s t e rn 8 2 1 0 % 5 0 1 6 0 % 3 < 1 % 4 < 1 % 1 0 3 1 2 % 9 5 1 1 % 1 4 2 % 4 5 5 % 8 4 7
To t a l 9 0 4 1 3 % 3 , 2 8 1 4 6 % 8 8 7 1 3 % 2 5 < 1 % 1 , 0 2 3 1 4 % 4 6 4 7 % 1 6 9 2 % 3 8 3 5 % 7 , 1 3 6
2 . 5 T Y P E S O F D R U G S M I S U S E D
2.5.1 A number of surveys suggest that the
most commonly used illegal drug in
Ireland is cannabis.
13/14/15
Table 2.6 deals
with possession offences and this also
indicates that cannabis is the illicit drug
most commonly used throughout the
country, with little change occurring in
recent years. Heroin represents
approximately 13 per cent of all drug-
possession offences, almost all (96 per
cent) of which are recorded in the Dublin
region. Table 2.7 shows the seizures of
selected drugs by year. However, it should
again be pointed out that seizures might
not necessarily be related to usage in
Ireland as the drugs may have been 
in transit.
Table 2.6 – Number of possession offences and
percentage of total by year and drug type*
* An Garda Síochána Annual Reports 1996, 1997, 1998 and 1999.
* * Others include morphine sulphate tablets, medical and non-medical
methadone and other opiates, amphetamines, benzodiazepines, hypnotics
and sedatives and non-LSD hallucinogens as well as possession of forg e d
p rescriptions. 
2.5.2 Table 2.6 shows that ecstasy is the second
most commonly cited drug in possession
offences accounting for 14 per cent of
drug-possession offences in 1999, one
percentage point ahead of heroin
possession. Ecstasy is the third most
commonly misused drug after heroin and
cannabis for which individuals receive
treatment. 
2
1 3 Gleeson, M., Kelliher, K., Haughton, F., Feeney, A., and Dempsey, H. (1989). Teenage smoking, drug and alcohol abuse in the Mid We s t . D e p a rtment of Public
Health, Mid We s t e rn Health Board. 
1 4 Jackson, T.M.R. (1997). Smoking, Alcohol and Drug Use in Cork and Kerry. S o u t h e rn Health Board, Department of Public Health.
1 5 Moran, R., O’ Brien, M. and Duff, P. (1997). Treated Drug Misuse in Ire l a n d . National Report 1996. Dublin: The Health Research Board .
Drug Type 1996 1997 1998 1999
Cannabis (inc.plants) 355 12% 546 13% 441 8% 904 13%
Cannabis resin 1,441 51% 2,096 50% 1,749 31% 3,281 46%
Heroin 432 15% 564 14% 789 14% 887 13%
LSD 24 1% 39 1% 13 <1% 25 <1%
Ecstasy 340 12% 475 11% 439 8% 1,023 14%
Amphetamines 152 5% 239 8% 273 5% 464 7%
Cocaine 42 1% 97 2% 88 2% 169 2%
Other** 96 3% 65 2% 1,839 33% 383 5%
Morphine 6 <1%
Total 2,885 100% 4,156 100% 5,631 100% 7,136 100%
Table 2.7 – Quantities of drugs seized by year*
* An Garda Síochána Annual Reports 1996, 1997,1998 and 1999.
2.5.3 The increase in the use of cocaine, both
nationally and internationally and
particularly among young professionals,
was one of the emerging trends in drug
misuse identified during the public
consultation process and by the
EMCDDA.
16
A conference held by the
Nurses Addiction Network (NAN)
17
in 
May 2000 identified this trend in Ireland.
Garda statistics on the number of
possession offences for cocaine as shown
in Table 2.5 suggest a significant increase
in its usage. At present, attempts are
being made by the DMRD to identify
data on cocaine use for inclusion in 
a report to be published this year.
2
1 6 Annual Report on the State of the Drugs Problem in the European Union 2000, EMCDDA 2000.
1 7 C o n f e rence “Cocaine, An Emerging Pro b l e m ”. Clontarf Castle, May 2000, Nurses Addiction Network.
Drug Type 1996 1997 1998 1999
C a n n a b i s 2 . 4 k g 3 4 . 8 k g 4 4 . 5 k g 6 6 k g
Cannabis re s i n 1 , 9 9 3 k g 1 , 2 4 7 k g 2 , 1 5 7 k g 2 , 5 1 1 k g
H e ro i n 1 0 . 8 k g 8 . 2 k g 3 8 . 3 4 k g 1 6 . 9 5 k g
L S D 5,901 Sqs 1,851 Sqs 798 Sqs 577 Sqs
E c s t a s y 19,244 Ta b s 17,516 Ta b s 604,827 Ta b s 229,091 Ta b s
A m p h e t a m i n e s 7 . 6 k g 102.9kg + 3,889 Ta b s 45.4kg + 4,780 Ta b s 13.4kg + 12,051 Ta b s
C o c a i n e 6 4 2 k g 1 1 k g 3 3 1 . 1 7 k g 8 5 . 5 5 k g
2 . 6 D R U G M I S U S E I N P R I S O N S
2.6.1 The primary and most up-to-date source
of information on current drug misuse
within the Irish prison population is the
recent report
18
by the Department of
Community Health and General Practice,
Trinity College Dublin, on the prevalence
of use and risk to committal
19
prisoners in
1999. This report is, in fact, the second
phase of an earlier census survey report
20
.
At the time of the census survey, the
prison population was approximately
2,700 in 15 prisons and the census survey
sampled 1,205 of these in 9 prisons. By
conducting a committal survey, the study
included everyone who was commited
on that exact day, including prisoners
who had not yet been charged. In these
circumstances, a lot more non-serious
offenders are represented in the
committal survey than in the census
survey. The committal report surveyed
607 prisoners in 7 prisons. In both the
census and committal surveys there was a
mix of high and medium risk
21
prisons
involved (1 low risk prison was included
in the committal survey). It should be
noted that prisons in Dublin, where all of
the “high risk” prisons are located, have
more drug misuse among the prison
population and higher rates of infection
than other prisons throughout the country. 
2.6.2 The data show that the proportion of
prisoners reporting drug misuse, both
before entering and within prison, was
significantly lower in the committal
survey than in the census survey. Table 2.8
indicates the numbers of prisoners who
reported having smoked heroin in the
past year or having ever injected drugs. 
Table 2.8 – Pro p o rtion of Prison re s p o n d e n t s
who had smoked heroin or ever injected dru g s *
* Allwright et al., 1999, Long et al., 2000
Most of those prisoners who reported
having smoked heroin in the past year
(Table 2.9) had also injected drugs and
vice versa. Evidence, from both surveys,
showed that women prisoners were more
likely to smoke heroin and/or ever inject
drugs than male prisoners. 
Table 2.9 – Gender breakdown of re s p o n d e n t s
who had smoked heroin or ever injected dru g s *
* Allwright et al., 1999, Long et al., 2000
2.6.3 More than half of the respondents who
reported ever injecting drugs said they
had commenced injecting before their
18th birthday, 92 per cent reported
having first injected 3 years ago and over
70 per cent had injected in the week
prior to committal. In the light of this
evidence, the survey suggests that most
injectors were current drug misusers
(census survey). Although figures are
slightly lower as regards the drug misuse
behaviours of committal respondents,
evidence also suggests that the majority
of injectors responding to the committal
survey are also current drug misusers.
2
1 8 Long, J., Allwright, S., Barry, J., Reaper-Reynolds, S., Thornton, L., Bradley, F. (2000). Hepatitis B, Hepatitis C and HIV in Irish Prisoners, Part II :Prevalence and Risk
in Committal Prisoners 1999. P re p a red for the Minister for Justice, Equality and Law Reform by the Department of Community Health and General Practice,
Trinity College, Dublin. 
1 9 A committal survey was conducted in order to ensure adequate re p resentation of short - t e rm prisoners, as long-term prisoners are likely to be over- re p resented in
a census surv e y. 
2 0 Allwright, S., Barry, J., Bradley, F., Long, J., Thornton, L. (1999). Hepatitis B, Hepatitis C and HIV in Irish Prisoners: Prevalence and Risk. P re p a red for the Minister
for Justice, Equality and Law Reform by the Department of Community Health and General Practice, Trinity College, Dublin. 
2 1 Prisons were allocated their status of high, medium and low risk according to the estimated prevalence of dru g - related infectious diseases and the estimated
Census Committal
Smoked heroin in 
the last 12 months 46% 31%
Ever injected drugs 43% 29%
% Wo m e n % M e n
C e n s u s / C o m m i t t a l C e n s u s / C o m m i t t a l
Smoked heroin in
the last 12 months 6 0 / 6 5 4 5 / 2 8
Ever injected dru g s 6 0 / 6 0 4 2 / 2 6
2.6.4 Data from both surveys highlighted the
level of initiation into injecting drug use
and the sharing of drug using equipment
within prisons. A similar proportion of
injecting drug users reported starting
injecting while in prison (Table 2.10).
However, there are significant differences
in the injecting practices of prisoners
between the census and committal
surveys, in that a higher proportion in
the census population reported not
injecting in the month prior to the
survey, which may suggest that some
injectors may have stopped injecting
while in prison. Moreover, the 
proportion of prisoners that reported
sharing injecting equipment, both
outside and within prisons, was higher in
the census population.
2.6.5 There was a greater representation of
young people, i . e people younger than 18
years, in the committal survey than in the
census surv e y, as is indicated in Table 2.11.
Table 2.10 – Injecting and equipment-sharing
behaviour of drug misusing prisoners*
* Allwright et al., 1999, Long et al., 2000
Table 2.11 – Number of Under 18 Ye a r s
respondents that smoked heroin or ever injected*
* Allwright et al., 1999, Long et al., 2000
A higher percentage of clients, under 18
years, reported smoking heroin in the
past year and ever injecting in the census
prison population than in the committal
prison population.
2.6.6 In 1998, the Probation and Welfare
Service (PWS) carried out a survey on the
number of problem drug misusers among
offenders in contact with their service in
the Dublin region.
22
The survey was based
on the Probation Officers’ assessment of
clients’ drug usage. It included 54
community-based service personnel on 
12 community-based teams. At the time,
there were 2,183 offenders in contact/
under supervision with these personnel.
Results of the survey indicated that over
56 per cent of all surveyed had a known
history of problem drug use. Of these, 
82 per cent had misused drugs in the ten
months prior to the survey while only 
12 per cent were totally drug free at the
time of the survey. Of those that had
misused drugs in the ten months prior to
the survey, the primary drugs of misuse
were opiates (over two thirds of cases)
and cannabis (18 per cent). This high
percentage in the number of offenders
misusing opiates could be explained by
the fact that the survey was conducted 
in the Dublin region, where the majority
of opiate use is located. 
2
2 2 " P roblem Drug Use among offenders in contact with the Probation and We l f a re Service in Dublin", Probation and We l f a re Service, 2000, unpublished surv e y
p resented to the Review Group by the PWS on 14 July 2000.
Drug misuse behaviours Census% Committal% 
Started injecting in prison 21 17
Injecting in the month 
prior to the survey 45 72
Sharing injecting equipment
in month prior to imprisonment 37 33
Sharing injecting equipment
inside prison 58 43
Census Committal
Respondents Under 18 Years 3% 12%
Under 18 Yrs. who smoked 
heroin in past year 38% 16%
Under 18 Yrs. who ever injected 25% 16%
2 . 7 D R U G M I S U S E A M O N G Y O U N G
P E O P L E
2.7.1 In recent years, the prevalence of alcohol,
tobacco and drug misuse has been
growing amongst young people both in
Ireland and throughout the European
Union. A survey carried out by the
National Youth Council of Ireland
indicates that 53 per cent of young
people in Ireland have tried an illegal
drug.
23
Prevalence among young people
has long been a major concern, not least
because of the threat to public health,
but also because of the strong
relationship between alcohol and drug
misuse and antisocial and criminal
behaviour. One of the methods used in
measuring the alcohol and drug habits of
young people is to conduct school
surveys, as the school population
represents the majority of the age groups
of interest and is easily accessible. 
2.7.2 The pro p o rtion of young people pre s e n t i n g
for treatment has decreased.
24
While in
1995, 2% of those presenting for
treatment were under 15 years of age;
this had dropped to 0.6% in 1998. The
p ro p o rtion of 15 to 19 years olds dro p p e d
from 31 % in 1995 to 22% in 1998. 
Table 2.12 – Age Category of Clients 
who presented for Treatment for Problem
Drug Misuse*
* National Drug Treatment Reporting System, Health Research Board .
2.7.3 Many organisations, particularly the
Health Boards, have carried out a number
of local school surveys throughout the
country in recent years. In 1999,
25
a survey
was conducted on substance misuse in
early adolescents among pupils in the
Dublin region. The study demonstrated
that just under one third reported use of
at least one illicit substance. Cannabis
was the most commonly used illegal
substance followed by the use of
inhalants. The reported mean age for
first time use of cannabis, amongst the
Dublin pupils who had used the drug,
was 12.5 years. Results of a survey
conducted by the Department of Public
Health of the Mid-Western Health Board
showed that, other than alcohol,
cannabis and inhalants were the main
drugs used by the students in this
region.
26/27
Almost 30 per cent of the
students surveyed had tried at least one
drug in their lifetime, with over 12 per
cent using at least one drug at the time
of the study. The lifetime
28
and current
use of all drugs (except inhalants) were
found to increase systematically with age.
The rates for both lifetime and current
drug misuse were higher in urban areas.
2
2 3 National Youth Council of Ireland, 1998.
2 4 National Drug Treatment Reporting System, (NDTRS) Health Research Board. 
2 5 B r i n k l e y, Fitzgerald & Green (1999). Substance use in early adolescents. A study of the rates and patterns of substance use among pupils in Dublin.
2 6 Gleeson et al. ibid.
2 7 K i e rnan, R. (1995). Thesis on substance use among adolescents in the We s t e rn Health Board Area. Unpublished Thesis. Faculty of Public Health Medicine, Royal
College of Physicians of Ireland. 
2 8 Lifetime use refers to substance ever taken. Current use refers to substance use within the past month.
Age Category 1 9 9 5 1 9 9 6 1 9 9 7 1 9 9 8
Under 15 Ye a r s 8 4 1 . 9 % 4 3 0 . 9 % 3 6 0 . 7 % 3 9 0 . 6 %
15 to 19 Ye a r s 1 , 3 6 1 3 1 % 1 , 4 4 6 2 9 . 8 % 1 , 2 6 9 2 6 . 0 % 1 , 3 2 7 2 2 . 0 %
1999 ESPAD Report
2.7.4 Within the EU, the majority of countries
have conducted national school surveys
over recent years, mainly as part of the
European School Survey Project on
Alcohol and Other Drugs (ESPAD).
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The
most recent ESPAD Report was conducted
in 1999 (Report published in 2001). The
main feature of the ESPAD study is the
prevalence of drug use, both legal and
illegal, among 16 year-old school goers.
The study describes the substance use
behaviours, as well as related beliefs and
attitudes, among over 80,000 15-16 year
olds in 30 European countries.
30
The
methodology involved the use of an
identical questionnaire in each of the
participating countries, which was then
collected, using the same methods to
allow for the collation of a
comprehensive and comparable dataset. 
Table 2.13 –Proportion of 15-16 year old
students using drugs, alcohol and tobacco
compared to the ESPAD average*
* Data taken from the 1995 and 1999 ESPAD Report s .
2.7.5 In Ireland, the study involved 2,277
students (the majority born in 1979 and
in 5th year) from 98 schools that were
randomly selected nationwide. The main
results of the study are outlined in Table
2.13. Results indicate that the percentage
of Irish students who had experimented
with each of the substances was higher
than that of the EU average, particularly
in relation to the use of cannabis
although it has declined from the 1995
figure. However, further studies need 
to be conducted that ensure sample
representativeness, before any firm
conclusions on comparative data are
drawn. Figure 2.1 shows the Irish position
vis-a-vis other ESPAD countries in the EU
and the United States in 1995 and 1999
as regards the use of cannabis and
ecstasy by 15-16 year olds.
2
2 9 Hibell et al., (2001). The 1999 ESPAD Report: Alcohol and Other Drug Use Among Students in 30 European Countries. 
3 0 The ESPAD Study: Implications for Pre v e n t i o n . D rugs: Education, Prevention and Policy, Vol. 6, No. 2, 1999. 
Proportion of Irish students that Irish 1995 % Irish 1999 % ESPAD countries ESPAD countries
avg % 1995 avg % 1999
Had any alcohol in last 12 months 86 89 80 83
Were drunk in the last 12 months 66 69 48 52
Ever smoked 74 73 67 69
Smoked in last 30 days 41 37 32 37
Used cannabis 37 32 12 16
Used any drug but cannabis 16 9 4 6
Used tranquillisers/sedatives 8 5 7 7
Used Solvents n/a 22 n/a 9
Figure 2.1 – Percentage of 15-16 year olds have
used Cannabis and Ecstasy in selected ESPAD
countries and the United States in 1995 & 1999
Alcohol and Tobacco Use
2.7.6 Throughout the consultation process,
alcohol misuse was identified as a major
problem within Irish society, particularly
among young people. The National
Health and Lifestyle Surveys published in
1999 took account of the consumption 
of alcohol and tobacco in the population.
The surveys are separated into two
studies – SLÁN (Survey of Lifestyles,
Attitudes and Nutrition) represents adults
aged 18 years and above and the HBSC
(Health Behaviour in School-Aged
Children), which represents school-going
children aged 9–17 years. 
2.7.7 Research relating to the consumption of
alcohol and tobacco is contained in the
HBSC/SLÁN
31
report published in February,
1999. The report states that the pattern
of drinking behaviour among adults in
Ireland has changed. Data from the
report indicate that a higher percentage
of males than females, across all ages,
consume alcohol regularly. Consumption
is becoming more regular within younger
age groups. Another report
32
suggests
that 59 per cent of school children drink
occasionally and 16 per cent drink
regularly. As well as drinking more
regularly, the SLÁN report indicates that
27 per cent of males and 21 per cent of
females consume more than the
recommended weekly limits of “sensible”
alcohol consumption.
33
2
3 1 Friel, S., Nic Gabhainn, S. and Kelliher C. (1999) National Health & Lifestyle Surv e y s .
3 2 Brinkley et al 1999. op cit.
3 3 Sensible alcohol consumption is re g a rded as 21 units for males and 14 units for females per week. 
Table 2.14 – Percentage of Males/Females
Consuming more than the Recommended
Limits of Alcohol*
* The National Health and Lifestyle Surveys, SLÁN Report .
The results indicate that consumption in
excess of the sensible limit of alcohol is
greatest among males in the 18 – 34 year
age bracket, among semi-skilled (SC5)
and unskilled (SC6) individuals. 
2.7.8 The HBSC survey, conducted in 1998,
indicates that 32 per cent of school
respondents reported ever having had a
drink. Overall 29 per cent admitted to
having a drink in the past month. Of
these, boys were more likely to report
current drinking than girls, 34 per cent
compared to 24 per cent respectively. A
similar trend applied to the number of
respondents who reported having been
“really drunk”, with a greater number of
boys than girls more likely to have
consumed amounts of alcohol which
made them “really drunk”. For both boys
and girls, the majority of those who
reported currently drinking and ever
being “really drunk” were in the 15–17
years age bracket. 
2.7.9 The progression of use from tobacco and
alcohol to cannabis and, then, to other
drugs is a consistent finding in a number
of studies conducted on young people.
Although it is not inevitable that
someone who smokes cigarettes or drinks
alcohol will progress to the use of
cannabis or other drugs, the risk of using
cannabis and other drugs is much higher
among individuals who smoke or drink
alcohol, than among non-smokers and
non-drinkers.
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The SLÁN survey reports
that 31 per cent of the Irish adult
population smoke, with a marginally
higher percentage of male (32 per cent)
than female (31 per cent) smokers. Of the
31 per cent who smoke, the majority (39
per cent) of smokers are within the 18 –
34 year age group, a trend similar to that
of alcohol consumption. 
2 . 7 . 1 0 The HBSC report shows that almost half
of school-aged children have had a
cigarette, which is substantially higher
than the percentage who reported
having had a drink (32 per cent). Overall,
21 per cent of the children were current
smokers, with the majority in the 15 –17
year age bracket. The data highlighted
that, overall, more girls (36 per cent) than
boys (31 per cent) smoked within that
age bracket.
2
3 4 Social class distribution of SLÁN – SC1: Professional workers, SC2: managerial and technical, SC3: Non-manual, SC4: Skilled manual, SC5: Semi-skilled, SC6:
U n s k i l l e d .
3 5 Evaluating Drug Prevention in the European Union. EMCDDA Scientific Monograph Series No 2. EMCDDA.
Age Category SC 1-2
34
SC 3-4 SC 5-6
% Males/Females % Males/Females% Males/Females
18 – 34 Years 34/27 32/34 40/22
34 –54 Years 23/11 30/16 21/8
55 + Years 23/8 24/15 25/21
D rug Misuse outside the School
S y s t e m
2 . 7 . 1 1 Although school surveys may represent
the majority of the age groups of interest
when referring to young people, they do
not represent those young people that
are most at risk i.e who are not in the
school system. Treatment data from the
NDTRS indicate that, in 1998, just over a
quarter of clients (26.8%) had left school
before the official school-leaving age of
15 years. Over half (55.4%) had left
school before the age of 16 years.
Seventy nine per cent had left school
before the age of 17 years. Records of
students entering the second-level school
system are collected and maintained by
the Department of Education and
Science. These records are checked
against the number of students taking
junior and senior cycle exams each year,
so that the retention rates of each of the
26 counties can be ascertained at each
cycle. Data from the 1993 retention
profiles
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(began post-primary in 1993)
indicate that Dublin South and Dublin
County Borough had the highest rates of
early school-leaving. For example, of the
students who began post-primary
education in 1993, in those areas, almost
30 per cent had left school without
sitting the Leaving Certificate and 10 per
cent without sitting the Junior Certificate
examinations. Throughout the rest of the
25 counties, figures varied from between
14 and 30 per cent for the number of
individuals that had left school without
sitting the Leaving Certificate. 
2 . 7 . 1 2 As regards drug abuse, data from the
NDTRS Statistical Bulletin 1997 and 1998
indicate the number of clients who
presented for treatment for problem
drug use during 1997 and 1998 and the
age at which these clients had left school
(Table 2.15). 
Over half (55.4%) had left school before
the age of 16 years, whereas 3 per cent
of the individuals receiving treatment for
problem drug use in 1998 were still in
school. 
Table 2.15 – Treatment Contacts during 
1997 & 1998
National Drug Treatment Reporting System Statistical Bulletin 1997 & 1998.
2
3 6 P o s t - P r i m a ry Pupils’ Database/Examinations System, Department of Education and Science.
School Leaving Age Per cent %
1997 1998
Never went to school 0.2 0.1
Under 15 Years 26.9 26.8
15 Years 27.3 28.6
16 Years 22.4 23.1
17 Years 12.0 11.4
18 Years and Over 6.7 7.1
Still at school 4.6 3.0
Total 100 100
Total Number 4,910 6,043
D rug Misuse amongst Third 
Level Students
2 . 7 . 1 3 Finally, in relation to young people and
drug misuse, there are approximately
140,000 full-time and part-time students
currently in higher and further education
colleges in Ireland. In 1998, the Union of
Students in Ireland (USI) published a
national drugs survey of third level
students.
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This survey, which was
conducted among students, aged
between 17-24 years attending higher
and further education colleges
nationwide, is one of the few sources of
information compiled to date on drug
misuse among third level students and
was based on a sample of 1,000 students.
Figure 2.2 – Drugs first used by 
third level students 
Results from the survey indicated that 80
per cent of third level students in Ireland
have taken an illegal drug and over half
of these were still taking the same drug
at the time of the study. The range of
drugs taken by students was very broad
and is outlined here in Figure 2.2.
Overall, the survey suggests a relatively
high level of drug misuse within the
current student population, although as
Figure 2.2 shows, the drugs involved were
overwhelmingly non-opiates. 
2
3 7 USI National Drugs Survey of Third Level Colleges 1997/98. The Union of Students in Ireland (USI), May 1998. 
2 . 8 O T H E R AT R I S K G R O U P S
2.8.1 In 1998, the Combat Poverty Agency
commissioned research into the
correlation between drug misuse and
poverty.
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The findings indicated that;
n The majority of people being treated
for drug misuse are unemployed and
have low educational attainment, 
and the age profile of those in
treatment is declining;
n Opiates and, heroin in particular, were
found to be drugs most likely to be
associated with deprived areas, although
there is a marked contrast between the
level of heroin misuse in Dublin and in
the rest of the country; and
n Poverty and deprivation are more likely
to encourage, rather than discourage,
drug misuse.
The key findings of this research remain
valid in the context of current
epidemiological trends. 
The public consultation highlighted a
number of other at risk groups, amongst
whom there is a perceived high
prevalence of drug misuse e.g. the
homeless, the Traveller Community and
those involved in prostitution. T h e
Review Group looked at available
evidence in relation to these three gro u p s .
The Homeless Population 
2.8.2 The prevalence of drug misuse among
homeless people in Ireland is a particular
problem and is extremely difficult to
quantify. The latest assessment carried
out by the Department of the
Environment and Local Government in
March 1999 estimates that there are
some 5,234 homeless people nationwide.
Although the exact percentage of drug
misusers among this population is
unknown, a survey carried out by Focus
Ireland, in June 1999, found that 36 per
cent of the 762 homeless people
interviewed were misusing drugs. 
2.8.3 In 1999, the Merchants Quay Project
conducted a study of homeless people
availing of treatment for drug misuse. It
found that drug-taking practices
increased in risk among homeless drug
misusers, particularly with regard to
sharing needles and public usage. The
report
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stated that:
n 56 per cent of the respondents
reported an increase in their drug
misuse as a result of being homeless; 
n 92 per cent of rough-sleeping misusers
interviewed reported injecting drugs in
public places, compared to 37 per cent
of those who were staying with friends;
and 
n 49 per cent reported sharing injecting
equipment.
2
3 8 O’ Higgins (1998). Review of Literature and Policy on the links between Poverty and Drug Abuse. Combat Poverty Agency/ESRI. 
3 9 Cox, G. and Lawless, M. (1999). W h e rever I Lay My Hat: A Study of Out of Home Drug Users. M e rchants Quay Project: Dublin. 
2.8.4 According to Focus Ireland, in 1999
Dublin Corporation evicted 30 tenants,
under the Housing Acts and an estimated
90 per cent of these evictions were drug-
related.
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However, a recently published
study
41
carried out on the impact of the
Acts states that they fail to take account
of the difficulty of differentiating
between drug misuse and drug dealing,
although often the drug misuser will
engage in small-time dealing to support
his/her own habit. That said, it should be
noted that the term “anti-social
behaviour” is tightly defined in the
Housing (Miscellaneous Provisions) Act
1997, which differentiates between drug
dealing and drug use.
2.8.5 The Department of the Environment and
Local Government re p o rted to the Review
Group that Dublin Corporation and other
local authorities only carry out evictions
in extreme circumstances and only when
all other options have been exhausted.
The number of evictions must be viewed
in the context of a total local authority
stock of some 100,000 houses. Furt h e rm o re ,
the eviction of tenants or exclusion of
individual family members is contrary to
the ethos of local authorities as social
housing providers. The Department
envisages that the relevant local
a u t h o r i t i e s will develop mechanisms in
co-operation with the LDTFs that
facilitate early intervention in drug
related cases so that such action may be
avoided to the greatest extent possible. 
The Traveller Community 
2.8.6 In general, there is no evidence to
suggest that illicit drug use among the
Traveller Community is, at present, a
major issue, although obviously there is
always potential for such a problem to
develop in the future. In 1999, Pavee
Point Travellers’ Resource Centre
conducted a survey
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on drug misuse
within the Traveller Community using
information collated from treatment
centres via questionnaire, focus groups
with Travellers and a consultative
meeting with Traveller groups. Outcomes
from the survey indicate that the nature
of drug misuse among the Traveller
population is similar to drug misuse
trends among young people outside the
Dublin region. In general, it would
appear that substances most commonly
misused are cigarettes, alcohol and
cannabis, followed closely by ecstasy,
amphetamines and solvent misuse.
Heroin misuse within the Traveller
Community is still at a relatively low
level. Other notable outcomes from the
survey were that:
n Of all the Drug Service Providers (21)
surveyed, only one third were aware of
whether or not travellers were
accessing their services; and
n Cannabis appears to be the most
commonly used drug, even more so
than alcohol, as Travellers have easier
access to cannabis than alcohol,
because of the difficulties they face in
accessing pubs and off-licences. The use
of cannabis is “normalised” and is not
perceived as being an illegal activity by
the majority of the Traveller community.
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4 0 Focus Ire l a n d ’s Submission to the Review of the National Drugs Strategy. 
4 1 M e m e ry, C. and Kerrins, L. (2000). Estate Management and Anti-Social Behaviour in Dublin. A Study of the Impact of the Housing Act 1997. T h reshold Publication. 
4 2 Pavee Point Yo u t h s t a rt 1998-9, D rugs and the Traveller Community Pro j e c t , Pavee Point Travellers’ Resource Centre, Dublin, August 1999. 
Persons involved in Prostitution 
2.8.7 Little information is available as to the
exact extent of drug misuse among
persons working in prostitution.
However, estimates are available from
projects that have close contact with this
group. Figures by outreach workers
coming in contact with women involved
in prostitution show that, since 1997, the
numbers have increased significantly
(Table 2.16). In 1999, the Women’s Health
Project of the Eastern Health Board,
conducted re s e a rch on drug-using women
working in prostitution. Over 84 per cent
of the women reported injecting heroin
in the month prior to the study
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and
most women reported taking more than
one drug at the time of the research,
highlighting a trend of poly-drug use
amongst this group. Results also indicated
that the main reason 83 per cent of the
women were working in prostitution was
financial, in most cases to “make money
for drugs”. Similarly, the outre a c h
m a n a g e r of the Ruhama Women’s Project
reports
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that since 1998, some 90 per
cent
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of their contacts are involved in
prostitution to fund either their own, or
their part n e r s ’ d rug habit. The most up to
date inform a t i o n, relating to the outreach
work, indicates an increase in the number
of contacts
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with women involved in
prostitution over the past 3 – 4 years. The
Project estimates that there were 402
women working in prostitution at the
end of 2000, an increase of 139 on the
previous year.
Table 2.16 – Total Contacts from 1997 – 2000*
* Ruhama Wo m e n ’s Project. 
2.8.8 According to the Gay Men’s Health
Project’s 1997 pilot study report on Males
in Prostitution, drug misuse is also
prevalent amongst this group. Twenty
seven men involved in prostitution were
interviewed and the drugs they had used
included cannabis (76%), poppers (72%),
speed (56%), ecstasy (52%), cocaine
(44%) and heroin (20%).
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4 3 D rug Using Women Working In Pro s t i t u t i o n . The Wo m e n ’s Health Project, Eastern Health Board, Dublin, Ireland and European Intervention Project, AIDS
P revention for Prostitutes Supported by the EU DGV under its Programme “Europe against AIDS”, 1999.
4 4 The Ruhama Wo m e n ’s Project is a national voluntary organisation working with women in pro s t i t u t i o n .
4 5 Based on personal communication between Ruhama Wo m e n ’s Project and contacts of the Pro j e c t .
4 6 The number of contacts re p resents the number of women the Project comes in contact with while working on the streets at night.
4 7 R e p o rt on Men in Pro s t i t u t i o n, Eastern Health Board/Gay Men’s Health Project, 1997.
Year No of contacts with No of nights
women working worked by
in prostitution the Project
1997 619 46
1998 1,087 82
1999 1,932 99
2000 2,012 126
2 . 9 H E R O I N M I S U S E R S I N T R E AT M E N T
2.9.1 The Central Treatment List, which is
compiled by ERHA, is the only register of
patients receiving methadone
maintenance within Ireland at present. As
a result of the Methadone Treatment
Protocol, this list now also includes those
patients receiving methadone
maintenance from GPs working under
the Protocol. According to the Central
Treatment List, at December 2000, there
were 5,032 patients availing of
methadone maintenance treatment
throughout Ireland. Table 2.17 shows the
breakdown of patients on the Central
Methadone Treatment List for 1995-2000.
This list only covered the Eastern Health
Board area up to and including 1998. 
Table 2.17 – Central Methadone Treatment List*
* Data taken from the Central Treatment List, Eastern Regional Health
A u t h o r i t y.
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Breakdown of Patients Dec 1995 Dec 1996 Dec 1997 Dec 1998 Dec 1999 Dec 2000
ERHA Clinics 424 616 1,182 1,939 2,502 2,849
Provincial Clinics N/A N/A N/A N/A N/A 41
Trinity Court 305 260 207 504 515 513
Attending General
Practitioners within
ERHA area 629 985 1,470 1,167 1,252 1,574
Attending General
Practitioners outside
ERHA area N/A N/A N/A N/A 63 55
Total number of patients 1,358 1,861 2,859 3,610 4,332 5,032
2.9.2 At the end of 2000, over 56 per cent of
patients were receiving treatment in 49
ERHA clinics and almost one-third from
GPs in the ERHA area. Over 10 per cent
are receiving treatment in Trinity Court,
which is a Dublin-based treatment centre.
The remaining patients, which account
for just under 2 per cent are availing of
treatment in four Provincial Clinics –
Athlone, Carlow, Portlaoise and
Waterford or from GPs outside the ERHA
area. This highlights the fact that opiate/
heroin misuse remains largely confined to
the ERHA area, particularly Dublin. 
Figure 2.3 – Methadone Treatment Numbers 
at end year 1995-2000 from the Central
Treatment List
2.9.3 Figure 2.3 shows the marked increase in
the numbers of drug misusers accessing
treatment; from 1,358 in 1995 to 5,032 at
the end of 2000. This increase is all the
more significant when account is taken of
the strong local opposition to the
provision of treatment centres. This is the
case even in some of the areas worst
affected by the drugs problem. The ERHA
is continuing to work in these areas and
with those communities where, at
present, there are still significant gaps in
treatment service provision. 
2
4 8 O’ Higgins, K. (1996). Treated drug misuse in the Greater Dublin area. A review of five years 1990 – 1994. The Health Research Board, Baggot St. Dublin, Ireland. 
2.9.4 There has been a 16 per cent increase in
the number of patients availing of
methadone treatment nationwide from
December 1999 to December 2000. The
2000 data set also includes data from
Provincial Clinics which now offer
methadone maintenance treatment,
where previously such treatment was
unavailable. Although the figures show
that there has been an increase in the
number of individuals in treatment, this is
more than likely a reflection of the
development of treatment service
provision available for drug misusers
throughout Ireland
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which is
encouraging more users to come forward
and to avail of these services. 
2.9.5 Table 2.18 shows the number of
participating GPs and pharmacies, both in
and outside the ERHA area, for 1998,
1999 and 2000.
Table 2.18 – Area Breakdown of Participating
Pharmacies and GPs*
* Central Treatment List, Eastern Regional Health Authority.
2.9.6 As of December 2000, according to the
the Methadone Waiting List, there wer e
469 clients currently waiting to avail of
methadone treatment in Ireland. Of this
number, over three quarters were male
clients of which almost 45 per cent were
in the 20 – 24 year age bracket. Almost
60 per cent of the female clients were in
the 20 – 24 year age bracket. Table 2.19
compares waiting list figures in June 1998
and in December 2000.
Table 2.19 – Gender breakdown of the
Methadone Treatment Waiting List as in June
1998 & December 2000*
* East Coast Area Health Board .
2.9.7 There has been a significant increase in
the number of individuals waiting to
avail of methadone maintenance
treatment between June 1998 and
December 2000. This has been matched
by an increase in the number of
treatment places as demonstrated in
Figure 2.3. The most significant increase
occurred in the number of male clients
waiting to avail of treatment. However, it
must be stated that the increase in the
waiting list may again reflect growth in
the provision of methadone treatment
services throughout the country which, in
turn, encourages more people to come
forward and seek treatment.
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Area breakdown of
Participating Pharmacies 1998 1999 2000
Pharmacies within
ERHA area 145 154 158
Pharmacies outside
ERHA area 30 49 58
Total 175 203 216
Area breakdown of
Participating GPs
No. of GPs participating 
within ERHA area 97 122 130
No. of GPs participating 
outside ERHA area 28 32 27
Total 125 154 157
Gender June 1998 December 2000
Females 113 113
Males 143 356
Total 256 469
2 . 1 0 P R E VA L E N C E C O M PA R I S O N S W I T H
O T H E R C O U N T R I E S
2 . 1 0 . 1 National prevalence figures for EU
countries are often difficult to obtain
and, therefore, difficult to compare. The
EMCDDA Annual Report on the state of
the drugs problem in the European Union
is based on the collation of data and
national reports provided by each of the
National Focal Points operating within
the REITOX Network. The DMRD is the
designated Focal Point within Ireland.
Part of each EMCDDA Annual Report
demonstrates the prevalence, patterns
and consequences of drug misuse and
provides updated information on
indicators of the prevalence of drug
misuse, health consequences, law
enforcement and illicit drug markets
within the EU. The EMCDDA has, over
recent years, compiled information from
national population surveys on drug
misuse in 11 Member States, including
Ireland, although, prevalence figures,
such as those given below in Figure 2.4
should be interpreted as crude estimates
only. At present, there are an estimated 1
to 1.5 million problem drug users (mainly
heroin) in the EU.
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Figure 2.4 High, mid and low points of the
estimates (rates per thousand population) of
national problem drug prevalence in the EU
and Norway* 
2 . 1 0 . 2 The evidence from Figure 2.4 highlights
the wide-ranging scale within which
prevalence estimates must be calculated.
The figure refers to the number of
problem drug users, as defined by the
EMCDDA, per thousand in the 15-64 year
old age group. Luxembourg and Italy
have the highest rates, taking into
account both the lowest and highest
range of estimates. As regards Ireland,
the mid point between these two
estimates is 3.8, putting it just above the
EMCDDA country average of 3.68. Heroin
has been identified as the main substance
of problem drug use within the EU. The
overall prevalence of problem drug use,
particularly heroin, appears not to have
increased in most EU Member States over
recent years.
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4 9 Total EU population of 375 million.
5 0 Annual Report on the State of the Drugs Problem in the European Union, EMCDDA, 2000.
D rug-Related Deaths
2 . 1 0 . 3 In many countries throughout the EU, the
number of drug-related deaths began to
stabilise and even decrease in some cases,
in the late 1980s and early 1990s.
However, a number of countries are still
experiencing increases, particularly
Ireland. The scale of the number of
deaths varies dramatically between each
country, as can be seen in Figure 2.5. 
Figure 2.5 – Number of Acute Drug-Related
Deaths Recorded 1990-98
Figure 2.5 (contd) – Number of Acute Drug-
Related Deaths Recorded 1990-98
However, in the absence of harmonised
definitions and methodologies across
Europe, direct comparisons of drug-
related death statistics between countries
can be misleading. Data for Ireland show
that the number of drug-related deaths
rose from 7 in 1990 to 90 in 1998. The
increase between 1994 and 1998,
however, may be mainly due to improved
recording practices as the use of
restrictive, or more inclusive definitions,
of drug-related deaths can lead to very
different estimates. 
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2 . 1 1 A D D R E S S I N G G A P S I N P R E VA L E N C E
D ATA
2 . 1 1 . 1 Recognising that research and
information gaps exist about the nature
and extent of the drug problem in
Ireland, the Government, through the
Cabinet Committee on Social Inclusion,
established the Interim Advisory
Committee on Drugs in 1999. As part of
its subsequent report,
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the Interim
Committee set out priority policy
information needs and recommended a 
3 year programme of research, which
would be overseen by a National
Advisory Committee on Drugs (NACD). 
2 . 1 1 . 2 The Interim Committee also identified a
range of research and information gaps
under the headings of prevalence,
prevention, treatment and consequences.
It concluded that a more focused and
integrated approach was required in the
collection and assimilation of data and
this could be achieved through
establishing a central database on
problem drug use in Ireland. This
database should contain all research and
information relating to problem drug use
and addiction and be easily accessible to
all the relevant organisations and policy-
makers involved in drug-related issues. 
2 . 1 1 . 3 On foot of the Interim Committee's
recommendations, the National Advisory
Committee on Drugs was established by
Government in July 2000. The Committee
is overseeing the delivery of a three year
research programme aimed at addressing
the priority information gaps and
deficiencies in the area of drug misuse.
This programme includes compiling a
comprehensive inventory of existing
research relating to the prevalence,
prevention, treatment/rehabilitation and
consequences of problem drug use in
Ireland. The Committee is also looking at
how best to determine the size and
nature of the drug problem in Ireland,
the effectiveness of existing models and
programmes in the area of prevention,
treatment and rehabilitation and the cost
to society of the drug problem. In view of
the large amount of research and
information which is currently being
produced by various agencies and groups,
the Government also designated the HRB
as a central point to which all such
information should be channelled.
2
5 1 R e p o rt of the Interim Advisory Committee on Dru g s , D e p a rtment of Tourism, Sport and Recreation, Febru a ry 2000.
2 . 1 2 S U M M A RY
The main points made in this overview of
drug misuse are: 
n the most commonly used illegal drug in
Ireland is cannabis, followed by ecstasy;
n in terms of harm to the individual and
the community, heroin has the greatest
impact; 
n heroin misuse remains, almost
exclusively, a Dublin phenomenon;
n cocaine is seen as an emerging drug of
misuse though the numbers presenting
for treatment so far remain quite small;
n the majority of those presenting for
treatment are male, under 30 years of
age and unemployed;
n over half those presenting for
treatment inject their main drug while
a third smoke it; 
n over half of those presenting for
treatment had left school by the age 
of 16;
n in 1999, the highest number of drug
possession offences were in the Dublin
region, followed by the Southern
region;
n there is clear evidence of a significant
level of drug use occurring within Irish
prisons. Overall, surveys estimate that
two fifths of the Irish prison population
have a history of injecting drug use,
nearly half of whom continued to
inject while in prison;
n the proportion of young people (under
19 years of age) presenting for
treatment has decreased;
n in 1999, the percentage of Irish
students who experimented with drugs,
alcohol and tobacco was higher than
the EU average, particularly in relation
to the use of cannabis, although it had
declined since the 1995 ESPAD survey; 
n over 5,000 people are cur rently
receiving methadone maintenance
treatment, the majority in the ERHA
area; 
n there are less than 470 people currently
awaiting treatment, the majority of
whom are male; 
n there is a serious problem of poly-drug
use, including heroin, among men and
women involved in prostitution;
n heroin is the main substance of
problem drug use in the EU;
n there are an estimated 1m – 1.5m
problem drug users (mainly heroin) in
the EU;
n the overall prevalence of problem drug
use, particularly heroin, appears not to
have increased in most EU countries in
recent years; 
n using the mid-point of national
prevalence estimates for problem drug
use, Ireland is marginally above the EU
average;
n while the number of drug-related
deaths in Ireland is amongst the lowest
in the EU, the rate of increase is
significantly higher than in any other
EU country – though this may be
mainly due to improved recording
methods.
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3 . 1 I N T R O D U C T I O N
Evolution of Current Response
3.1.1 During the 1960s and 1970s, the use of
amphetamines and LSD appeared to be
the main drug problem in Ireland. Policy
responses included the formation of the
Garda Drug Squad, the establishment of
the National Advisory and Treatment
C e n t re for Drug Abuse and the enactment
of the Misuse of Drugs Act in 1977.
However, the early 1980s witnessed a
growth in heroin use in inner city areas
and other deprived communities in
Dublin. A number of Government
Committees were established, which
recommended the introduction of a
series of legislative provisions. In
addition, a number of educational,
structural, community and youth services
and treatment changes were re c o m m e n d e d,
including the setting up of the National
Co-ordinating Committee on Drug Abuse
in 1985 and the subsequent
strengthening of the co-operation
between the enforcement agencies, in
particular, An Garda Síochána, Customs
and Excise and the Naval Services.
Notwithstanding these developments,
however, the drug problem continued to
increase in scale and scope, especially in
deprived communities.
3.1.2 In order to ensure that services were co-
ordinated at the highest level, the
National Co-ordinating Committee was
re-constituted and strengthened in 1990
under the aegis of the Department of
Health. In response to recommendations
from the Committee and others to tackle
drug misuse and trafficking, a Strategy
was put in place based on four pillars of
supply reduction; demand reduction;
manpower training and development and
international co-operation. Measures
designed to implement the Strategy
included (i) better co-ordination between
statutory and voluntary agencies in the
provision of services; (ii) involvement by
general practitioners; (iii) increased
powers for enforcement agencies;(iv) the
development of a Drug Education 
Programme for schools and colleges; 
(v) in-service training for teachers; (vi) the
establishment of Community Drug Teams
under the auspices of the Health Boards
and (vii) the creation of links between
the educational, treatment and
community services and the prisons. 
First Ministerial Task Force Report
3.1.3 Despite these measures, by the mid
1990s, the drug problem, particularly in
Dublin, was still growing. The
Government responded to widespread
public disquiet by setting up a Ministerial
Task Force on Measures to Reduce the
Demand for Drugs in 1996, to deliver an
“integrated range of services covering
the areas of treatment, rehabilitation and
education/prevention”. 
3.1.4 The First Report of the Task Force , which
focused on heroin misuse, concluded that
social and economic disadvantage,
unemployment and poor living conditions
were predictors of drug misuse. It also
concluded that such misuse had
consequences which included a severe
localised effect, a life of crime and
associated prison records, ill-health, poor
employment prospects, deterioration in
the quality of life, low educational
attainment, high levels of family
breakdown and the prevalence of
communicable diseases. The Report
extrapolated from the treatment statistics
to establish heroin addiction trends and
suggested that there were approximately
8,000 heroin addicts in the greater Dublin
area at that time.
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3.1.5 The First Report emphasised education
and prevention as long-term solutions to
the drugs problem. The Report also
envisaged circumstances where
“everyone who so wishes should be
afforded access to treatment and
rehabilitation services”. Achieving this
would address, inter alia, the waiting lists
for methadone treatment. Critically, the
First Report proposed administrative
structures to ensure strategic delivery of
the drugs policy in a coherent,
integrated, cost effective manner in areas
of the most severe drug misuse. The
structures proposed included (i) a Cabinet
Committee to confer political leadership
on the policy and to resolve inter-
organisational barriers to effective
responses and (ii) an Inter-Departmental
Group (IDG), representing the Assistant
Secretaries at those Departments serving
on the Cabinet Committee, to address
policy issues and review progress. It also
proposed a National Drugs Strategy Team
(NDST) to (i) operate on a cross-
departmental basis and ensure effective
co-ordination, (ii) identify and consider
policy issues before referring them to the
IDG and (iii) co-operate with and oversee
the work of the Local Drugs Task Forces
(LDTFs) who w e re to co-ordinate delivery
of the pro j e c t s in the areas of highest
heroin use. 
Local Drugs Task Forces 
3.1.6 The LDTFs were set up in areas identified
as having the highest levels of drug
misuse. Originally, 12 LDTFs were
established in the Greater Dublin area:
North Inner City, South Inner City,
Ballymun, Ballyfermot, Finglas/Cabra,
Dublin 12 (Crumlin, Drimnagh, Kimmage
and Walkinstown), Dublin North East,
Canal Communities (Bluebell, Inchicore
and Rialto), Blanchardstown, Clondalkin,
Tallaght and Dun Laoghaire-Rathdown.
An LDTF was also set up in North Cork
City, where the emphasis is primarily on
prevention. Following a review of the
LDTFs in 1999, Bray was designated as a
Task Force area. 
3.1.7 The LDTFs each have a chairperson and
employ a co-ordinator who helps prepare
local action plans which include a range
of measures in relation to treatment,
rehabilitation, education, prevention and
curbing local supply. In addition, the
LDTFs provide a mechanism for the co-
ordination of services in these areas,
while at the same time allowing local
communities and voluntary organisations
to participate in the planning, design and
delivery of those services. The
Government originally allocated £10
million to support the implementation of
234 separate measures contained in the
plans. In July 1999, the Cabinet
Committee on Social Inclusion approved
further funding of £15 million per annum
to enable the LDTFs to update their drug
action plans. The focus of these plans is
on the development of community-based
initiatives to link in with and add value to
the programmes and services already
being delivered or planned by the
statutory agencies in the LDTF areas.
Currently, the LDTFs are updating their
plans for the next three years. A sum of
£122 million has been provided in the
National Development Plan to support
the work of the LDTFs up to 2006.
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Second Ministerial Task Force Report
3.1.8 In 1997, the Second Report of the
Ministerial Task Force commented on 
the progress made since the First Report
was published. It also focused on the
nationwide use of drugs other than
heroin, such as cannabis and ecstasy,
drug misuse in prisons and the need 
for authoratitive research to inform
the Government’s policy on drugs. 
Its recommendations included:
n the establishment of a Youth Services
Development Fund with a contribution
from the Exchequer of £20m, to
develop youth services in disadvantaged
areas, where a significant drug
problem exists or has the potential 
to develop;
n the training and employment of 
youth leaders from disadvantaged
communities under the FÁS Community
Employment Programme and other
social economy measures;
n the continued development of
education/awareness initiatives,
including the expansion of substance
misuse prevention/education
programmes in primary and second
level schools;
n the development of properly superv i s e d
treatment programmes for “low risk”
offenders who misuse drugs and are
convicted of petty crimes, as an
alternative to prison;
n the continued development of security
measures in Mountjoy to prevent the
smuggling of drugs into the prison;
n the establishment of an Advisory Body
to conduct research into the causes,
effects, trends etc. of drug misuse 
and to evaluate the effectiveness of
different models of treatment; and
n the establishment of an independent
Expert Group – containing
international expertise – to assess how
treatment services inside and outside
prison interact and to make
recommendations for the improved co-
ordination/integration of those services
for drug misusers coming into contact
with the criminal justice system.
Minister of State
3.1.9 In 1997, the Government appointed a
Minister of State for Local Development
at the newly created Department of
Tourism, Sport and Recreation, with
special responsibility for co-ordination 
of the National Drugs Strategy.
3
Evaluation of the LDTFs
3 . 1 . 1 0 An external evaluation of the LDTF
Initiative was completed in June, 1998 by
PA Consulting. The consultants
recognised that, given the need for an
urgent response to the drugs problem,
there had been considerable “learning on
the job” with some Task Forces being
overly project driven. Nevertheless, the
Task Forces had provided local
communities with a focus for their efforts
and had improved inter-agency working
relationships as well as those between
agencies and local communities.
Notwithstanding these positive
developments, PA Consulting took the
view that there was a need for some
Departments and agencies to show a
stronger commitment and to make a
more effective contribution to the
initiative. It was also felt that the
effectiveness of representation at local
level could be improved. Specific
recommendations included:
n the continuation of the LDTFs for two
further years with updated plans;
n a greater level of guidance for LDTFs,
particularly for planning and
evaluation; and
n a clear project-monitoring and
evaluation framework.
In response, the NDST established
working groups to examine Task Force
aims and objectives, roles and
responsibilities, the preparation of new
plans and monitoring. This led to the
publication of a handbook, Local Drugs
Task Forces, A Local Response to the Drug
Problem, in 2000. The handbook
specifically addresses many of the
operational recommendations arising in
the PA Consulting Report and provides
guidelines which are being overseen by
the NDST, in co-operation with a 
facilitator dedicated to work with the
Task Forces. Arising from a review of the
membership of the LDTFs, local elected
representatives were invited to
participate in their work. Other key
recommendations, such as the
formalisation of links between the Task
Forces and Local Area Partnerships and
the roles of the Departments of
Education and Science and Social,
Community and Family Affairs are the
subject of on-going negotiations.
Young People's Facilities and
S e rvices Fund
3 . 1 . 1 1 The Young People’s Facilities and Services
Fund (YPFSF) was established in 1998 to
support the development of youth
facilities, including sport and recreational
facilities, and services in disadvantaged
areas where a significant drug problem
exists or has the potential to develop.
The overall aim of the Fund is to attract
young people in disadvantaged areas – at
risk of becoming involved in problem
drug use – into more healthy and
productive pursuits. The target group for
the Fund is youth aged 10 to 21 years
who traditionally have found themselves
outside the scope of mainstream youth
activities because of their family
background, their involvement in crime
or drug misuse or their lack of education. 
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Four Pillars of the 
G o v e rnment's Response
3 . 1 . 1 3 The main elements of the Government's
response to the drug problem have
continued to evolve, over the past three
years, around four distinct but inter -
linked pillars which, in the process, have
been refined into: 
n supply reduction;
n prevention (including education and
awareness); 
n treatment (including rehabilitation and
risk reduction); and
n research 
Furthermore, the pillars are now
underpinned by improved inter-agency
co-operation and co-ordination. The
location of principal responsibility for
each of these areas lies amongst the
State agencies, as outlined in Table 3.1.
The Department of Tourism, Sport
and Recreation is responsible for the
overall co-ordination of the National
Drugs Strategy.
Table 3.1
3 . 1 . 1 4 There is, of course, a necessary sharing of
responsibility. For example, An Garda
Síochána have an important role in
primary prevention and the Prisons
Service in rehabilitation, in addition to
their more high profile roles in supply
control. The allocation of responsibility
across functional categories is made more
diffuse and, arguably more effective, by
the role in Ireland and elsewhere, of the
community and voluntary sectors across
the four pillars of the drug strategy.
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P i l l a r Lead Depart m e n t / A g e n c y Other Key Actors
Supply Reduction Dept. of Justice, Dept. of the Enviro n m e n t
Equality & Law Reform & Local Govern m e n t
An Garda Síochána Local Authorities
Customs & Excise Service in the Community & Vo l u n t a ry
O ffice of the Revenue Commissioners S e c t o r s
Prisons Serv i c e
Naval Serv i c e
P revention Dept. of Education & Science An Garda Síochána 
Dept. of Health & Children Community & Vo l u n t a ry
Regional Health Board s S e c t o r s
Treatment Dept. of Health and Children Prisons Serv i c e
Regional Health Board s P robation & We l f a re Serv i c e
F Á S Community & Vo l u n t a ry
S e c t o r s
R e s e a rch Health Research Board
National Advisory Committee on Dru g s
3 . 2 S U P P LY R E D U C T I O N P I L L A R
D e p a rtment of Justice, Equality and
Law Reform
3.2.1 The main focus of supply reduction strategy
over the past five years has been on:
n updating legislation to reflect the
modern reality of drug trafficking; 
n greater specialisation by enforcement
agencies; and 
n a new emphasis on co-ordination and
co-operation amongst the main
enforcement agencies. 
The Department of Justice, Equality and
Law Reform has administrative
responsibility for the Courts, Prisons and
Probation and Welfare Services and for
An Garda Síochána and also has
responsibility for policy on the reduction
of the supply of drugs. In recent years,
several legislative and criminal justice
measures have been put in place, under
the aegis of the Department, to inhibit
the supply of drugs, as summarised in
Table 3.2 below.
Table 3.2 – Legislative and Criminal 
Justice Measures
A c t E n f o rc e m e n t Ye a r
Criminal Justice Act S e i z u re & confiscation of assets derived 1 9 9 4
f rom the proceeds of drug traff i c k i n g
Money laundering
I n t e rnational mutual assistance
in criminal matters
Criminal Justice Detention of persons suspected of 1 9 9 6
( D rug Tr a fficking) Act d rug trafficking for up to 7 days
Criminal Assets The establishment of the 1 9 9 6
B u reau Act Criminal Assets Bure a u
P roceeds of Crime Act The freezing and forf e i t u re 1 9 9 6
of the proceeds of crime
D i s c l o s u re of Cert a i n Exchange of information between 1 9 9 6
I n f o rmation for Taxation the Revenue Commissioners & the Gard a í
& Other Purposes Act
Bail Act Allows for the refusal of bail to a person 1 9 9 7
who has been charged with a “serious offence” 
Criminal Justice M a n d a t o ry minimum 10 year sentences for 1 9 9 9
( D rug Tr a fficking) Act d rug traff i c k i n g
3
An Garda Síochána
3.2.2 An Garda Síochána are responsible for
the enforcement of drug laws and are an
important component of the national
drugs strategy. A number of specialist
Garda Units have been created with the
objective of putting greater focus on
certain key tasks in stemming the supply
of illicit drugs and building up expertise
in these areas. In addition, their Policing
Plan 2000 sets requirements for each
Garda District and Sub-District to
establish its own Drug Policing Plan,
which would include multi-agency
participation in targeting drug dealing at
local level. 
3.2.3 The Criminal Assets Bureau (CAB) was set
up in 1996 specifically as a cross-agency
response, including An Garda Síochána,
the Revenue Commissioners and the
Department of Social, Community and
Family Affairs, to target the proceeds of
crime, in particular, drug trafficking. The
success of the Bureau is recognised both
nationally and internationally. The Garda
National Drugs Unit was established in
1995 with specific responsibility for
targeting national and international drug
trafficking. The National Crime Council 
Table 3.3 – Initiatives of An Garda Síochána
has also been established to inform
public policy on crime, including drug-
related crime and drug prevention. In
addition, Community Policing Fora (CPF)
have been introduced on foot of co-
operation between the Gardaí and the
LDTFs in order to deal with the drug
problem at a local level. At present, CPF
operate in some of the LDTF areas on a
pilot basis. Once evaluated, it is the
intention that best practice will be
identified for the future development of
CPF in other LDTF areas on a needs basis.
3.2.4 As well as the CAB and the Garda
National Drugs Unit, other specialist
Garda units include the Garda Bureau of
Fraud Investigation, the National Bureau
of Criminal Investigation and the local
Garda Drugs Units. Moreover, various
initiatives have been, or are being, taken
to target drug-related crimes, such as
those described in Table 3.3 below.
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O p e r a t i o n D e s c r i p t i o n
D ó c h a s Focused patrolling in areas where drug dealing is pre v a l e n t
C l e a n s t re e t U n d e rcover Gardaí targeting suspected dealers in are a s
w h e re drugs are known to be available
M a i n s t re e t Ta rgets drug dealing and use in and around the O’Connell Street are a
N i g h t c a p Ta rgets venues such as nightclubs where drugs are being sold
Customs and Excise Serv i c e
3.2.3 The Customs and Excise Service in the
Office of the Revenue Commissioners has
primary responsibility for the prevention,
detection, interception and seizure of
controlled drugs, which are smuggled
either at importation or exportation. A
Memorandum of Understanding
concerning the relationship between the
Customs and Excise Service and An Garda
Síochána, with respect to drugs law
enforcement, was endorsed jointly by the
Ministers of Finance and Justice in 1996.
Other initiatives to combat the supply of
drugs have included agreements with
trade associations and individual
companies in the matter of detection of
illegal drug smuggling and the Customs
Drugs Watch Programme which enlists
the help of coastal communities and
maritime personnel (fishermen and
pleasure craft owners) in reporting
suspicious activities.
3.2.4 Following the agreement of the
Memorandum of Understanding between
the Customs and Excise Service and the
Gardaí, a number of operational and
liaison structures have been developed.
These include:
n a joint task force comprising Customs,
Garda and the Naval Services; 
n personnel exchange between the
respective organisations at Head Office
level; 
n liaison between nominated Customs
and Garda officers at local level; and 
n an ad-hoc group, comprising a Deputy
Commissioner of An Garda Síochána,
the Assistant Secretary of the Revenue
Commissioners with responsibility for
Customs and the Flag Officer of the
Naval Service. 
The Customs and Excise Service is also
represented on the Multi-disciplinary
Group on Organised Crime which was
established at national level in 1997. This
Group feeds into a similar structure at
European level which co-ordinates the
fight against organised crime. In
addition, there is on-going liaison with
the Garda National Drugs Unit and the
CAB. In response to the challenge
presented by the EU Single Market, the
Customs National Drugs Team was set up
by the Revenue Commissioners and
targets the illegal importation of drugs
into Ireland.
3.2.5 At international level, the Customs
Services in all EU Member States are
linked electronically to facilitate quick
and effective exchanges of information
on the suspicious movement of people
and goods. In addition, a Customs and
Fiscal Attaché has been assigned to the
Irish Embassy in London with particular
responsibility for liaising with the UK
intelligence services and the Drugs
Liaison Officer Network. Appointments
are also being made to Europol in The
Hague.
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Prisons Serv i c e
3.2.6 The Prisons Service has responsibility for
the provision and maintenance of a
secure, efficient and progressive system
of containment and rehabilitation for
offenders committed to custody. This role
is undertaken in a co-operative and co-
ordinated way with prisoners, their
families, the community, other
Government Departments and statutory
agencies. However, serious capacity
problems have, in the past, led to
overcrowding, particularly in Mountjoy
prison, which was, until recently, the
main committal prison in the State. This
severely undermined the development of
prison-based treatment services in the
past. However, the current prison
building programme will alleviate this
situation and will, accordingly, facilitate
the on-going development of these
services. In the past year, two new prisons
have come on stream, Cloverhill Prison in
Clondalkin and the Midlands Prison in
Portlaoise. In addition, extensive
redevelopment work is planned for Cork,
Limerick and Mountjoy prisons. In this
regard, approx. 1,000 extra prison places
have been provided and 1,000 more are
planned. 
D e p a rtment of the Enviro n m e n t
and Local Govern m e n t
3.2.7 Under the 1997 Housing Act, the
Department of the Environment and
Local Government provides financial
support to local authorities for housing
management activities and other
initiatives, on local authority estates,
which are associated with problems of
drug-related crime and anti-social
behaviour.
3 . 3 P R E V E N T I O N P I L L A R
3.3.1 There are a number of Government
Departments and Agencies involved in a
range of education, prevention and
awareness measures which aim to reduce
demand for drugs in Irish society.
D e p a rtment of Education & Science
3.3.2 The Department of Education and
Science has a number of initiatives to
combat drugs, all of which are closely
linked with the package of measures it
has to combat educational disadvantage
e.g. early intervention with pupils at risk
under programmes such as the
Disadvantaged Area Scheme, the Stay in
School Retention Initiative and the
Home-School Liaison Scheme. The
Department operates two initiatives in
the context of preventative actions – the
Substance Misuse Prevention Programme
(SMPP), “Walk Tall", for primary schools
and the Substance Abuse Prevention
Project (SAPP), “On My Own Two Feet",
aimed at second level school pupils. The
Department is also co-operating with the
Department of Health and Children in
delivering health promotion programmes
in primary and second level schools. As
part of its effort to increase awareness
amongst young people of drugs and
drug-related issues, the Department
works closely with FÁS on joint-funded
initiatives such as Youthreach and in the
running of workshops aimed at
increasing drug awareness in areas wher e
acute drug problems are apparent. 
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3.3.3 The “Walk Tall” Programme – which was
launched in 1996 – has three main aspects:
n a substance misuse awareness
programme for students, parents and
teachers;
n the development of education resource
materials and in-service training for
teachers; and 
n targeting schools where there is a
noticeable incidence of substance
abuse, particularly heroin. 
The main aims of the Programme are to
give students the confidence, skills and
knowledge to make healthy choices, to
seek to avert or delay experimentation
and to reduce the demand for legal and
illegal drugs. The Programme has
established links with the Gardaí, Health
Boards, LDTFs, parents groups and
education centres. Approximately 2,400
schools have participated in the day
seminars of the “Walk Tall” Programme
to date. 
3.3.4 The post-primary programme, “On My
Own Two Feet”, was developed in co-
operation with the Department of Health
and Children and the Mater Dei
Counselling Centre and was introduced in
1995. The Programme consists of a
number of resource materials and in-
service training and the approach taken is
to enable post-primary pupils to take
control over their own health and
welfare. The introduction of the new
Social, Personal and Health Education
(SPHE) Programme in second level
schools, from September 2000, will
ensure that Substance Misuse Prevention,
which is a part of SPHE, will become an
integral part of the school curriculum for
junior cycle students. 
D e p a rtment of Health and Childre n
3.3.5 The Department of Health and Children
also places considerable emphasis on the
need for education and prevention. The
National Health Promotion Strategy,
approved by the Government in 2000, has
a strategic aim “to endeavour to reduce
the numbers engaging in drug misuse”.
The Health Promotion Unit (HPU)
promotes a multi-faceted approach to
drug awareness, education and
prevention. A range of activities are
supported, for example:
n the “Substance Abuse Prevention
Programme (SAPP)”; 
n life-skills programmes; 
n award programmes for schools; 
n initiatives in the youth service; 
n the dissemination of resource material;
and 
n local campaigns in ERHA areas.
3.3.6 The HPU also formulates preventative
policies. However, the implementation of
these policies on the ground is very much
a matter for the regional Health Boards,
as the Department’s role – at the policy
level – has been to monitor and oversee
implementation and to provide resources.
The Department situates its policy
responses in the context of UN efforts to
combat drugs through establishing
targets to be achieved by 2008.
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An Garda Síochána
3.3.7 The Gardaí also have a role under this
pillar. High priority has been accorded to
engaging with young people involved, or
at risk of becoming involved in drugs and
crime. The Garda Youth Diversionary
Projects are operated by multi-agency
Management/Advisory Committees,
which encompass the Gardaí, Probation
and Welfare Service personnel, youth
organisations, local clergy and
representatives of local statutory and
community and voluntary groups. As of
April 2001, there are 51 projects in
operation. The concept of introducing a
specific drug prevention element to these
projects is currently under review. Other
community based Garda initiatives
include the Drug Awareness Programme
for communities; Garda Schools
Programmes; Garda Mobile Anti-Drugs
Unit and the Juvenile Diversion
Programme. Moreover, Garda Juvenile
Liaison Officers also serve throughout the
country.
Young People's Facilities and
S e rvices Fund
3.3.8 In 1998, the YPFSF was set up to develop
youth facilities, including sport and
recreational facilities, and services in
disadvantaged areas where a significant
drug problem exists or has the potential
to develop. The primary focus of the
Fund is on LDTF areas and selected urban
areas (i.e. Galway, Limerick, South Cork
City, Waterford and Carlow) where a
serious drug problem exists or has the
potential to develop. A sum of £102
million has been provided under the
National Development Plan (2000 – 2006)
to support measures under the Fund, of
which approx. £46 million has been
allocated to date in the first round of
funding. 
3.3.9 In establishing the Fund, the Cabinet
Committee set up a National Assessment
Committee to (i) prepare guidelines for
the development of integrated plans in
the target areas, which meet the overall
aims and objectives of the Fund; (ii)
facilitate the establishment of the local
structures charged with developing plans;
(iii) assess the plans emanating from each
of the target areas and (iv) make
recommendations on funding to the
Cabinet Committee on Social Inclusion.
The National Assessment Committee is
responsible for monitoring on-going
progress in implementing the plans and
strategies approved and addressing any
difficulties or issues arising. It is also
overseeing an external evaluation of the
Fund, in conjunction with the
Department of Education and Science,
which will provide a comprehensive and
independent assessment of the Fund,
taking account of its overall aims and
objectives. The evaluation of the Fund
commenced in April 2001.
Local Drugs Task Forc e s
3 . 3 . 1 0 The LDTFs, in the context of implementing
their Action Plans, are delivering a range
of measures in the education, prevention
and awareness areas. Initiatives include
community-based drug awareness
programmes in schools, youth clubs and
other places where young people
congregate; drug awareness programmes
for parents, teachers etc; peer education
programmes and projects to prevent
early school-leaving. 
3
3 . 4 T R E AT M E N T P I L L A R
D e p a rtment of Health and Childre n
3.4.1 The Department of Health and Children
has overall policy and legislative
responsibility for health, social services
and child welfare in Ireland, as well as
various responsibilities for aspects of drug
policy, principally treatment and
rehabilitation services. In developing its
policy on drug misuse, the Department
has adopted a health promotion
approach. The Department’s national
policy on the treatment of alcohol and
drug misuse stresses the need for
community based interventions rather
than specialist in-patient approaches.
These services include family support and
community medical and social services.
3.4.2 Responsibility for the provision of
treatment and rehabilitation services for
drug misusers is vested with the ten
Regional Health Boards. The Health
Boards also provide support and training
for community groups which are involved
in dru g - related prevention or re h a b i l i t a t i o n
activities, as both the community and
voluntary sectors play a significant part in
the provision of drug related services,
especially in the LDTF areas. The Health
Boards have appointed Regional Drug
Co-ordinators and many have also
established Regional Drug Co-ordinating
Committees comprising representatives of
the relevant Health Board, An Garda
Síochána, Education Services and the
community and voluntary sectors. There
is regular contact between the NDST and
the Regional Drug Co-ordinators. 
3.4.3 Growth in drug-related problems
throughout the country has resulted in
the need for many of the Health Boards
to formulate a specific drug strategy for
their region. This is especially the case in
the area of development of services,
which are local and tailored to the needs
of particular communities. The majority
of these strategies are being developed
at present in accordance with emerging
trends which are specific to the individual
regions. Perhaps not surprisingly, the
emphasis in many Health Boards outside
of the Eastern region has been on
education and prevention initiatives.
However, because of the nature of the
drug problem in the Eastern catchment
area, the Eastern Regional Health
Authority (ERHA) has been involved in a
significant degree of activity and
expansion of treatment services within its
area.
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The expansion of services in the
ERHA area has been a priority in order to
protect the health of misusers
themselves, to prevent the spread of
infectious diseases and to reduce the
effect of chaotic behaviour on certain
neighbourhoods.
3.4.4 Although waiting lists remain a problem
in the successful treatment and
rehabilitation of drug misusers in the
Eastern region, there has, nonetheless
been an extensive development of
treatment facilities especially in the
Greater Dublin area. For example, at the
end of 1997 there were 21 treatment
locations in the Eastern Health Board
area, while there are now 55. Due to
difficulties associated with estimation and
resistance amongst some users to
treatment, service planners do not always
have the opportunity to plan services
around accurate prevalence figures.
Nevertheless, it is envisaged that over the
next 2-3 years, supply will approach
actual demand for treatment and
rehabilitation.
3
5 2 F a rrell et al., 2000 op cit.
Prisons Serv i c e
3.4.5 In October 2000, the Government
approved in principle the implementation
of the recommendations contained in the
Report on Prison-Based Drug Treatment
Services which was produced by a
Steering Group, established by the
Director General of the Prison Service.
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These proposals will result in a major
overhaul of prison-based drug treatment
services and should make a major
contribution to breaking the cycle of
drug dependency, crime and
imprisonment which are inextricably
linked at present. Perhaps the main
conclusion of the report is that the
Prisons Service must replicate in prison,
the level of medical and other supports
available in the community for drug
dependent people, to the maximum
extent possible.
3.4.6 In addition, the report proposes a multi-
disciplinary approach to the drug
problem in prisons and the appointment
of a senior figure from the ERHA to co-
ordinate the overall treatment service in
the Dublin prisons, as well as drugs
counsellors and extra nurses,
psychologists and probation service staff.
All staff in the relevant institutions will
receive training in drugs-related issues
and refresher courses every year
thereafter. Links are also being
established with local community and
voluntary groups, through liaison
committees, to enhance the throughcare
and aftercare arrangements for prisoners
in receipt of drug treatments in custody.
Implementation of the recommendations
of the report are progressing at present. 
3.4.7 The Probation and Welfare Service,
although not a primary drug treatment
agency, co-ordinates a range of drug
treatment initiatives, in co-operation with
a number of rehabilitation agencies and
the community.
D rug Court
3.4.8 A Drug Court was established in January
2001 in the North Inner City of Dublin. It
has as its primary aim “the reduction of
crime through rehabilitation of the
o ffender but not excluding punishment
should the circumstances so warr a n t ” .
5 4
Rehabilitation and structured supervision
will be used to help participants to
escape the cycle of offending with the
ultimate objective of ending all criminal
activity. It is hoped that best practice will
be identified to allow for expansion, as
appropriate. 
F Á S
3.4.9 FÁS works closely with the voluntary,
community and state sectors on projects
aimed at prevention, treatment and
rehabilitation. Specific drug-related
programmes, operated by FÁS, include
the Special Drugs Community
Employment Programme, on which 1,000
places have been set aside for recovering
drug misusers.
55
Employment Service
Offices, which are based throughout the
country, provide trained staff to work
with stabilised drug misusers to assist
them to secure employment or further
training. Similarly, a number of
“advocates”, located in severely
disadvantaged areas, provide a
mentoring service to young people
experiencing drug problems. 
D e p a rtment of the Enviro n m e n t
and Local Govern m e n t
3 . 4 . 1 0 Special high support hostel accommodation
is necessary for homeless people with
drug dependence problems. Under the
Homeless Strategy, funding has been
provided by the Government for the
provision of two high support hostels in
Dublin for people with drug and alcohol
dependence problems. In view of the
number of people with such problems in
Dublin, Dublin Corporation and the ERHA
are taking the lead role in drawing up
and implementing suitable proposals.  
3
5 3 First Report of the Steering Group on Prison-Based Drug Treatment Serv i c e s, July 2000, The Prisons Serv i c e .
5 4 First Report of the Drug Court Planning Committee, Pilot Pro j e c t, August 1999, Dublin; The Stationery Off i c e .
5 5 800 places were taken up on the FÁS programme at end April 2001.
Vo l u n t a ry Drug Treatment Network
3 . 4 . 1 1 The Voluntary Drug Treatment Network 
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provides a framework for a number of
voluntary drug groups working in the
area of treatment to meet, share issues of
concern and develop more
comprehensive responses to the
prevention and treatment of problem
drug use. The Network is an umbrella
group that aims to challenge drug misuse
and related issues in a creative, caring
and motivational way. It provides a
comprehensive range of drug treatment
methods that range from harm reduction
intervention through to long-term
residential drug-free programmes. There
are two core strands to the composition
of the Network. These are localised
community-based treatment responses,
that have emerged from local residents
and individuals seeking to respond to
issues in their areas and regional
responses that provide treatment at
national and, occasionally, at EU level.
3 . 4 . 1 2 The Network has representatives on the
National Aids Strategy Committee, the
NDST and the National Advisory
Committee on Drugs (NACD). They are
also members of the Community Platform
that forms part of the Community and
Voluntary Pillar of the Social Partnership.
However, the Network itself does not
have a national remit to represent all the
voluntary drug treatment organisations
in the country. It is primarily for the
Dublin based organisations which deal
with drug misuse but some of its
members do have a national focus in
terms of treatment and training. The
Network engages with various
Government Departments and Regional
Health Boards who assist in the funding
of its services. 
3 . 5 R E S E A R C H P I L L A R
D rug Misuse Research Division of
the Health Research Board
3.5.1 As set out in Chapter 2, the Drug Misuse
Research Division (DMRD) of the Health
Research Board was established in 1989
and is responsible for operating the
National Drug Treatment Reporting
System (NDTRS) which is the main source
of information on drug misuse in Ireland.
The NDTRS is an epidemiological
database, which provides data on people
who avail of treatment services for
problem drug use, on a nationwide basis.
This provides information on the current
patterns and trends of treated drug use
and drug addiction in Ireland. Data is
provided to the NDTRS through centres
or service locations where drug misuse is
treated.
3.5.2 The Government has designated the
DMRD as the central point to which all
research data and information should be
channelled. In order to deliver on the
role assigned to it, the DMRD is
developing a National Documentation
Centre which policy-makers and other
interested parties can use to access all
relevant and up-to-date information and
research in the field of drug misuse in
Ireland and internationally. In addition to
existing data, all future research and
information will be channelled or, as
appropriate, its existence notified and
recorded in a way which facilitates ease
of retrieval by policy-makers and other
interested parties. The Documentation
Centre will build on the existing resources
of the DMRD and will capitalise on its
position as the National Focal Point for
the European Monitoring Centre for
Drugs and Drug Addiction (EMCDDA).
3
5 6 The Vo l u n t a ry Drug Treatment Network is comprised of Addiction Response Crumlin, Ana Liff e y, CASP, Coolmine Therapeutic Community, Fetterc a i rn DP,
K i l l i n a rden ARP, Mater Dei Counselling, Merchants Quay Project, Saol Womens Project, Ballymun YA P.
National Advisory Committee on
D rugs (NACD)
3.5.3 The NACD was established in July 2000 to
advise the Government in relation to the
prevalence, prevention, treatment and
consequences of problem drug use in
Ireland, based on the Committee's
analysis and interpretation of research
findings and information available to it.
The Committee is overseeing the delivery
of a three year prioritised programme of
research and evaluation on the extent,
nature, causes and effects of drug misuse
in Ireland, identifying the contribution
which can be made by all the relevant
interests. Its membership reflects
statutory, community, voluntary,
academic and research interests as well as
representation from the relevant
Government Departments. The
Committee operates under the aegis of
the Department of Tourism, Sport and
Recreation.
Health Promotion Unit (HPU) of the
D e p a rtment of Health and Childre n
3.5.4 The HPU of the Department of Health
and Children is also involved in the
publication and dissemination of
information and literature which
promotes the avoidance of drug misuse.
In this regard, the National Health
Promotion Strategy sets clear aims and
objectives to support best practice models
which promote the non-use of drugs and,
where they are used, the minimisation of
the harm done by them.
3 . 6 C O-O R D I N AT I O N A C R O S S T H E
P I L L A R S
Cabinet Committee on Social
I n c l u s i o n
3.6.1 The Cabinet Committee on Social
Inclusion gives overall political direction
to the Government's social inclusion
policies, including the national drugs
strategy. It has, inter alia, responsibility
for reviewing trends in the area of drug
misuse, assessing progress in
implementing the national drugs strategy
and resolving policy or organisational
difficulties which may inhibit effective
responses to the problem. 
D e p a rtment of Tourism, Sport and
R e c re a t i o n
3.6.2 The Department of Tourism, Sport and
Recreation is responsible for the overall
co-ordination of national policy to tackle
drug misuse with a Minister of State who
reports to the Cabinet Committee on
Social Inclusion. The Department chairs
and provides the secretariat to the IDG
and funds both the NDST and the NACD. 
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I n t e r- D e p a rtmental Group 
on Drugs (IDG)
3.6.3 The IDG oversees progress on the
implementation of the national drugs
strategy and reviews Government policy
on issues which may arise, including
submissions from the NDST and the
National Assessment Committee for the
YPFSF. It meets on a monthly basis and is
chaired, at Assistant Secretary level, by
the Department of Tourism, Sport and
Recreation which also provides the
secretariat to the Group. The following
Departments are represented, at Senior
O fficial level, on the IDG: Taoiseach; Finance;
Education & Science; Enterprise, Trade &
Employment; Environment & Local
Government; Health & Children and
Justice, Equality & Law Reform. The Chair
of the NDST is also a member of the IDG.
National Drugs Strategy 
Team (NDST)
3.6.4 The NDST, which has joint monthly
meetings with the IDG, is a cross-
departmental team comprised o f
personnel from a number of D e p a rt m e n t s
and Agencies. Members have direct
access to their respective Ministers and
the heads of the relevant Departments
on matters relating to the effective
implementation of the various pro g r a m m e s
and initiatives operating under their
aegis, particularly in so far as they relate
to the 14 LDTF areas. Their time is
divided evenly between their parent
Department/Agency and the Team. The
community and voluntary sectors each
have a representative on the NDST and,
as such, the Team is a partnership
between the statutory, community and
voluntary sectors. 
3.6.5 The NDST is chaired, at Principal Officer
level, by the Department of Health and
Children. Full-time secretarial and
administrative support for the NDST is
provided by staff seconded from the
Department of the Taoiseach and the
ERHA. The NDST ensures that there is
effective co-ordination between
Departments and Agencies, oversees the
work of the LDTFs, identifies and considers
policy issues and, through joint meetings
with the IDG, ensures that policy is
i n f o rmed by the work of and lessons fro m
the LDTFs. Each member of the NDST acts
as a liaison person for one or more LDTFs.
The NDST also meets on a regular basis
with the chairs and co-ordinators of the
LDTFs to review progress and identify
issues to be addressed. 
3
Local Drugs Task Forces (LDTFs)
3.6.6 Membership of the LDTFs include
representatives of all the relevant
agencies such as the Health Board, the
Gardaí, the Probation and Welfare
Service, the relevant Local Authority,
elected public representatives, the Youth
Service and FÁS. Moreover, LDTFs also
include representation from voluntary
agencies, community representatives, a
chairperson nominated by the local Area
Partnership and a co-ordinator provided
by the relevant Health Board. 
3 . 7 P U B L I C E X P E N D I T U R E O N T H E
C U R R E N T D R U G S S T R AT E G Y
3.7.1 The cost of drug misuse at a societal level
is extremely difficult to quantify
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as it
encompasses areas like the public health
costs of disease associated with drug
dependence, the cost of acquisitive crime
and associated losses and insurance costs
which are borne by both business and
individuals. The level of State spending
on drugs-related issues is also difficult 
to estimate and is complicated by the 
fact that expenditure is spread across 
a number of Departments, Local
Authorities, Agencies and other statutory
organisations. Even within Departments
and Agencies, it is difficult to arrive at an
accurate estimate of costs associated
specifically with drug misuse as services
such as An Garda Síochána, the Prisons,
the Courts and Probation and Welfare
Services and the various health agencies
deal with drugs issues as part of their
wider daily services.
3.7.2 Bearing these limiting factors in mind
and using the information supplied to
the Review Group, it is estimated that the
development, co-ordination and delivery
of the four pillars that make up the
current National Drugs Strategy
approximated to £144 million in 2000.
This is broken down by Departments and
Agencies in Table 3.4.
3
5 7 The EMCCDA, in consultation with the Pompidou Group, is currently re s e a rching improved mechanisms for the establishment of costs to society of drug misuse.
Table 3.4 – Direct Expenditure in 2000
* Rounded to one decimal place.
Notes: The expenditure for the
Department of Education and Science
includes the YPFSF. The expenditure for
the Department of Tourism, Sport and
Recreation is mainly for the
implementation of the LDTF action plans
and is paid through the implementing
Departments and Agencies. The
expenditure figure for the Department of
Enterprise, Trade and Employment
represents funding for the Special Drugs
Community Employment Programme run
by FÁS for recovering drug misusers.
Expenditure for the Department of
Health and Children comprises the
additional funding granted to Health
Boards from 1996 to 2000 plus the 2000
funding allocated (from other sources as
well as the Department of Health and
Children) to the DMRD. 
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D e p a rt m e n t / A g e n c y E x p e n d i t u re £
Dept. of Justice, Equality & Law Reform 9 7 . 0 m l
Dept. of Health & Childre n 2 5 . 2 m l
Dept. of Enterprise, Trade & Employment 4 . 7 m l
Dept. of Education & Science 5 . 9 m l
Dept. of Tourism, Sport & Recre a t i o n 9 . 1 m l
Revenue Commissioners (Customs and Excise) 1 . 5 m l
State Laboratory 0 . 4 m l
T O TA L 1 4 3 . 8 m l


4 . 1 T H E I N T E R N AT I O N A L T R A D E
I N D R U G S
4.1.1 Drugs are an international problem and
the trade in drugs is worth many billions
of pounds annually. A 1997 report by the
United Nations Drug Control Programme
(UNDCP) estimated that the trade in
drugs amounted to 8% of total
international trade, that is roughly the
same as textiles, oil, gas or world tourism.
There is a marked difference between the
price of drugs sold in Ireland, in the
source country and while in transit. Prices
can vary for a number of reasons, e.g.
size of the crop, number of seizures,
demand etc. but as an example, a kilo of
heroin is sold in Afghanistan for IR£1,000,
in Turkey for IR£8,750, in the Netherlands
for IR£19,000 and in Ireland for
IR£80,000. It can then realise up to four
times this figure on the streets,
depending on the number of exchanges
and the level of purity.
4.1.2 While narcotic crops are cultivated
worldwide and cannabis products, in
particular, are produced in a number of
regions, three areas of the world account
for the vast majority of cocaine (coca)
and heroin (opium) production. Cocaine
production is concentrated in South
America (primarily Colombia but both
Peru & Bolivia also produce significant
amounts – see figure 4.2). Heroin is
primarily produced in South West Asia
(overwhelmingly in Afghanistan) and to a
lesser degree in South East Asia (the
Golden Triangle which straddles Burma,
Laos, Thailand and Vietnam – see figure
4.1). Colombia and Mexico have also
developed significant potential heroin
production capability. By 2000, they
accounted for approx. 2.4% of 
world heroin production which is
targeted mainly at the U.S. Although
there is some limited domestic
production of cannabis and some
synthetic drugs (mainly ecstasy), Ireland is
primarily an importer of drugs and is also
sometimes used as a transit point for
other European destinations. The main
routes for these drugs into the country
are as follows:
n Heroin – Heroin mainly originates in
Asia and comes through Turkey and the
Balkans and arrives in Ireland primarily
through the UK or the Netherlands.
Amounts are generally quite small and
are for the home market. Due to the
size of the quantities, they can be
transported in a number of different
ways and can be difficult to detect.
n Cocaine – Cocaine is shipped in much
larger amounts from South America, in
many cases through the Caribbean,
arriving in Ireland in most cases
through other EU countries, in
particular the UK.  
n Cannabis – Cannabis can be produced
anywhere but the bulk of cannabis sold
in Ireland comes from North Africa,
mostly Morocco, via sea-going yachts as
well as articulated trucks using cross-
channel ferries. In general, the
shipments are quite large in size.
n Ecstasy – Ecstasy and other synthetic
drugs can also be produced anywhere
although most of the ecstasy that is
sold in Ireland is believed to be sourced
in the Netherlands and Belgium, but
increasingly drugs are being sourced
from Eastern Europe.
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Figure 4.1 – Estimated Worldwide Heroin
Production in Metric Tonnes by Country in
2000* (Total 510 Metric Tonnes)
* “Southwest Asia – Opium Cultivation and Production Estimates 2000”,
publication of the United States Office for National Drug Control Policy,
2 0 0 0 .
Figure 4.2 – Estimated World Cocaine
Production in Metric Tonnes by Country 1999
(Total 765 Metric Tonnes)*
* “Major Coca & Opium Producing Nations – Cultivation and Pro d u c t i o n
Estimates, 1995-1999”, publication of the United States Office for National
D rug Control Policy, 1999.
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4 . 2 E U R O P E A N U N I O N
4.2.1 The EU Member States have been
adopting common measures for
combating drug addiction since the mid-
1980s. In 1990, the Rome European
Council adopted the first European Plan
to Combat Drugs, which was then revised
and updated by the Edinburgh European
Council in 1992. The 1995-1999 EU Action
Plan stressed the need for a multi-
disciplinary and integrated response,
centred around demand reduction,
supply reduction, the fight against illicit
trafficking and international co-operation
and co-ordination at national and EU
level. The more recent EU Action Plan
2000 – 2004 is based upon the
conclusions of the Cardiff and Vienna
European Councils. The Strasbourg based
Council of Europe also plays a key role in
a pan-European response to the drugs
problem, particularly through the
Pompidou Group which is currently
chaired by Ireland.
4.2.2 The EU Action Plan to Combat Drugs
(2000-2004) emphasises the continuing
threat to society posed by illicit drugs.
The Plan outlines the need for a balanced
approach between demand and supply
reduction. The main aims and objectives
of the 2000-2004 Plan are:
n to ensure that the issue of the fight
against drugs is kept as a major priority
for EU internal and external action;
n to continue the EU integrated and
balanced approach to the fight against
drugs, in which supply and demand
reduction are seen as mutually
reinforcing elements;
n to ensure collection, analysis and
dissemination of objective, reliable and
comparable data on the drugs
phenomenon in the EU with the
support of European Monitoring
Committee on Drugs and Drug
Addiction (EMCDDA) and Europol;
n to promote international co-operation,
integration of drug control into EU
development co-operation and to
support the efforts of the UN and of
the United Nations Drug Control
Programme (UNCDP), in particular, to
develop international co-operation,
based on the principles adopted at
United Nations General Assembly
Special Session on Drugs (UNGASS); and
n to emphasise that, while not bidding
for new resources, the successful
implementation of the strategy and
actions mentioned in this Action Plan
will necessitate appropriate resources.
The Plan emphasises the need to evaluate
experience and identify best practice to
ensure continuity and consistency in
order to build upon the previous Action
Plan. It identifies many new challenges
and re-affirms the Union’s commitments
to the relevant UN Conventions.
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Furthermore, it sets targets under its six
key headings: co-ordination; information
and evaluation; reduction of demand;
prevention of drug misuse and of drug-
related crime; supply reduction and
international co-operation. 
4
5 8 The 1961 Single Convention of Narcotic Drugs, the 1971 Convention on Psychotropic Substances and the 1988 Convention against Tr a ffic in Narcotic Drugs and
P s y c h o t ropic Substances. Under these Conventions, the parties are obliged to apply specified measures to substances listed in the Conventions and to any
substance subsequently brought within the scope of the Convention by the United Nations Commission on Narcotic Dru g s .
4.2.3 The following are key features of the EU
Action Plan:
n it provides for the European
Commission to organise appropriate
evaluations at mid-term and on
completion of the EU Drugs Strategy
(2000 – 2008). Each Member State will
have to account for the actions they
have taken in accordance with the
relevant sections of the Action Plan;
n including in the EU Annual Report on
Drugs an overview of measures taken
as follow-up to the Action Plan;
n completion of a study into the
definitions, penalties and practical
implementation of laws by the Courts
and law enforcement agencies for drug
trafficking within the Member States;
n completion of work on the five key
epidemiological indicators and the
development of indicators on drugs
related crime, the availability of illicit
drugs and drug-related social exclusion;
n launch of a study on attitudes to drugs
throughout the EU;
n establishment of measurable targets so
that assessments can be made on
progress in achieving objectives in the
Action Plan; and
n evaluation of the co-ordination
arrangements that are in place.
4.2.4 The EU has also prioritised the fight
against drugs in its external relations. In
this regard, it has applied two categories
of action. First, is the active support for
global policy-making, the strengthening
of strategy settings by UN institutions
and the effective functioning of informal
bodies. Second, is the need for bilateral
and regional actions in the area of trade
policy, technical assistance and political
dialogue. It is envisaged that the Union
will use the full range of measures at its
disposal in the field of external relations,
including enhancement of common
foreign and security policy. In addition,
co-operation agreements with third
countries regularly feature drugs clauses. 
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4 . 3 O V E RV I E W O F S E L E C T E D N AT I O N A L
D R U G P O L I C I E S
4.3.1 The Review Group also looked at national
drugs policies in the Netherlands,
Portugal, England, Scotland, Spain,
Sweden, Australia and Switzerland as
broadly representative of the spectrum of
recent national strategic responses. The
approach to dealing with drug misuse
across all these States shared common
twin emphases – a focus on the needs of
the drug misuser, coupled with attempts
through various enforcement measures
and agencies to cut off the supply of
drugs, with the degree of emphasis
varying according to the country’s
fundamental philosophy on tackling the
drugs issue. 
4 . 4 A U S T R A L I A
4.4.1 The Australian Drug Strategy is based on
the principle of harm reduction. Harm
includes levels of illness and disease,
criminal offences and personal and social
disruption from drug misuse. It recognises
explicitly that there is a heavy
commitment outside of the Strategy to
the treatment of disease and trauma
caused by misuse of drugs and to law
e n f o rcement to restrict the supply of dru g s .
In these circumstances, the Strategy, in its
own right, is intended to be a catalyst for
change and innovation. It supports a
diverse range of drug and alcohol services
in the areas of treatment, prevention,
supply control and education and
training. The specific initiatives embraced
by the Australian Strategy include
partnerships between various
governmental and non-governmental
agencies, media campaigns and the
production of core educational resources.
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4 . 5 T H E N E T H E R L A N D S
4.5.1 The main aim of drugs policy in the
Netherlands, as in Australia, is to reduce
the risks experienced by drug misusers,
those in their immediate environment
and Dutch society in general. For
misusers, the central goal is the
protection of their health which is
achieved through prevention and care
measures. Such measures are buttressed
by the activities of the police and other
enforcement agencies. Dutch policy is
also formulated on the premises that:
n t h e re is a distinction to be made between
“ h a rd” drug and “soft” drug misuse;
n processing of misusers through the
criminal justice system is more
damaging to the misuser than the use
of drugs; and 
n every effort should be made to inhibit
drug misusers from ending up in an
illegal environment where outreach
can be difficult.
Prevention interventions are carried out
by local or regional organisations in the
fields of education, health, drugs, youth
and social work. Information and
education campaigns can be generic or
targeted at specific high-risk groups. In
the health sector, the objective includes
the prevention through harm reduction
policies of further deterioration. The
actions designed to achieve this include
syringe exchange and methadone
maintenance programmes and the
provision of food and shelter to misusers.
4.5.2 An experiment involving the prescription
of heroin under strict medical supervision
has also been in place in the Netherlands
since 1998. It involves a group of 750
serious misusers whom it is considered
can no longer be helped by the regular
care system. The experiment involves the
comparison of two different treatments –
treatment with methadone and
treatment with methadone in
combination with heroin. The aim of the
study is to examine whether the
prescription of heroin has a beneficial
effect on the physical or mental health
and social functioning of drug misusers.
Amsterdam and Rotterdam were chosen
for the first phase of the experiment and
50 misusers in each area are being
prescribed heroin, in addition to
methadone. An evaluation of the
experiment has not yet been carried out.
4.4.3 Overall, Dutch policy attempts to provide
differentiated care which, insofar as is
possible, is attuned to the wide range of
needs of the individual drug misuser.
4
4 . 6 P O RT U G A L
4.6.1 The basic principles underpinning the
Portuguese Strategy embrace: 
n prevention to minimise demand for
drugs through appropriate education
and information programmes;
n recognition of the human dignity of
misusers and the complexity of the
issue of drug misuse;
n an openness to innovative and evidence-
based responses to the drugs pro b l e m ;
n co-ordination between various
governmental and non-governmental
agencies; and
n community mobilisation.
4.6.2 The objectives of Portuguese Strategy
include effective international co-
operation; the provision of good quality
information about drug misuse to the
Portuguese population; information on
the use of drugs by young people and
the securing of the necessary resources
for the treatment and social re-
integration of drug misusers. 
4.6.3 Portugal aims to deliver a broad range of
strategic actions, consistent with the
harm reduction policies and humanistic
philosophies adopted in other countries.
4 . 7 E N G L A N D
4.7.1 The UK Drugs Strategy “Tackling Drugs to
Build a Better Britain” was launched in
1998. Scotland, Wales and Northern
Ireland have since developed their own
drug strategies which are aligned with
and reflect the key elements of the UK
Strategy. The key aim of the 10-year
Strategy is to create a healthy and
confident society, increasingly free from
the harm caused by the misuse of drugs.
There are four main elements:
n Young People – to help young people
resist drug misuse in order to achieve
their full potential in society;
n Communities – to protect communities
from drug-related anti-social and
criminal behaviour;
n Treatment – to enable people with
drug problems to overcome them and
live healthy and crime-free lives; and
n Availability – to stifle the availability of
illegal drugs on the streets.
4.7.2 Young people: the Strategy seeks to
prepare young people both to resist
drugs and, as necessary, to handle drug-
related problems. This is achieved
through the provision of information,
skills and support especially to at risk
groups. The main mode of delivery is
through the education system starting
with the teaching of broad life-skills at
primary school.
Communities: the Strategy seeks to
protect communities from drug-related
crime and anti-social behaviour by
identifying drug misusing offenders at
key points in the criminal justice system
and encouraging them to take up
appropriate treatment or other effective
programmes of help. The evaluations of
the “Arrest Referral Scheme” and the
“Drug Treatment” and “Testing Order”
pilot schemes indicate significant
reductions in drug use and crime
committed by offenders whilst on the
schemes. These schemes are now being
rolled-out nationally.
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Treatment: the Strategy seeks to improve
the provision of drug treatment to
enable all problem drug misusers to have
proper access to support from
appropriate services, including primary
care, when needed, which will have a
positive impact on health and crime.
Availability: the Strategy seeks to stifle
the availability of illegal drugs on UK
streets by focusing on disrupting and
dismantling the trafficking groups who
are responsible for the bulk of illegal
drugs supplied to and distributed within
the UK.
4.7.4 The structures put in place to deliver the
strategy is headed by the Ministerial
Steering Group on Drug Misuse (MSGD).
The UK Anti-Drugs Co-ordinator and his
deputy, along with the UK Anti-Drugs Co-
ordination Unit (UKADCU), have a key
role in co-ordinating the Strategy and
assessing and driving forward progress
against key targets. Strategic co-
ordination of the strategy in England is
driven forward by the Strategic Planning
Board (SPB) which takes ownership of the
strategy targets, agrees business plans for
each aim of the Strategy and advises
MSGD accordingly. Drug Action Teams
(DATs) are responsible for co-ordinating
the local delivery of the drugs strategy.
Representation on DATs is from the core
agencies of education, social services,
health, police, prisons, local housing
authority and probation service.
4 . 8 S C O T L A N D
4.8.1 Four key pillars underpin the Scottish
S t r a t e g y. They are social inclusion,
partnership, co-ordinated action and
evidence-based responses and
accountability.
4.8.2 Effective drug education for all young
people lies at the heart of policy on
prevention in Scotland. The emphasis is
on health education, including drug
education, within a comprehensive
programme of personal and social
development aimed at providing young
people with the necessary knowledge
and skills to choose a healthy lifestyle.
The actions taken to reduce drugs within
communities in Scotland include (i) the
tackling of drug misuse within a wider
social programme; (ii) reducing drug-
related crime through substitute
prescribing regimes; (iii) implementing
and evaluating Drug Action Teams; (iv)
promoting initiatives to cut drug crime
through arrest referral and diversion and
(v) education programmes for parents. 
4.8.3 Treatment in Scotland is designed to
improve the general health of misusers.
Aims include stemming the spread of
infections, the induction of abstinence
through detoxification and residential
care programmes. Pharmacy needle
exchanges, together with specialist drug
service needle exchanges, have been
developed throughout Scotland and
methadone prescription is a major part of
treatment strategy.
4.8.4 The police and other enforcement
agencies accord a high priority to drug
enforcement in Scotland. The Scottish
Prisons Service has mandatory drug
testing, a feature which has led to a
substantial increase in the number of
prisoners seeking support for their drug
misuse problems.
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4 . 9 S PA I N
4.9.1 The main goals of Spanish policy on dru g s
include the prioritisation of prevention,
demand and harm reduction; the
fostering of programmes which promote
the re-integration of drug dependent
persons into Spanish society; and the
reduction of supply through concerted
action against drug trafficking, money
laundering and other related crimes.
4.92 Prevention, which is primarily aimed at
young people, is considered to be the
most important strategy for dealing with
the drug problem in Spain. Prevention is
structured around certain principles,
priorities and objectives. These principles
include (i) the co-ordination of actions by
the State agencies; (ii) the active
participation of communities and (iii) the
promotion of “education for health”,
measures aimed at preventing the spread
of disease and a reduction in illness and
associated infectious conditions. The
priorities for intervention are schools,
families, the workplace, communities and
the media. The objectives of the Spanish
Strategy buttress these priorities.
4.9.3 Harm reduction in Spain aims to reduce
the harm caused by drugs consumption as
regards the wider society as well as the
individual user’s health. Harm reduction
covers, amongst other things, syringe
exchange and methadone maintenance
programmes. Integration of drug
misusers into Spanish society operates on
the premises of equitable treatment for
users throughout the country, the co-
ordination of the actions of relevant
intervention agencies and the provision
of quality controlled, differentiated,
evidence-based and localised
programmes.
4.9.4 Another element of Spain's harm
reduction programme is the recent
provision of injecting rooms for misusers
in the Autonomous Region of Madrid.
Although not officially in accordance
with Spain's national strategy on drugs,
the injecting rooms opened in Madrid in
June 2000 and approximately 1,200
misusers availed of the service in the first
3 months.
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The Madrid region has a
population roughly the size of Ireland
and has between 14,000 – 15,000 heroin
misusers. Services are divided into two
levels of care – primary care which
includes a needle exchange programme
(2 million needles exchanged last year),
methadone maintenance (in 1999, over
8,000 drug misusers received methadone
of which over 3,500 were new to the
programme), as well as psychiatric and
emergency care. The injecting rooms are
aimed at those intravenous drug takers
who are the highest risk group, are
frequently homeless and the least likely
to come within any of the normal social
services. No evaluation of the
effectiveness of the Madrid programme
has been carried out to date.
4.9.5 The Strategy on supply control in Spain
involves co-operation with security
services across Europe including Europol,
combating the internal distribution of
drugs through the actions of specialised
investigation units and reducing street
supply and dealing.
4
5 9 Personal communication from Cabrera Form e i ro (head of the Autonomous Region of Madrid’s Anti-Drug Agency).
4 . 1 0 S W E D E N
4 . 1 0 . 1 The overriding aim of Swedish policy is a
“drug free” society. Consequently, the
problem of drug misuse is treated
primarily as a matter for the criminal
justice system as distinct from the social
services. The aim is that drugs should
never become an integral part of Swedish
society and that drug misuse should be
regarded as unacceptable behaviour and
as a marginal phenomenon. 
4 . 1 0 . 2 In Sweden, the overriding aim of the
d rugs policy crystallises into three sub-goals:
n reducing the number of new 
drug misusers;
n inducing more misusers to abstain; and
n reducing the supply of drugs.
Sweden takes the view that the essential
pre-requisite of a successful drugs policy
is for people of all ages to disassociate
themselves from drugs and drug misuse.
With this objective in mind, the main
purpose of information provision in
Sweden is to re-enforce public hostility to
drug misuse. In this context, school
programmes have a crucial role to play
and the school curriculum requires every
school to draw up a special action plan
for alcohol, narcotic drugs and tobacco
instruction. School programmes are re-
enforced by generic or targeted
information campaigns.
4 . 1 0 . 3 In Sweden, all non-medical usage of
d rugs is unacceptable. As a result, Sweden
takes a restrictive position on methadone
maintenance treatment and needle
exchange programmes. For example,
methadone maintenance is strictly
controlled under rules defined by the
National Board of Health and Welfar e
and the number of patients may not
exceed 600.
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By international standards,
however, Sweden has an unusually small
proportion of heroin misusers, as heavy
drug misuse is generally dominated by
stimulants such as amphetamines. The
2000 EMCDDA Report indicates that
Sweden has one of the lowest national
prevalence estimates for problem drug
use in the EU. More specifically, the
percentage of clients admitted for
treatment for opiate use in Sweden is
also among the lowest in the EU.
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4 . 1 0 . 4Persistent drug misusers, who are likely to
harm themselves seriously, can be
admitted into care against their wishes as
a form of compulsory restraint.
Therapeutic approaches in Sweden cover
the range of psychotherapeutic and
sociotherapeutic interventions in
residential and outpatient environments.
As Swedish drug policy is primarily
concerned with preventing the spread of
drug misuse, supply is looked upon as a
grievous offence. Over the years the list
of offences and penalties has been
expanded and augmented.
4
6 0 A Preventive Strategy – Swedish Drug Policy in the 1990’s, The Swedish National Institute for Public Health 1998:21 & Fact Sheet No.4 March 1999, Ministry of
Health and Social Affairs, Sweden.
6 1 E u ropean Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2000) Annual Report on the State of the Drug Problem in the European Union, 2000.
4 . 1 1 S W I T Z E R L A N D
4 . 1 1 . 1 Swiss drugs policy is predicated on a four
pillars model: prevention; therapy and re-
integration; harm reduction and
repression and control. Complementary
measures such as information
dissemination, research and evaluation,
epidemiology and co-ordination and co-
operation between differing agents
support these pillars. The goals of Swiss
drugs policy are:
n to decrease initial drug misuse and
avoid evolution towards addiction;
n to help misusers overcome addiction;
n to improve the living and social
conditions and health of drug misusers;
and
n to inhibit trafficking and supply.
4 . 1 1 . 2 The concept of prevention in Switzerland
is very broad and encompasses both
primary and secondary prevention. As
such, it recognises the linkages between
prevention and treatment and between
the consumption of legal and illegal
drugs and considers community
participation in prevention activities to
be vital. The Swiss framework for
prevention includes schools, local
authorities, sports facilities and
organisations and youth associations. The
exercise of prevention activities is, as a
rule, delegated to local agencies.
4 . 1 1 . 3 Swiss drug policy, in the fields of therapy
and treatment, aims to promote
abstinence where possible and to foster
the social and psychological health of
those who remain dependent. Therapies
are differentiated and attuned to
individual needs and are carried out in
residential settings, outpatient facilities
and prisons. Outpatient treatments
include methadone substitution
programmes and the prescription of
heroin under medical supervision. Harm
reduction covers activities to improve the
medical and social conditions of those
most heavily addicted. Actions taken to
uphold this aim include social support,
involving the provision of employment
and housing; health care, where needle
exchange programmes and sterile
injecting environments play a part and
prison projects.
4
4 . 1 1 . 4 In relation to heroin prescription in
Switzerland, evaluations have been
mixed. The results ascribed to this
programme include: (i) better retention
and compliance rates when compared to
injectable morphine and methadone; 
(ii) improvements in physical health; 
(iii) diminished use of illicit heroin and
cocaine; (iv) better housing and fitness
for work; (v) decline in contact with drug
misusers and the drug scene and (vi) a
decrease in income from illegal and semi
legal activities.
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A study of the Swiss
programme urged the continuation of
heroin-assisted treatment provided it was
confined to and directed at, an
appropriate target group and was
delivered in suitably equipped and
supervised outpatient clinics. 
4 . 1 1 . 5 However, the report of an external
evaluation
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on the Swiss study was more
sceptical. The Report of the External
Panel concluded that:
n it was medically feasible to provide an
intravenous heroin treatment
programme under highly controlled
conditions where the prescribed drug is
injected on site, in a manner that is
safe, clinically responsible and
acceptable to the community; and
n p a rticipants re p o rted impro v e m e n t s in
health and social functioning and a
decrease in criminal behaviour and in
reported use of illicit heroin.
Nevertheless, the External Panel felt t h e re
was a need for continued scepticism about
the specific benefits of one short acting
opioid over others and that there was a
need for further studies to establish
objectively the differences in the effect of
these different opioids. This scepticism
was predicated on the view that the
Swiss studies were not able to determine
whether improvements in health status
or social functioning in the individuals
treated were causally related to heroin
prescription per se or a result of the
impact of the overall treatment pro g r a m m e . 4
6 2 Uchtenhagen, A., et al. (1999) P rescription of Narcotics for Heroin Addicts: Main Results of the Swiss National Cohort Study.
6 3 Ali, R. et al (1999) Report of the External Panel on the Evaluation of the Swiss Scientific Studies of Medically Prescribed Narcotics to Drug Addicts, Executive
S u m m a ry, p. 1.
4 . 1 2 S U B S T I T U T I O N T R E AT M E N T S I N T H E
E U R O P E A N U N I O N
4 . 1 2 . 1 While methadone remains the dominant
treatment type in many European
countries, including Ireland, Table 4.1
indicates the range of alternative
treatment types that are now being
employed across Europe :
Table 4.1 – Substitution Treatments in the EU*
Notes: Methadone remains the dominant treatment type in most Euro p e a n
c o u n t r i e s .
( a )Dates refer to the year the political decision was taken to prescribe the
s u b s t a n c e .
( b )B u p renorphine is in the form of SubutexR and not Te m g e s i cR as this only
contains small amounts of the substance.
( c ) Trial only.
( d )Date not known.
( e )Consultant Psychiatrists who are responsible for the clinical management
of drug misuse services in the ERHA, where the majority of opiate misusers
reside, are examining the potential of alternative products for use in the
t reatment of drug misusers, bearing in mind the possible side effects of
these pro d u c t s .
•S o u rce: EMCDDA 2000 Annual Report on the State of the Drugs Pro b l e m
in the European Union.
4
Country Methadone Treatment Introduction of other 
Introduced substitution substances (a)
Belgium 1994 Occasional use of 
buprenorphine(b), dihydrocodeine
Denmark 1970 Buprenorphine (b,c) and LAAM 
(both 1998) (c)
Germany 1992 D i h y d rocodeine (1985), heroin (1999)(c),
LAAM (1999), buprenorphine (2000) (b)
Greece 1993 No other substance prescribed
Spain 1983 LAAM (1997)
France 1995 Buprenorphine (1996) (b)
Ireland 1970 No other substance prescribed (e)
Italy 1975 Buprenorphine (1999) (b,c)
Luxembourg 1989 Dihydrocodeine (1994) (c),
MephenonR (d)
Netherlands 1968 Heroin (1997) (c)
Austria 1987 Slow-release morphine (1997),
buprenorphine (1997) (b,c)
Portugal 1977 LAAM (1994) (c)
Finland 1974 Buprenorphine (1997) (b)
Sweden 1967 No other substance prescribed
UK 1968 Buprenorphine (1999) (b)
4 . 1 3 O V E R A L L C O M M E N T S
4 . 1 3 . 1 Strategies in the countries reviewed for
dealing with drugs issues fall, bro a d l y
speaking, into two camps: Firstly, those
that focus on the needs of the drug
misuser as a citizen in society with rights,
entitlements and responsibilities – the so-
called humanistic approach – and, secondly,
those that place the primar y, but not
exclusive emphasis, on the criminality
associated with drug importation,
trafficking, supply and, in certain
circumstances, use. While international
debate has, to some extent, tended to be
polarised around those respective
extremes, it would be wrong to conclude
that they are absolutes. Countries with a
humanistic perspective have vigorous
policies to combat drug supply at all
levels, while those with a more restrictive
approach have, in varying degrees,
education, prevention and treatment and
rehabilitation programmes as
components of their national policies. In
both approaches there is, therefore, a
range of interventions employed to
tackle the problem. 
4 . 1 3 . 2 One of the most controversial
interventions in the harm reduction field
that arose in the study of the strategies
reviewed was the provision of heroin
prescription and/or injecting rooms as
described in Switzerland, the Netherlands
and Spain. As outlined in this chapter, the
evaluations of these experimental
treatments have either not yet taken
place (Netherlands and Spain) or are
mixed (Switzerland) and, therefore, there
is a need for further evaluation and
continued research to establish
objectively the benefits of such
treatments. In this context, the Review
Group is also cognisant of the opposition
of the International Narcotics Control
Board (INCB) – who is responsible for
overseeing and monitoring international
policy in relation to international drug
controls – to such forms of treatment.
The INCB is responsible for overseeing
and monitoring international policy in
relation to international drug controls.
4 . 1 3 . 3 Given Ireland's international obligations
in this regard, the Review Group does not
consider that the introduction of such
forms of treatment is warranted at this
time. However, the situation should be
kept under review and the results of
research, both national and international,
should be monitored.
4
6 2 I N C BR e p o rt 1999, Pgs 26, 27 & 60.


5 . 1 I N T R O D U C T I O N
One of the most striking features of the
extensive public consultation process
carried out by the Review Group, was the
mature and deep level of understanding
of the nature of the cur rent drug
problem and the burden it places on
individuals, their families, communities
and society. However, this should not be
confused with any broader acceptance of
drug misuse. The consultation process
was, by and large, free of moral or
ethical discussions on the rights and
wrongs of drug misuse or associated
issues about freedom of choice. Both the
public fora and the submissions made by
state agencies, the voluntary and
community sectors, individuals, user
groups, families of drug misusers and
professionals working in the areas of
prevention, treatment and rehabilitation
and enforcement, made it very clear that
drug misuse is a societal ill because it
causes harm, which permeates thro u g h o u t
all levels of society. Discussions thro u g h o u t
the public consultation process were very
wide-ranging and the main issues
emerging in the context of the terms of
reference for the Review are outlined in
this Chapter under the headings of:
(i) supply reduction; 
(ii) prevention (including education and
awareness);
(iii) treatment (including rehabilitation, and
risk reduction); and 
(iv) co-ordination.
5 . 2 S U P P LY R E D U C T I O N
The main issues raised regarding 
supply reduction fell under the broad
headings of:
n Legislative and judicial Issues; 
n Garda Role; and
n Prisons.
Legislative and Judicial Issues
5.2.1 The vast majority of submissions were
supportive of the current legislative
framework, but there was a perceived
leniency in relation to the sentencing of
drug traffickers. In addition, it was felt
that An Garda Síochána may need to
devote additional resources to targeting
medium and larger dealers. 
5.2.2 There was strong support for the concept
of a Drug Court and for its potential
extension depending on the outcome of
the initial pilot phase. There was
commentary on community and voluntary
sector involvement in the new structures
and on the dangers of the Drug Court
being perceived as a “fast track” to
methadone treatment.
5.2.3 Throughout the consultation process,
there was consistent recognition of the
success of the CAB and a recurrent
suggestion that consideration be given to
introducing more localised CABs. It was
also suggested that assets seized by the
CAB should be dedicated to the provision
of prevention and rehabilitation
programmes in the communities in the
a reas most affected by the drugs pro b l e m .
5
5.2.4 There was a widespread feeling that
those aged under 18 should not be
prosecuted for drug possession offences,
rather they should be referred to the
relevant support agency. There were also
concerns that, at present, the sentencing
regime is inconsistent. At the opposite
end of the spectrum, there were a small
number of submissions which advocated
a “zero tolerance” approach to all drugs
and who argued that the perceived
primary focus on methadone
maintenance within current policy was an
expression of the State’s tacit acceptance
of drug misuse. 
5.2.5 Finally, a small number of submissions
debated the potential impact of
decriminalisation for possession of small
amounts of cannabis or the use of
discretion by the Gardaí in arrest
procedures. Decriminalisation of the
possession of heroin for personal use was
also mentioned as a measure that might
enable resources currently allocated to
imprisonment to be spent on treatment
and rehabilitation. There were also a
small number of submissions which
referred to heroin prescription and the
provision of heroin injecting rooms. 
An Garda Síochána
5.2.6 There was general consensus that those
involved in illicit drug dealing should be
the main focus of Gardaí activities and, in
this regard, it was suggested that known
dealers should be targeted. Furthermore,
while there was considerable support for
the Gardaí and recognition of their
successes to date in reducing the supply
of drugs, there was also concern that
drug dealing was still occurring openly on
the streets, particularly in disadvantaged
areas. The need to increase the resources
devoted to supply control was
emphasised. The success of Community
Policing Fora (CPF), where they are in
existence, was commended and there was
a strong view that this form of co-
operation should be extended. In areas
where there is an emergent drugs
problem, it was suggested that there
should be dedicated Garda Drug Units in
order to target dealers. In this context,
information sharing between the Gardaí,
Local Authorities and relevant agencies in
different areas was regarded as essential
to prevent the movement of dealers
throughout the country and the
consequent establishment of markets for
drugs previously unavailable, or not
widely used, in areas outside of Dublin.
5.2.7 The Garda Youth Diversionary Projects
were regarded as being generally
successful. The view was expressed that
these projects create positive links
between young people potentially at risk
and the Gardaí, which might eventually
facilitate a reduction in supply, crime and
misuse of drugs. The view was also
expressed that the enforcement agencies
should work more closely with local
communities on collaborative supply
control projects.
5
Prisons Serv i c e
5.2.8 The role of the Prisons Service as regards
supply control was highlighted
throughout the consultation process.
While prison clearly impacts on supply
control by providing a sanction against
drug misuse and drug dealing, it was the
perceived under-utilisation of the prison
system in the rehabilitation of drug
misusers which was the main focus of
comment. There was considerable
concern that drugs are so widely
available within prisons that some
prisoners who formerly had not used
drugs may come into contact with and
start to use drugs for the first time while
in prison. Similarly, there were concerns
that, while in prison, young offenders
come into contact with hardened drug
dealers and gain an “education” in drug-
related crime which they may use upon
release. Both of these factors were
regarded as subverting the prisons role in
supply control. 
5.2.9 There was widespread concern that the
prison system is failing to realise its
potential, not only in addressing the
needs of those who are addicted to 
drugs through the provision of suitable
treatment, but also in the provision of
the kinds of counselling, education and
training which would impact on the
offender’s behaviour after release. A
related factor was the perceived
w i d e s p read availability of drugs in prisons
and the sense that, if prisoners can
maintain drug habits while in prison, there
is neither the opportunity nor the incentive
to engage in rehabilitation programmes.
5 . 2 . 1 0 The issue of more community and
voluntary involvement in prison
structures in order to ensure that there is
a continuity of care within the community
for the offender post-release also arose.
H o w e v e r, there was also acknowledgement
of the possible operational implications
of such involvement.
5 . 3 P R E V E N T I O N
Education 
5.3.1 Consolidation of measures to counter
early school-leaving, especially in the
LDTF areas, was regarded as a priority
issue. Similarly, the need to provide pre-
school supports for children who are at
risk and who may well drop out of the
school system before they can fully
benefit from the existing programmes was
identified. The imperative to involve
parents in school drugs education
p rogrammes was also identified, not with-
standing the difficulty of engaging the
parents of children who are most at risk.
5.3.2 Overall, there was general support for
“Walk Tall” and “On My Own Two Feet”
Programmes in schools. However, there
was some concern that the material used
may need to be reviewed to ensure that
it is still culturally relevant, age
appropriate and it was suggested that
they should, perhaps, incorporate a
spiritual dimension. The need to
implement these programmes
immediately, particularly, in all schools in
the Task Force areas was highlighted in a
number of submissions, as was the need
to provide drug prevention materials for
third level students. 
5.3.3 It was suggested that the Department of
Education and Science should have a role
in drafting guidelines to assist schools in
developing a school drugs policy.
P revention 
5.3.4 There was widespread recognition of the
link between disadvantage and
problematic drug misuse and consequent
support for measures designed to counter
disadvantage. The need for these policy
measures to be targeted – in a concerted
manner – at those communities where
both disadvantage and drug misuse are
most prevalent, through mechanisms such
as the Integrated Services Process (ISP),
was also highlighted.
5
5.3.5 A recurring theme was the role of the
family in prevention. Parental attitudes
and behaviours to alcohol and drugs
were regarded as having a significant
impact on their children’s attitude to
drug taking. Indeed, there were strong
concerns expressed at many of the fora,
p a rticularly those held outside of Dublin,
in relation to the amount of alcohol
being consumed by young people and
the potential that such drinking has to
lead young people into drug misuse.
Reference was also made to the wider
difficulties experienced by parents who
may not have the necessary time to
devote to the supervision of their
c h i l d ren or who do not have the necessary
knowledge and skills to address drug-
related issues. Provision of parenting
skills, particularly for at risk families and
of drug prevention education for children
were identified as mechanisms for
overcoming these difficulties. 
5.3.6 There was significant recognition of the
role of sport and recreation in drug
prevention and there was quite
widespread support for the YPFSF. The
continued need for a wide range of
recreational activities to be made
available was highlighted. There was a
need to provide funding for activities
which will appeal particularly to young
people who would not typically become
involved in mainstream sporting
activities. Key target groups identified
included Traveller children, early school-
leavers and homeless youth.
Aw a re n e s s
5.3.7 There was strong support for a national
media awareness campaign, but a degree
of scepticism about the use of shock or
scare tactics in such campaigns. As an
alternative, the potential for using
popular culture and key media figures to
endorse an anti-drugs message was
highlighted. It was suggested that, prior
to the initiation of an advertising
campaign, young people, especially
within the communities where drug
misuse is most prevalent, should be
consulted about possible content.
Moreover, a review of the campaigns,
which have been “rolled out” in other
countries, should be conducted. The need
for corresponding ancillary campaigns –
using a variety of media and targeted at
specific groups, including existing drug
misusers and other at risk groups – was
also expressed.
5.3.8 There was a strong sense that alcohol
and drug misuse were related in Irish
society. The view was expressed that
there needs to be greater awareness,
particularly amongst parents and young
people of the association between these
types of abuse.
5.3.9 At a general level, there was support for
the generation of an easily accessible
data source of all local and national
support services available to those who
are either using or “experimenting” with
drugs. Communities which are currently
relatively unaffected should have access
to such a data source which would help
identify a drugs problem as it emerges. 
5
5 . 3 . 1 0 There was considerable concern
expressed about the way in which drugs
issues are presented in the national
media. To address this, it was suggested
that there should be a source of accurate,
unbiased information available to the
media and that there should be greater
journalistic responsibility in the reporting
of drugs issues. The stigmatisation of
drug misusers in some sections of the
national press was regarded as being
unhelpful to the goals of generating
community support for the provision of
treatment and rehabilitation services. 
5 . 3 . 1 1 It was felt that there was very limited
involvement of the corporate sector in
the consultation process. However, this
sector was identified as having a role to
play in the sponsorship of awareness
activities. There was also a suggestion
that the corporate sector may need to
become more aware of drug misuse
amongst employees and, particularly,
amongst young professionals.
5 . 4 T R E AT M E N T
The importance of treatment and
rehabilitation, including risk reduction, in
the context of a National Drugs Strategy,
was widely acknowledged in the
consultation process. 
Tre a t m e n t
5.4.1 The need for the provision of a
comprehensive range of drug treatment
options was a critical component in a
number of submissions relating to
treatment. Throughout the consultation
process, the need to expand the
treatment options available was
highlighted strongly, as was the need to
endorse holistic patient care to include a
wide range of services for the drug
misuser. The continuum of care
philosophy was identified as an
important approach, whereby drug
misusers could eventually attain a drug-
free lifestyle. Moreover, providing an
adequate treatment service to all drug
misusers, within an acceptable time
period, was a consistent demand. 
5.4.2 Where the current strategy has focused
on the development of a range of
responses to the heroin problem in the
eastern region of the country, a number
of submissions suggested that there is a
need to consolidate and further develop
treatment options aimed at a range of
addictions and types of drug misuse. The
need to expand the current response 
to include all illicit drugs, as well as
alcohol and prescribed medication,
emerged repeatedly throughout the
consultation process. 
5
5.4.3 Methadone maintenance received a
mixed response in the submissions, as
well as among the participants at the
consultation fora. Those submissions in
favour of methadone as a means of
treatment acknowledged its effectiveness
in reducing drug misuse, drug-related
disease and drug-related crime etc.
However, the need to clarify the role of
GPs in the provision of drug treatment
was highlighted, particularly as regards
the perceived slow growth in GP
involvement since the introduction of the
Methadone Treatment Protocol. Reducing
the current waiting lists to increase the
accessibility of methadone maintenance
emerged as a key issue. On the other
hand, a number of submissions were
opposed to the concept of methadone
maintenance as a means of treatment.
The point was made that methadone
maintenance was keeping misusers within
the user environment, with little focus on
attaining a drug-free lifestyle. In this
context, treatment as a medical response
and not a behavioural response, was
questioned. Broadly speaking, there was
a perception expressed at the fora that
there was a general lack of
understanding about the objectives of
methadone maintenance. 
5.4.4 Throughout the submissions, reference
was made to the Methadone Treatment
Protocol which was implemented in 1998,
as well as the need now for a protocol on
the prescription of benzodiazipienes. The
perceived emergence of poly-drug use
was a cause for concern in a number of
submissions, as was the risk of
methadone becoming a “street” drug.
5.4.5 Throughout the consultation process
there was consistent agreement about
the need for treatment services which
were aimed specifically at young people,
i.e those under 18 years. This was
considered to be an important priority
for the new Strategy. The overall
perspective envisaged a comprehensive
range of geographically accessible
treatments targeted directly at young
people. The importance of addressing the
needs of young drug misusers, in the
context of the family, was also highlighted.
R e h a b i l i t a t i o n
5.4.6 Local, community-based support systems
were identified as an integral aspect of
rehabilitation, particularly, the role of the
FÁS Community Employment Programme
for recovering drug misusers. The general
lack of residential care facilities was also
highlighted in the context of providing a
managed environment of care. The need
for increased funding for existing
facilities, as well as the provision of
additional aftercare facilities, in the form
of half-way houses was outlined in a
number of submissions. The potential to
engage Prison Officers in the delivery of
counselling and rehabilitation
programmes was identified, as was the
need to adequately resource the
Probation and Welfare Service, both
within the Prisons Service and in the
broader community.
5.4.7 The development of comprehensive
rehabilitation services within prisons was
identified in the submissions as an
opportunity that should be further
utilised in order to restore misusers to a
drug-free lifestyle. The point was made
that, in order to provide such services, 
an expansion of staff, particularly 
medical and counselling staff, was a
necessary condition. 
5
Risk Reduction 
5.4.8 The submissions and participants in the
consultation fora expressed repeated
concern about the need for harm
reduction measures in the overall
provision of drug treatment services.
Although it was acknowledged that the
spread of drug-related diseases has been
controlled somewhat in Ireland, the need
to minimise the spread of such diseases,
in particular Hepatitis C, through the
increased use of needle exchange
facilities was identified in a number of
submissions. However, the absence of a
proper national system for needle and
syringe exchange emerged as a perceived
gap in the treatment services, the overall
perception being that a properly planned
and co-ordinated needle exchange service
would have a positive effect on drug
taking practices. Concern about reducing
the proportion of injecting drug misusers
also emerged in the submissions. 
5 . 5 C O-O R D I N AT I O N
C o - o rd i n a t i o n
5.5.1 The need for greater co-ordination
within and between agencies was,
perhaps, the most common theme
throughout the consultation process.
There was a perceived lack of clarity
about the structures charged with the
delivery of national drugs policy. In this
context, there was significant support for
the need to adopt a more co-ordinated
approach at Departmental level. There
was also a recurrent suggestion that the
Department of Social, Community and
Family Affairs should be represented on
the IDG and the NDST.
5.5.2 The appropriateness of vesting
responsibility for overall co-ordination of
the National Drugs Strategy in the
Department of Tourism, Sport and
Recreation was questioned. The view was
expressed in a small number of
submissions that responsibility for the
Strategy should be vested elsewhere e.g.
the Department of the Taoiseach or the
Department of Health and Children.
5.5.3 As regards mechanisms to improve
interagency co-ordination, it was
suggested that an ISP style approach
should be used to facilitate greater co-
ordination between agencies, even
though increased co-ordination would
require additional time, training of staff
and expenditure on the necessary
information technology. There was some
concern that statutory representatives
were not receiving the necessary support
from their parent Departments or
Agencies to enable them to deal with the
additional workload required to ensure
co-ordination in the day-to-day delivery
of responses.
5
5.5.4 There was widespread support for the
role of the community and voluntary
sectors in the delivery of the current
Strategy based on experience in the LDTF
areas and for structures which harness
the activities of these sectors to national
and strategic goals. Most commentary on
the community and voluntary sectors
related to the role of these sectors in the
LDTF areas. A key concern was the need
to ensure that community and voluntary
sectors representatives on LDTFs remain
truly representative of their
constituencies. In this context, it was
suggested that community
representatives should be elected on to
Task Forces by the local community and
should serve for a defined period. The
need to establish mechanisms through
which community opinion can be
channelled on a regular basis to the
community representative was
highlighted. However, the potential
intimidation of individuals who are seen
to be involved in efforts to curtail drug
dealing was also identified.
5.5.5 During the consultation fora, there was
some discussion about the merits of the
various approaches which had been
adopted by the community and voluntary
sectors outside the Task Force areas.
Notwithstanding this, there was concern
that community and voluntary sectors
projects outside of the LDTF areas are
operating in a policy vacuum and, as
such, are responding to perceived local
needs, rather than complying with the
overall goals of a national policy. As a
result, there was some concern about
duplication of effort at local level and
some more serious anxieties about the
quality of project delivery. It was
suggested that criteria for the delivery of
treatment, rehabilitation, education and 
awareness projects be established and
that all projects – while being responsive
to local needs – should also demonstrate
compatibility with these criteria prior to
receipt of funding. There was also the
related concern that such criteria should
be developed in co-operation with the
community and voluntary sectors to
ensure that they have the necessary
flexibility to enable an appropriate
response to be delivered locally. It was
suggested that, as a quality control
mechanism, all projects should be subject
to external evaluation after a pre-
determined interval.
5.5.6 Finally, many community and voluntary
project promoters felt that they were
dedicating disproportionate resources to
researching and accessing funding
sources. It was also felt that the duration
of funding cycles should be lengthened in
order to give projects a realistic
opportunity to achieve their objectives. 
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6 . 1 I N T R O D U C T I O N
6.1.1 Following the foregoing review of
national and international drug
strategies, the Review Group has reached
a number of conclusions which are set
out in this chapter.
6.1.2 Despite on-going efforts by Governments
around the world to deal with problem
drug use, no single universally acceptable
effective response model has emerged. In
Ireland, the Government's approach to
tackling the drug problem has developed
around the four pillars of supply,
prevention (including education and
awareness), treatment (including
rehabilitation and risk reduction) and
research. This approach incorporates,
more or less, the full range of activities
which are the hallmarks of modern drugs
strategies in other jurisdictions studied by
the Group. Central to the Irish approach
has been the bringing together of key
agencies, in a planned and co-ordinated
manner, to develop a range of
appropriate responses to tackle drug
misuse, not just in relation to the supply
of drugs but also in providing treatment
and rehabilitation for those who are
addicted, as well as developing
appropriate preventative strategies. The
current strategy has been further
enhanced by the growing involvement of
the community and voluntary sectors and
by the ever increasing effectiveness of
international co-operation in areas such
as supply control and research. 
6.1.3 An important element of the overall
response has been the work carried out
by the 14 Local Drugs Task Forces in the
areas worst affected by problem drug
use. The principal strength of the Task
Forces is that they allow local community
and voluntary groups to work hand in
hand with the State agencies in
responding to the drug problem in their
areas. The Task Forces provide a range of
drug programmes and services in the
areas of treatment, rehabilitation,
awareness, prevention and education and
they are currently updating their local
action plans for the next three years. The
setting up of the Local Drugs Task Forces
has been a positive development and is
generally regarded as an effective
mechanism for tackling the drug
problem.
6.1.4 While the Review Group recognises that
much remains to be done, there are
encouraging signs of progress in recent
years, which suggests that the current
approach to tackling the drug problem is
proving to be effective. Huge strides have
been made in providing treatment for
those who are dependent on drugs. In
particular, there has been a very
significant degree of activity and
expansion in the services provided by the
ERHA over the past five years – where the
majority of heroin users reside – resulting
in “probably one of the most innovative
community drug service programmes in
Europe.”
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This has resulted in a major
expansion in the numbers on methadone
maintenance – from under 1,400 in 1995
to over 5,000 at the end of 2000. The
number of treatment locations has risen
from 21 at the end of 1997 to 55 at
present, a very significant achievement
given the strong community opposition
to the location of these centres in many
areas. There is also a relatively high level
of provision of in-patient and residential
rehabilitation services in Dublin.
6
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In addition, there have been significant
developments in the delivery of services
to drug misusers through GP and
pharmacy-based services in the past five
years. Currently, there are 216 pharmacies
and 157 GPs participating in the
methadone protocol, the highest number
since its introduction in 1998.
6.1.5 The importance of moving drug misusers
currently in treatment towards full
rehabilitation and re-integration into
society is widely recognised. In this
context, over 800 stabilised drug misusers
are currently participating in a specially
designed FÁS Community Employment
Programme which offers them
counselling, training and other necessary
supports. It is also very encouraging to
note the number of drug misusers on
methadone maintenance who are finding
employment. In 2000, a study found that
a number of clinics informally reported
that around 40% of those on methadone
programmes were returning to work. In
this context, it is worth noting that rates
of 30% are considered remarkable by
international standards.
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6.1.6 There have also been a number of other
significant achievements in recent years :
n over 120 of the original LDTF projects
have now been mainstreamed and the
Task Forces are currently updating their
plans for the next three years;
n the NACD, which was established in
July 2000, is overseeing a three year
prioritised programme of research and
evaluation on the extent, nature,
causes and effects of drug misuse in
Ireland;
n over 340 projects are being developed
as part of the YPFSF, in recognition of
the important role that diversionary
activities, such as involvement in sport
and recreation, can have on young
people at risk of drug misuse;
n a joint policy on prison-based drug
treatment services has been agreed
between the Prisons Service and the
ERHA and is being implemented at
present; and 
n a pilot Drug Court has been set up in
the North Inner City of Dublin which
will provide opportunities to divert
people away from the criminal justice
system into alternative and more
effective treatment and rehabilitation
programmes. 
6.1.7 Given the complex nature of drug misuse,
the Review Group recognises that it will
take time for many of these measures to
make a significant impact on the
problem. However, the Review Group
believes that the present approach
provides a solid foundation from which
all those involved in trying to tackle the
problem should work for the future. The
new Strategy should, therefore, endorse
the existing approach and should expand
and strengthen the pillars and principles
which underpin it.
6
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6.1.8 The Group believes that the current
Drugs Strategy would be further
strengthened if all the State Agencies
involved in its delivery specify annual
targets in terms of outputs and desired
outcomes for their respective
programmes and initiatives. This should
be agreed with the IDG, in consultation
with the NDST, and used as a benchmark
for performance review on an annual
basis by the Cabinet Committee on Social
Inclusion. Such a development would
sharpen the focus of the Strategy and
bring further clarity to its aims and
objectives for service providers, drug
misusers and the public at large. 
6.1.9 The Group welcomes the Government's
positioning of the National Drugs
Strategy within the wider social inclusion
policy and the strong commitment to
areas of disadvantage in the National
Development Plan 2000-2006. The Group
fully recognises that, notwithstanding the
obvious benefits for communities
affected by the drugs problem of having
a specific drugs strategy, the best
prospects for these communities, in the
longer term, rest with a social inclusion
strategy which delivers much improved
living standards to areas of disadvantage
throughout the country.
6 . 1 . 1 0 Set out below are the Group's conclusions
from its review of the individual pillars
that constitute the current strategy. Out
of these conclusions, the Group have
developed 100 individual actions which
are designed to build on the existing
approach and drive the new strategy
forward.
6 . 2 S U P P LY
6.2.1 Law enforcement and interdiction are
crucial elements of the national drugs
strategy. The Review Group considers
that law enforcement resources should
continue to be targeted at disrupting the
activities of organised crime groups as
there is ample evidence that the same
organisational networks involved in drug
trafficking also engage in other forms of
illegal activity. Consequently,
interventions that reduce several forms of
crime are more likely to be cost-effective.
6.2.2 The Review Group found that
international co-operation in measures to
reduce supply is important particularly
for the following reasons: 
n as drug dealers are increasingly mobile
and drug dealing takes place within an
international context, co-operative
efforts are critical to the effective
detection and prosecution of major
dealers;
n it reflects society’s interest in curtailing
drug misuse within national boundaries
and also signifies a willingness to assist
other countries in their efforts to
reduce supply; and 
n parties to international agreements can
benefit from working with each other
to control supply.
6.2.3 Ultimately, individuals involved in the
trafficking of illegal drugs should be
aware that there are effective national
and international sanctions against such
action and that the Irish enforcement
agencies have both the full support of
their international partners and the
appropriate resources to detect and
prosecute drug traffickers. Ireland should
continue to work proactively towards the
consolidation and enrichment of existing
international co-operation mechanisms,
with particular emphasis on co-operative
actions with Ireland's EU partners, in
particular through the new European
Crime Prevention Network. 
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6.2.4 As regards legal issues, the Review Group
noted that substantial progress has been
made in recent years in terms of
legislation dealing with drug-related
crime. In fact, the success of the Criminal
Assets Bureau (CAB), in tackling the twin
menaces of drugs and organised crime,
has been recognised at a national and
international level and this was
highlighted repeatedly through the
public consultation process. That said, the
point was made consistently during the
course of the review that no matter how
good the legislation, it must continue to
be implemented if it is to be effective.
6.2.5 A principal role of the law enforcement
agencies is to dissipate the influence of
criminal groups. The Review Group
considers that community oriented
policing strategies can play a vital role in
this regard. The criminal justice system
contributes to a reduction of crime, not
only by reactive policies of detection and
punishment of offenders, but also by
preventative policing policies in
partnership with community groups. The
Review Group also noted that local
information is an essential component of
the drug control activities conducted by
the enforcement agencies. The
strengthening of relationships between
the community and law enforcement
agencies and the development of
mechanisms for sharing information are
core elements of supply reduction. Over
recent years, successive Garda operations,
as well as the development of
programmes of estate management, have
inhibited open drug-dealing. The Review
Group concluded that these
developments must be sustained and safe
mechanisms for individuals and
communities to actively co-operate with
the enforcement agencies must be
developed in order to reduce supply
radically. Individuals, families,
communities and a range of statutory
and non-statutory agencies each have a
role in curtailing the amount of illicit
drugs in circulation.
6.2.6 The Prisons Service is another critical
element of the supply reduction “pillar”.
The threat of imprisonment is both a
sanction against and a punishment for,
involvement in supply activity. The
imprisonment of drug dealers is critical to
the disruption and eventual destruction
of established drug markets. Prison can
also play an important role in the
rehabilitation of offenders, however, the
Irish Prisons Service has suffered capacity
constraints which have inhibited the
development of an integrated drugs
policy within the Service. This is being
addressed by the Department of Justice,
Equality and Law Reform, which in
addition to the 1,000 additional places
provided in recent years has plans for
1,000 more. 
6.2.7 The Review Group welcomes the Report
of the Steering Group for Prison-Based
Drug Treatment Services, which has been
approved in principle by Government and
is now being implemented. Prisons
should aim to equip prisoners with the
necessary social and vocational skills to
reject drug dealing post-release. Clearly,
the success of such initiatives is
contingent on the provision of ancillary
supports in the form of housing, social
welfare supports and employment
opportunities when the offender returns
to his or her community. In addition, the
Group welcomes the involvement of the
community and voluntary sectors in
liaison meetings with the Prisons Service
and feel that this role should be
expanded. 
6.2.8 In common with all elements of the
National Drugs Strategy, the activities
under the supply reduction pillar should
be subject to regular evaluation.
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6 . 3 P R E V E N T I O N
6.3.1 Reducing the demand for drugs is central
to Irish drugs policy and it is clear that
such demand reduction activities must be
continued and reinforced. In this regard,
most recent literature points to the need
for comprehensive demand reduction
strategies which include programmes
that:
n seek to strengthen resilience amongst
young people in or out of school by
fostering positive stable relationships
with family or key community figures
especially in the early years, thereby,
enhancing their sense of belonging to
family or social group or locality and
i n c reasing their educational and training
o p p o rtunities and employment pro s p e c t s ;
n are cognisant of the complexity of
youth culture and which can effectively
influence young people’s choices in
relation to drug misuse;
n seek to increase the community’s
understanding of the antecedents of
drug misuse and effective interventions
to reduce harm;
n link drug-specific interventions with
interventions in related areas such as
youth crime prevention and mental
health promotion strategies,
employment, education and training
initiatives; and
n maximise the effectiveness of school-
based programmes through efforts to
keep young people engaged in school
and the identification and provision of
s u p p o rts for at-risk children, management
of drug-related incidents and a broad-
based curriculum which supports all
aspects of the child’s development.
6.3.2 A considerable component of Irish drug
policy has evolved as a direct response to
the on-going heroin problem. The
opportunity afforded by the Task Force
process to address this problem has
facilitated the implementation of a more
proactive Strategy, of which prevention is
a key component. That said, there is 
considerable debate on the efficacy of
different preventative approaches and,
undoubtedly, current responses will need
to be augmented as a greater
understanding of the circumstances in
which people become involved in drug
misuse emerges, particularly the strong
correlation between early school leaving
and drug misuse.
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6.3.3 As well as effective drug specific
prevention strategies, tackling poverty,
better housing, access to educational
opportunities, supportive environments
for parents and employment prospects,
all have a role to play in prevention and
management of drug misuse and drug-
related harm. In this regard, the efficient
and effective implementation of the
YPFSF and other targeted local
development initiatives will be critical to
the future success of the National Drugs
Strategy. There is a need to develop an
inclusive approach which aims to ensure
that young people are afforded
opportunities for well-structured leisure
activities and that these activities have
good levels of appropriate adult
supervision included within them. 
6.3.4 As regards awareness, while the Review
Group's research analysis indicates that
problematic drug misuse is more closely
associated with certain groups and
communities than others, evidence of
growth in drug misuse nation-wide, in
particular amongst young people,
indicates that throughout Irish society,
children, professionals, families,
employers and a range of high-risk
groups are increasingly exposed to drug
misuse and drug-related harms. As drug
education programmes have only been
delivered in schools by the Department of
Education and Science since 1995, there
still is a large section of the population
who have never received any formal
education about drugs. 
6
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of the clients presenting for treatment left school by the time they were 16 years old. 
6.3.5 Misinformation, or a lack of information,
undermine investment in harm reduction
measures and can also contribute to the
stigmatisation of the individual drug
misuser and his or her family. It is,
therefore, imperative that Irish people
become more aware of the risks
associated with drug taking, the nature
of drug misuse and the supports and
services which must exist to minimise
harm.
6.3.6 A National Awareness Campaign to
highlight the facts about drug misuse
should be put in place, which would aim
to facilitate informed, open and
constructive discussion on approaches to
drug prevention. A multi-media approach
that will raise visibility of drug misuse
among young people and other
vulnerable groups is advocated. The
approach should take account of previous
campaigns which suggest that young
people do not respond positively to a
simplistic “Don't Take Drugs” message.
Experience in other countries would also
suggest that awareness campaigns
around drug misuse need to be sustained
over a prolonged period in order to have
the maximum impact on the target
audience. Other elements of
international campaigns have included
targeting the drugs of first use as a key
to longer-term prevention and demand
reduction strategies, information and
help for parents, teachers, sports coaches
etc. and the maintenance of a consistent
message through the co-ordination of
media efforts with other initiatives in
schools and communities.
6.3.7 While there is considerable debate
evident in the international literature
about the efficacy of school
programmes,
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there was strong support
throughout the consultation process for
the need to implement school-based
programmes as “a first line of defence”
as individuals are experimenting with and
becoming addicted to drugs at an earlier
age. Initial evaluations of such
programmes are favourable but
comprehensive longitudinal studies are
required. Notwithstanding that, it is
essential that current programmes are
supported fully and implemented
effectively in all schools. 
6.3.8 The Review Group acknowledges that
issues involved in the design of schools
drug policies are complex. On the one
hand, schools must minimise the dangers
caused to children by drug misuse and
drug misusers within schools and on the
other, neither parents nor students
should be afraid to ask schools for help in
addressing drug misuse. Nevertheless, the
Group feels that such policies should be
developed and that there should be a
range of measures available in cases
where students are misusing drugs. It is
noted that the ultimate sanction of
expulsion can have the effect of
alienating a student from mainstream
sources of help and may result in the
student becoming more involved in the
culture of drug misuse.
6.3.9 Finally, there is also a requirement to
ensure that drug education and
awareness programmes are integrated
into broader community-based
approaches and are reinforced by mass
media responses. Although not a central
part of the implementation of the
National Drugs Strategy, it is felt the
media can help foster a broader
awareness, which, in particular, can help
generate parental understanding of and
engagement with, their children about
approaches to reducing the risk of drug
involvement.
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6 . 4 T R E AT M E N T
Tre a t m e n t
6.4.1 The need to progress towards a more
fully integrated and holistic treatment
service also emerged as a critical element
of the consultation process. There are
two related components to the
attainment of this goal;
n the expansion of the range of available
treatment types; and
n the provision of additional treatment
places.
Similar to other countries, methadone is
the dominant mode of treatment as the
current strategic response developed
largely as a reaction to the heroin
problem. Moreover, links between the
treatment and criminal justice fields
(including both the courts and prisons)
are key priorities to ensure the most
effective utilisation of existing resources
and the maximum impact of treatment
on drug-related crime. 
6.4.2 The provision of a comprehensive range
of drug treatments has been a critical
component of national drug policy over
the past decade. Much of this focused on
the development of a broad range of
responses to the heroin problem in the
eastern region of the country and was
accompanied by a high commitment to
investing in treatment. By the standards
of other countries, there is a relatively
high level of provision in Ireland,
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but at
present, demand for treatment is still
outstripping supply. However, the ERHA is
confident that with 6,000 treatment
places it could manage the demands on
s e rvices and significantly reduce or eliminate
waiting lists (at the end of December
2000 there were 469 people waiting for
treatment in the Greater Dublin area). In
this regard, it should be noted that the
number of people in treatment is a
moving population. At any given time
people will be moving to different phases
of treatment and rehabilitation, some
becoming drug-free. The provision of,
say, 6,000 places will cater for a number 
of patients well in excess of that number.
For example a detoxification programme
takes around 6 weeks. Therefore 1
detoxification bed will cater for around 8
patients per year. Others can be detoxed
on methadone treatment. A proportion
of these people will continue to remain
drug-free and no longer require a place
within treatment services. Some may
relapse, however and may need to re-
enter the system. 
6.4.3 It is important that the level of GP and
pharmacy involvement in the provision of
treatment programmes is increased. By
providing a service in the community in
which the drug misuser lives, the GP and
pharmacist can aid the stabilisation and
rehabilitation of the misuser. In this
regard, pharmacists need to be more
involved in the overall treatment
programme for the recovering misuser as
they are in a unique position to identify
early on any problems the misuser is
experiencing. In addition, increased
capacity at the primary care level will
have the effect of alleviating the pressure
on the secondary care services which are
currently over-subscribed.
6.4.4 There is also a need for the continuation
of treatments which are proven to be
effective and for the broader provision of
treatment, particularly in prisons, where,
mainly due to capacity constraints, such
provision was not previously available.
There is also now a need to consolidate
and further develop treatment
approaches which recognise international
evidence-based responses to drug misuse
and drug dependency. In particular, the
provision of treatment for young people
who have begun to experiment with
drugs is a matter of urgency. There is also
a need to ensure that any further
development of services is tailored to
demand and that resources are
appropriately allocated to the most
efficient and effective of these services,
based on pre-defined performance
indicators. 
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6.4.5 When evaluated by a range of criteria,
including outcomes in health, social well-
being, economic prosperity and levels of
crime, drug treatment proves to be cost-
effective. Furthermore, experience has
shown that treatment over the longer-
term is more cost effective than
detention in prison. Accordingly, people
with drug problems should be
encouraged at every opportunity to enter
drug treatment, given the benefits that
can accrue to them as individuals, as well
as to the general community. For the
future, every effort must be made to
ensure that treatment is attractive and
accessible to all who need and can
benefit from it. More attention should
also be given to ensuring an assertive
follow-up of known users who do not
avail of treatment and to supporting the
development and operation of mutual
self-aid or self-help organisations and
services. In these circumstances, all efforts
to divert individuals from the criminal
justice system into treatment should be
explored and further developed. The
development of a Drug Court system and
the evaluation of this intervention should
provide further information on the cost
effectiveness and social impact of this
particular approach.
6.4.6 In the consultation process it was
represented that the use of methadone
may be inhibiting the use of alternative
treatment types. However, it must be
acknowledged that methadone is
internationally accepted as one of the
most beneficial substitute drugs in the
treatment of heroin addiction and is the
most evaluated type of treatment.
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As
part of an overall continuum of care for
people who are addicted to heroin,
methadone has been widely used in
Ireland and in most other countries.
However, as alternative medical and non-
medical treatment types gain ground and
as new forms of addiction emerge, there
may be a need to expand the range of
treatment types available to the drug
misuser. In this regard, the Consultant 
Psychiatrists who are responsible for the
clinical management of drug misuse
services in the ERHA area, where the
majority of opiate misusers reside, are
currently examining the potential of
alternative products for use in the
treatment of drug misusers, while also
bearing in mind the possible side effects
of these products. 
6.4.7 Throughout the consultation process, the
most commonly cited substitutes,
recommended for use as alternative
treatment options, included Lofexidine,
LAAM (L- Alpha Methadol Hydrochloride)
and buprenorphine. Lofexidine is a non-
opioid and can be used to detoxify
people who are dependent on opiates. It
may be particularly useful in treating
young people who are at an early stage
in addiction. LAAM is a substitute drug
similar to methadone in composition and
pharmacological effects. It has a much
longer duration of action than
methadone (up to 72 hours). However, it
should be noted that the European
Agency for the Evaluation of Medicinal
Products (EMEA) have expressed concerns
about possible side effects from its use
and are currently advising prescribers not
to introduce any new patients to this
therapy. Buprenorphine is a semi
synthetic opiate and is another form of
treatment for heroin and other opiate
addiction. It produces less euphoria than
heroin. As with all substitute treatments,
their applicability to the treatment of
heroin misuse in an Irish context should
be rigorously evaluated and closely
monitored. 
6.4.8 Detoxification programmes followed by
drug-free residential programmes have
been used with varying degrees of
success in the treatment of opiate and
other forms of addiction. However, to
date they have been somewhat
overshadowed by the demand-led
requirement to eliminate waiting lists for
methadone treatment. Expansion of both
types of facilities go hand in hand as 
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many residential drug-free facilities
require clients to be drug-free on
admission. The expansion of residential
provision requires a corresponding
increase in detox capacity. Delays in
accessing detox programmes impact
negatively on motivation and the drug
misuser may no longer be willing to
detoxify when a detox placement
becomes available. In this context, there
is a clear requirement for increased
provision of both residential and detox
places, although again it should be noted
that by European standards, Ireland has a
quite high level of provision. There is also
a need to incorporate innovative non-
medical approaches to the treatment of a
range of addictions
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where they are
found to be appropriate. 
6.4.9 The apparent younger age of initiation
into drug misuse and dependent drug
misuse
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has created a corresponding
need for the development of treatment
types catering specifically for the needs
of young people under 18 years of age.
Furthermore, as part of the National
Children’s Strategy “Our Children – Their
Lives”, it is proposed that specialist drug
treatment services for the under – 18s
will be expanded. Planning of such
services should be closely linked to the
national profile of drug misuse amongst
young people in order to make them
relevant to the needs of the young drug
misuser. To enable family involvement in
the treatment process, ideally, most
services should be located in the areas
where the drug misuse is occurring and is
most prevalent. 
6 . 4 . 1 0 While services for young people and
adolescents should be linked to existing
services, there are strong arguments
against services which enable close
contact between habitual and
younger/newer drug misusers. There were
also strong arguments presented in the
public consultations against the use of
methadone in the treatment of young
people. It is important to point out that 
the treatment of under – 18 years old
presents serious legal and other dilemmas
for professionals working in the area.
Family involvement is regarded as a
critical component of the treatment of
young people and, consequently,
treatment should also include family
therapy and community integration
phases. 
R e h a b i l i t a t i o n
6 . 4 . 1 1 Rehabilitation involves the provision of
the necessary supports to enable a
recovering misuser to attain an
acceptable quality of life. Given that
patterns of drug misuse and addiction are
far from homogenous, there is a need to
develop a wide variety of rehabilitation
supports, appropriate to each stage of
recovery and to the particular needs of
the client. 
6 . 4 . 1 2 To achieve successful reintegration of the
user into his or her community, it is also
essential that service providers recognise
and attempt to address community
concerns about the on-going
management of treatment centres and
that local communities accept
responsibility for ensuring that adequate
treatment facilities are provided for drug
misusers in their own locality.
6 . 4 . 1 3 The need for half-way houses for
recovering drug misusers, who are not
already being treated in the community,
was highlighted repeatedly during the
public consultations and in the
submissions to the review. An increased
rate of relapse was associated with an
immediate return to a drug-taking
environment and, in this context,
consideration should be given to
establishing a network of half-way
houses throughout the country.
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6 . 4 . 1 4 There is also a need to ensure that
recovering misusers have access to
housing, training and employment
opportunities. Drug misusers are
sometimes forced to leave the family
home, or otherwise become homeless,
through drug misuse. The effectiveness of
treatment and the goals of rehabilitation
are often undermined by the failure to
ensure that recovering misusers have
access to accommodation. It is particularly
important to ensure that the
accommodation needs of misusers
availing of residential treatment types
are met when the residential phase of
the programme is complete. There may
need to be closer liaison between
treatment providers, counsellors,
probation and welfare officers and the
relevant local authorities in this regard. 
6 . 4 . 1 5 For many drug misusers, the return to
employment is a critical stage in the
rehabilitation process. However, the
often negative stereotyping of former
drug misusers can be an impediment to
their employment. Consequently, it is
considered that FÁS should initiate
worthwhile contacts with employers on
behalf of drug misusers. Employer
organisations, trade unions and key
Government Departments and Agencies
should work in partnership to develop
mechanisms, which would increase
employment opportunities for former
misusers. 
6 . 4 . 1 6 The Labour Inclusion Programme, which
is currently being piloted in the Dublin
North East Task Force area, is designed to
assist recovering drug misusers in
obtaining and holding down
employment. The Programme is
supported by employers and trade
unions, as well as statutory, voluntary and
community organisations working in the
drugs area and provides a range of
supports to former drug misusers at a
particularly difficult stage in their
recovery. It is proposed to evaluate the
Programme and, if it is successful, to
replicate it in other areas. 
6 . 4 . 1 7 Rehabilitation may involve the
restoration of important relationships,
with family and friends or reintegration
to the work or training environment. At
an ideological level, the successful
rehabilitation of a recovering drug
misuser is also contingent on societal
attitudes towards drug misusers.
Mechanisms that work towards societal
and community acceptance of the
recovering drug misuser should be
developed.
6 . 4 . 1 8 It is difficult to quantify the level of
expansion required in current
rehabilitation provision, as much depends
on the nature of the client’s drug misuse
and individual circumstances.
Notwithstanding this, it seems likely that
investment in rehabilitation will make
existing treatment regimes more
attractive to users and will reduce
incidences of relapse.
6
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Risk Reduction
6 . 4 . 1 9 Traditionally, the dominant trend in
policy has been towards the achievement
of a reduction in drug misuse and the
ultimate attainment of a drug–free
society.
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However, the recognised link
between drug misuse and the spread of
disease has resulted in the need to adopt
strategies that reduce the risks posed by
such behaviour both to the individual
misuser and the wider community. The
importance of improving existing
mechanisms to reduce drug-related harm
emerged as a distinctive theme both
throughout the consultation process and
in the review of international strategies.
In all of the countries surveyed, harm
reduction is a considerable component of
national strategies. The need to develop
and expand existing harm reduction
measures and to investigate scientifically-
based innovative responses, appropriate
to Irish circumstances and consistent with
our obligations under international
conventions while also taking account of
international best practice, is vital for the
protection of drug misusers, those they
live with and the wider community.
6 . 4 . 2 0 It is important that a significant reduction
in the reported level of injecting drug
misuse and the rates of sharing injecting
equipment is achieved. These are
essential elements of containing the
spread of HIV and Hepatitis C etc. among
injecting drug misusers and should also
contribute to a decline in the prevalence
of these diseases amongst the non-using
population. These aims would also be
consistent with the objectives set out in
the National AIDS Strategy published by
the Department of Health and Children
in June 2000. Such a reduction will be
contingent on continued efforts to
enhance harm reduction measures such
as needle exchange facilities.
6 . 5 R E S E A R C H
6.5.1 An important element of any strategy is
the knowledge upon which it is based.
The provision of good quality
information on the extent and nature of
the problem in Ireland should underpin
the National Drugs Strategy. In doing so,
it would support and inform policy-
makers and service providers in drug-
related sectors. The issue of research on
drug-related issues is one that needs to
be strengthened in terms of acquiring
comprehensive and comparable data.
Indeed, the need for improved research
in each of the main themes – supply
reduction, education, prevention and
awareness and treatment and
rehabilitation, including risk reduction –
was a persistent theme of the
consultation process. Research is essential
to enable the dissemination of models of
best practice in line with EU and
Government policy.
6.5.2 The NACD will play an important role in
this regard. The Committee's primary
function is to advise the Government in
relation to the prevalence, prevention,
treatment and consequences of 
problem drug use in Ireland, based on its
analysis of research and information
available to it.
6.5.3 The Committee is overseeing the delivery
of a three year research programme
aimed at addressing the priority
information gaps and deficiencies in the
area of drug misuse. This programme
includes compiling a comprehensive
inventory of existing research and
information relating to the prevalence,
prevention, treatment/rehabilitation and
consequences of problem drug use in
Ireland. The Committee is also looking at
how best to determine the size and
nature of the drug problem in Ireland,
the effectiveness of existing models and 
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programmes in the area of prevention,
treatment and rehabilitation and the cost
to society of the drug problem. It is
essential that the findings of the
research, commissioned by the
Committee, are disseminated widely in a
format which is accessible to all bodies
and agencies with an interest in the
drugs issue and to the wider community.
6.5.4 The National Drug Treatment Reporting
System (NDTRS), which is run by the Drug
Misuse Research Division (DMRD) of the
Health Research Board (HRB), is the key
source of information and research in
relation to drugs issues. However, to
improve the efficiency and quality of this
flow of information, there is a need for
all treatment providers to report problem
drug use to the DMRD. Within treatment
facilities, this will involve the designation
of a staff member with specific
responsibility for ensuring that all
relevant data is returned to the NDTRS.
Responsibility for NDTRS data returns
should be incorporated into the contracts
of medical practitioners working in
treatment centres, in general practices
and in prisons. 
6.5.5 There is also a need to develop an
accurate mechanism for recording the
number of drug-related deaths in Ireland.
At present, drug-related deaths are
recorded by the General Mortality
Register (GMR) of the Central Statistics
Office, based on the ICD code system.
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Other countries have developed
dedicated systems for recording drug-
related deaths and it is important, for the
purposes of comparative analysis, that
the Irish system is capable of generating
an equivalent level of information. In the
short term, however, there should be a
focus on improving the data collection
process leading up to the recording of a
drug-related death.
6 . 6 C O-O R D I N AT I O N
6.6.1 The public consultation process indicated
a lack of clarity in relation to structures
and the respective roles involved in the
development and implementation of our
national drugs policy. Chapter three of
this Report outlines the current structures
and a number of actions are
recommended, particularly in relation to
individual remits, that would provide
greater clarity across structures for service
providers and the wider public alike.
6.6.2 Some of the submissions raised, as a
matter of some concern, the location of
lead responsibility for co-ordination of
the National Drugs Strategy in the
Department of Tourism, Sport and
Recreation. The Review Group found that
in the countries surveyed, the co-
ordination of their drugs strategies fell
under the remit of either the Prime
Minister’s Department or the Department
of Health. Clearly, from a strategic
perspective, both of these Departments
in Ireland, because of either political
authority or budget size, wield
considerable influence which could be
used to further the Strategy. However, in
the case of the Department of Health
and Children – as it is a service provider –
if it were to be accorded overall
responsibility, its ability to drive issues
surrounding supply control and education
and awareness issues would be limited.
The Department of Tourism, Sport and
Recreation can, however, be objective in
relation to all the thematic areas covered
by the national policy. In addition, the
Department has overall responsibility for
local development and for co-ordination
of a number of different programmes to
promote social inclusion. Given the
correlation between drug misuse and
social exclusion, it is considered that the
Department is strategically well placed to
take the lead role in the co-ordination of
the National Drugs Strategy. On balance,
t h e re f o re, it is proposed that re s p o n s i b i l i t y
for the co-ordination of the Strategy be
retained by the Department of Tourism,
Sport and Recreation.
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6.6.3 The creation of a post of National Anti-
Drugs Co-ordinator, along the lines of the
“Drugs Tsar” in the UK and USA, was
suggested in some of the submissions.
However, in Ireland, the Minister of State
at the Department of Tourism, Sport and
Recreation is responsible for co-
ordinating the National Drugs Strategy.
In addition, the Department chairs and
provides the Secretariat to the IDG.
Furthermore, through his Department’s
role in the IDG, the National Assessment
Committee for the YPFSF and the NACD,
the Minister of State is in a good position
to promote a cross-sectoral approach,
which has been an important objective of
the drugs strategy to date.
6.6.4 A common theme in the consultations
was the need for the creation of a
structure which has the capacity to reflect
and respond to the drug problem on a
national basis. The LDTFs are a specific
response to the scale of the drugs
problem in specific disadvantaged urban
areas. There was no conclusive evidence
available to the Review Group that any
other urban area is currently
experiencing a drugs problem
comparable to that experienced within
the LDTF areas. Consequently, the Review
Group considers that it is not appropriate
at this time to create Task Forces of this
kind in any other large cities/towns.
However, this is not to suggest that drug-
related problems do not exist throughout
the country and, consequently, the
situation should be kept under review.
6.6.5 The Review Group examined what
structures might be appropriate to tackle
drug misuse outside the LDTF areas. It
was noted that Regional Drug Co-
ordinating Committees already exist in
many of the Regional Health Board areas
and the Review Group examined how
these Committees might be aligned to
any new structures. In this regard, it was
felt that new Regional Drugs Task Forces
(RDTFs) should be developed which
would incorporate and expand the work
of the current Regional Drug Co-
ordinating Committees. The secretariat to
the RDTFs should be provided by the
relevant Health Boards. Each RDTF would
be responsible for putting a strategy in
place specifically for their region and
should have a budget to develop and
support the implementation of their
action plans. The Review Group
recognised that the geographical remit of
these Task Forces will make it difficult for
all the various statutory and non-
statutory sectors to have representatives.
However, it is considered that every effort
should be made to ensure that there is an
equitable regional spread of members
which also take account of differing
levels and natures of drug misuse within
any given region. 
6.6.6 The Review Group acknowledged that in
relation to the ERHA and SHB (Southern
Health Board) areas, the existence of
LDTFs raises certain issues for the
proposed Regional Drugs Task Forces. It
concluded, however, that while working
within overall regional plans in order to
maximise resources and minimise overlap
or duplication, every effort should be
made not to disrupt the work of the
LDTFs at this time, given their experience
and their concentrated focus on areas of
high opiate abuse. The current
framework should be built on and, as
natural linkages develop, the LDTFs
should feed into regional plans. 
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6.6.7 The LDTFs are currently updating their
existing strategies and the Cabinet
Committee on Social Inclusion has
approved many of these plans and has
allocated funding for them. A review of
the operations of the Task Forces has
been commissioned by the NDST and its
recommendations should be relevant to
the establishment of the proposed RDTFs.
6.6.8 The Department of Education and
Science has a key role to play in any
National Drugs Strategy and, particularly,
in regard to the LDTFs. However, as
currently structured, the Department is
not in a position to provide
representation on each of the 14 Task
Forces. Much attention has focused on
the lack of a direct link between
communities and the Department. The
recent Cromien report on the operations,
systems and staffing needs of the
Department reflects the difficulties faced
by it in delivering quality services in a
highly challenging environment. A high-
level Task Force within the Department is
preparing a blue print for the
implementation of recommendations
contained in the report. The Department
will be submitting proposals for
significant structure and service delivery
reforms, including the establishment of
local offices, to Government in the near
future. In this context, the Department's
representation on the LDTFs, which has
been an issue since the establishment of
the Task Forces, will be addressed.
6.6.9 There is also a perceived need to
strengthen and improve the level of
community representation on Task Forces
in order to ensure their effective
engagement. While this is necessary and
should be resourced, the need for greater
integration must be weighed against the
threat that such “formalisation” may
alienate community groups themselves
from their constituencies. The NDST
should commission research to examine
the training and support needs of groups
in order to equip them to participate
fully in the process at national, regional
and local levels. 
6 . 6 . 1 0 It is essential to the continued credibility
of the LDTF projects and, any new
projects which may emerge via the
proposed RDTFs, that they are able to
attract suitably qualified staff. Project
organisers must be able to offer
opportunities for professional
development and reasonable security of
t e n u re must be set out clearly in contracts.
6 . 6 . 1 1 The level of seniority of statutory
representatives on the LDTFs was
highlighted as a matter of concern in the
consultations. Similar anxieties might
arise in due course with regard to agency
representatives on the RDTFs. However,
there is a danger that insistence on
seniority may preclude individuals with a
particular understanding of, and
enthusiasm for the work, being
nominated to, Drugs Task Forces at local
or regional level.
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6 . 7 F R A M E W O R K F O R T H E N AT I O N A L
D R U G S S T R AT E G Y 2001 -2008
Overall Strategic Objective
The overall strategic objective for the
National Drugs Strategy 2001 – 2008 is : 
To significantly reduce the harm caused
to individuals and society by the
misuse of drugs through a concerted
focus on supply reduction, prevention,
treatment and research. 
Overall Strategic Aims 
The following are the overall strategic
aims of the Strategy : 
n to reduce the availability of illicit drugs; 
n to promote throughout society, a
greater awareness, understanding and
clarity of the dangers of drug misuse; 
n to enable people with drug misuse
problems to access treatment and
other supports and to re-integrate into
society; 
n to reduce the risk behaviour associated
with drug misuse;
n to reduce the harm caused by drug
misuse to individuals, families and
communities;
n to have valid, timely and comparable
data on the extent and nature of drug
misuse in Ireland; and
n to strengthen existing partnerships in
and with communities and build new
partnerships to tackle the problems of
drug misuse. 
6 . 7 . 1 O B J E C T I V E S A N D K E Y P E R F O R M A N C E
I N D I C AT O R S
In light of the analysis in Part 1, the
conclusions set out at the beginning of
this Chapter and the overall strategic
objective and aims set for the National
Drugs Strategy 2001 – 2008 as set out
across, the Review Group recommends
that the Government adopts the
following objectives and key
performance indicators (KPIs) under the
four pillars of supply reduction,
prevention (including education and
awareness), treatment (including
rehabilitation and risk reduction) and
research. A number of recommendations
in relation to co-ordination are also
made. 
In line with the EU Drugs Strategy, the
new Strategy will run from 2001 to 2008.
The objectives and KPIs will be reviewed
at the mid-term stage of the Strategy and
following this review, the KPIs may need
to be amended. These objectives and key
performance indicators should be
incorporated into the Statements of
Strategy of the relevant Departments 
and Agencies. 
6
0 8
Supply Reduction
Objectives
n To significantly reduce the volume of
illicit drugs available in Ireland, to
arrest the dynamic of existing markets
and to curtail new markets as they are
identified; and
n To significantly reduce access to all
drugs, particularly those drugs that
cause most harm, amongst young
people especially in those areas where
misuse is most prevalent.
Key Performance Indicators
n Increase the volume of opiates and all
other drugs seized by 25% by end
2004 and by 50% by end 2008 (using
2000 seizures as a base); 
n Increase the level of Garda resources in
LDTF areas by end 2001, building on
lessons emanating from the
Community Policing Forum model; 
n Strengthen and consolidate existing
coastal watch and other ports of entry
measures designed to restrict the
importation of illicit drugs;
n Establish a co-ordinating framework in
relation to drugs policy in each Garda
District by end 2001; and
n Co-operate and collaborate fully, at
every level, with law enforcement and
intelligence agencies, in Europe and
internationally, in reducing the amount
of drugs coming into Ireland. 
P re v e n t i o n
Objective
n To create greater societal awareness
about the dangers and prevalence of
drug misuse; and
n To equip young people and other
vulnerable groups with the skills and
supports necessary to make informed
choices about their health, personal
lives and social development.
Key Performance Indicators
n Bring drug misuse by schools-goers to
below the EU average and, as a first
step, reduce the level of substance
misuse reported to ESPAD by school-
goers by 15% by 2003 and by 25% by
2007 (based on 1999 ESPAD levels as
reported in 2001);
n Develop and launch an ongoing
National Awareness Campaign
highlighting the dangers of drugs, the
first stage to commence by end 2001;
n Develop formal links at local, regional
and national levels with the National
Alcohol Policy, by end 2001 and ensure
complementarity between the
different measures being undertaken;
n Publish and implement a policy
statement specifically relating to
education supports for LDTF areas,
including an audit of the level of
current supports, by end 2001;
n Nominate an official from the
Department of Education and Science
to serve as a member of each of the
LDTFs by end 2001;
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n Prioritise LDTF areas during the
establishment and expansion of the
services of the National Educational
Welfare Board;
n Have comprehensive substance misuse
prevention programmes in all schools
and, as a first step, implement the
“Walk Tall” and “On My Own Two Feet”
Programmes in all schools in the LDTF
areas during the academic year
2001/02;
n Complete the evaluation of the “Walk
Tall” and “On My Own Two Feet”
Programmes by end 2002; and
n Deliver the SPHE Programme (Social,
Personal & Health Education) in all
second level schools nation-wide by
September 2003.
Tre a t m e n t
Objectives
n To encourage and enable those
dependent on drugs to avail of
treatment with the aim of reducing
dependency and improving overall
health and social well-being, with the
ultimate aim of leading a drug-free
lifestyle; and 
n To minimise the harm to those who
continue to engage in drug-taking
activities that put them at risk.
Key Performance Indicators
n Have immediate access for drug
misusers to professional assessment
and counselling by health board
services, followed by commencement
of treatment as deemed appropriate,
not later than one month after
assessment;
n Have access for under-18s to treatment
following the development of an
appropriate protocol for dealing with
this age group;
n In c rease the number of treatment places
to 6,000 places by end 2001 and to a
minimum of 6,500 places by end 2002;
n Continue to implement the
recommendations of the Steering
Group on Prison-Based Drug Treatment
Services as a priority and implement
proposals designed to end heroin use
in prisons during the period of the
Strategy; 
n Have in place, in each Health Board
a rea, a service user charter by end 2002; 
n Have in place, in each Health Board
area, a range of treatment and
rehabilitation options as part of a
planned programme of progression for
each drug misuser, by end 2002; and
n Provide stabilised drug misusers with
training and employment
opportunities and, as a first step,
increase the number of such
opportunities by 30% by end 2004.
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R e s e a rc h
Objectives
n To have available valid, timely and
comparable data on the extent of drug
misuse amongst the Irish population
and specifically amongst all
marginalised groups; and
n To gain a greater understanding of the
factors which contribute to Irish
people, particularly young people,
misusing drugs.
Key Performance Indicators
n Eliminate all major research gaps in
drug research by end 2003; and
n Publish an annual report on the nature
and extent of the drug problem in
Ireland and on progress being made in
achieving the objectives set out in the
Strategy.
C o - o rd i n a t i o n
Objective
n To have in place an efficient and
effective framework for implementing
the National Drugs Strategy.
Key Performance Indicators
n Establish an effective regional
framework to support the measures
outlined in the Report by end 2001; 
n Complete an independent evaluation
the effectiveness of the overall
framework by end 2004.
n Each agency to prepare and publish a
critical implementation path for each
of the actions relevant to their remit
by end 2001; and
n Review the membership, work-load
and supports required by the National
Drugs Strategy Team to carry out its
terms of reference, by end September
2001.
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6 . 8 A C T I O N P L A N
6.8.1 The Review Group recommends a series
of actions to be taken across the full
range of Departments and Agencies
involved in the delivery of drugs policy,
to address specific gaps in the current
strategy, to strengthen each of the four
pillars which underpin it and to ensure
that the foregoing objectives are met.
These actions are listed below and their
implementation should be overseen by
the IDG, which in consultation with the
NDST, should report on progress to the
Cabinet Committee every six months.
D e p a rtment of Tourism, Sport and
R e c re a t i o n
1 The Department, through the IDG and
the NDST, to co-ordinate the
implementation of the National Drugs
Strategy in partnership with Government
Departments, State Agencies and the
community and voluntary sectors and to
bring to the attention of the Cabinet
Committee on Social Inclusion any
identified issues which have a
detrimental effect on the implementation
of policy.
2 The IDG, in conjunction with the NDST, to
establish an evaluation framework for
the Strategy, incorporating the
performance indicators against which
progress under the four pillars will be
assessed. Annual reports and mid-term
evaluations would facilitate progression
towards key strategic goals. The cost
effectiveness of the various elements of
each pillar of the new Strategy should be
established to enable priorities to be
established and a re-focusing, if
necessary, of strategic objectives from the
mid-term evaluation stage at 2004.
3 Continued provision of accessible,
positive alternatives to drug misuse in
areas where such misuse is most
prevalent through the YPFSF and, more
generally, through arts and culture youth
programmes, the schemes run by the Irish
Sports Council and the facilities provided
through funding under the Sports Capital
Programme. These should be accessible
and attractive to those most at risk of
drug misuse and those from socially,
educationally and culturally diverse
backgrounds. In this regard, the LDTF
areas should be prioritised. Specific
efforts should also be made to ensure
that the groups who are most at risk of
drug misuse are actively engaged in
recreational activities at local level.
D e p a rtment of Justice, Equality and
Law Reform
4 To oversee the establishment of a
framework to monitor numbers of
successful prosecutions, arrests and the
nature of the sentences passed.
5 To establish, in consultation with the
Gardaí and the community sector, best
practice guidelines and approaches for
community involvement in supply control
activities with the law enforcement
agencies.
6 To review the ongoing effectiveness of
crime legislation, in tackling drug-related
activity.
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G a rda Síochána
7 To increase the level of Garda resources
in LDTF areas by end 2001, building on
lessons emanating from the Community
Policing Forum model.
8 To establish a co-ordinating framework
for drugs policy in each Garda District, to
liaise with the community on drug-
related matters and act as a source of
information for parents and members of
the public. Each Garda District and Sub-
District be required to produce a Drug
Policing Plan to include multi-agency
participation in targeting drug dealers.
9 To target the assets of middle-ranking
criminals involved in drug dealing. 
10 To continue to target dealers at local
level by making additional resources
available to existing drugs units and for
the establishment of similar units in areas
where they do not currently exist.
11 To extend the Community Policing Fora
(CPF) initiative to all LDTF areas, if the
evaluation of the pilot proves positive.
The proposed RDTFs should be consulted
in assessing whether CPFs should be
established in regional areas of particular
need. Where CPFs do not exist, CPF
methods should be adopted as best
practice for mainstream policing policy.
12 To ensure that operations similar to
Dóchas, Nightcap and Cleanstreet are
implemented in urban centres
throughout Ireland, where drug dealing
is on-going. 
13 To monitor the efficacy of the existing
arrest referral schemes and expand them,
as appropriate. 
G a rda Síochána and Customs and
E x c i s e
14 To continue to work more closely
together in accordance with the
principles of their Memorandum of
Understanding. They should also co-
operate and collaborate fully with law
enforcement and intelligence agencies in
Europe and internationally in reducing
the amount of drugs coming into Ireland. 
15 To strengthen and consolidate existing
coastal watch and other ports of entry
measures designed to restrict the
importation of illicit drugs by end 2002 
16 To develop benchmarks against which
seizures of heroin and other drugs can be
evaluated under the EU Action Plan in
order to establish progress on a yearly
basis. 
17 To ensure greater integration of Customs
and Excise within a European context, an
Officer of the Customs and Excise Division
should be appointed to the Europol
National Unit. 
18 To have available to the enforcement
agencies detection dogs and other
resources to restrict the importation of
illicit drugs.
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G a rda Síochána and Health Board s
19 Incidences of early use of alcohol or
drugs by young people coming to Garda
attention to be followed up by the
Community Police and/or the health and
social services, in order that problem drug
misuse may be diagnosed/halted early on
through appropriate early intervention.
C o u rts Serv i c e
20 To have in all LDTF areas an early
intervention system, based on the Drug
Court model, if the evaluation of the
pilot in the North Inner City of Dublin is
positive. This should be accompanied by
appropriate familiarisation for the
judiciary on the role of the Drug Court. 
Prison Serv i c e
21 To continue to implement the
recommendations of the Steering Group
on Prison-Based Drug Treatment Services
as a priority and to implement proposals
designed to end heroin use in prisons
during the period of the Strategy.
22 To expand prison-based programmes with
the aim of having treatment and
rehabilitation services available to those
who need them including drug treatment
programmes, which specifically deal with
the reintegration of the drug using
offender into the family/community.
23 To commission and carry out an
independent evaluation of the overall
effectiveness of the Prison Strategy by
mid 2004. The review should cover all
aspects of drug services in prisons
including research on levels and routes of
supply of drugs in prisons. 
24 To expand the involvement of the
community and voluntary sectors in
prison drug policy via the on-going
development of Local Prison Liaison
Groups and the formal meetings between
the sectors and the Steering Group on
Prison-Based Drug Treatment Services.
D e p a rtment of the Enviro n m e n t
and Local Govern m e n t
25 To commission an external evaluation of
the impact of enforcement activity under
the Housing Acts (evictions, excluding
orders) on homelessness by end 2001.
26 To monitor and evaluate homelessness
initiatives in relation to drugs issues in
the context of the Homeless Strategy
and, particularly, in relation to the Dublin
Action Plan.
G a rda Síochána, the Health Board s
and Vintner Representative Bodies
27 Representative bodies including the
Vintners Federation of Ireland (VFI), the
Licensed Vintner’s Association (LVA) and
the Irish Hotel Federation (IHF) to
prepare guidelines, in association with
the Garda authorities and the Health
Boards, for publicans and night-club
owners regarding drug dealing on, or in
the vicinity of, their premises. These
guidelines should set out clearly the
actions which the owner of the premises
should take in response to drug dealing
e.g. co-operation with the Gardaí etc.
28 Gardaí to object to the renewal of
licences for publicans and night-club
owners where there has been a history of
drug dealing on the premises.
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D e p a rtment of Education and
S c i e n c e
29 To publish and implement a policy
statement on education supports in
LDTFs, including an audit of the level of
current supports by end 2001 and
nominate an official to serve as a
member of each Task Force. The
Department's representatives on the Task
Forces will meet to discuss crosscutting
issues, chaired by a senior official. This
will be done in the context of structure
and service delivery reforms which will be
considered by Government.
30 To prioritise LDTF areas during the
establishment and expansion of the
services of the National Educational
Welfare Board.
31 To put in place by end 2001 mechanisms
which will support, enhance and ensure
the delivery of school-based education
and prevention programmes in all schools
nation-wide over the next three years.
The ultimate aim of these programmes
should be to ensure that every child has
the necessary knowledge and life-skills to
resist drugs or make informed choices
about their health, personal lives and
social development. 
32 To implement “Walk Tall” and “On My
Own Two Feet” Programmes in all schools
in the LDTF areas, in the context of the
SPHE Programme during the academic
year 2001/02.
33 To deliver the SPHE Programme in all
second-level schools by September 2003.
34 To complete the evaluation of the “Walk
Tall” and “On My Own Two Feet”
Programmes by end 2002 and to continue
to evaluate the programmes in order to
establish whether they need to be
augmented or whether there is a need
for alternative programmes to address
key gaps. Furthermore, schools should
encourage the participation of parents in
such programmes, where appropriate. In
particular, mechanisms for engaging the
parents of at-risk children in programmes
should be examined with a view to
establishing models of best practice. 
35 To ensure parents have access to factual
preventative materials which also
encourage them to discuss the issues of
coping with drugs and drug misuse with
their children.
36 To ensure that every second-level school
has an active programme to counter early
school-leaving with particular focus on
areas with high levels of drug misuse.
37 Recommendations 31-35 to apply equally
to the non-school education sector e.g
VTOS, Youthreach and Community
Training Workshops operated by FÁS.
Such sectors often deal with young
people from more disadvantaged
backgrounds who are more at risk of
drug misuse. For this reason,
incorporating a drug element to the
education provided, as outlined earlier, is
important.
(The Health Promotion Unit of the
Department of Health and Children and
the Health Boards are partners in the
implementation of actions 31-35 and 37).
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D e p a rtment of Health and Childre n
38 To develop and launch an on-going
National Awareness Campaign
highlighting the dangers of drugs, based
on the considerations outlined in the
conclusions. The campaign should
promote greater awareness and
understanding of the causes and
consequences of drug misuse, not only to
the individual but also to his/her family
and society in general. The first stage
should commence before the end of 2001.
39 To ensure that adequate training for
health care and other professionals
engaged in the management of drug
dependency is available, including, if
necessary, arrangements with third level
institutions and professional bodies.
40 To consult all treatment and re h a b i l i t a t i o n
p roviders in order to ensure that perf o rm a n c e
indicators, used in the evaluation of
services, accurately and consistently
reflect the needs of specific areas i.e
performance indicators should reflect the
reality of the drug problem locally.
41 To oversee implementation of the
recommendations of the Benzodiazepine
Working Group, which is due to complete
its work by end June 2001, as part of the
overall strategy of quality improvement
of current services.
D e p a rtments of Education and
Science and Health and Childre n
42 To ensure that the design and delivery of
all preventative programmes is informed
by on-going research into the factors
contributing to drug misuse by particular
groups. The programmes should also
include the development of initiatives
aimed at equipping parents of at risk
children with the skills to assist their
children to resist drug use or make
informed choices about their health,
personal lives and social development.
43 To develop guidelines, in co-operation
with the Health Boards, to assist schools
in the formation of a drugs policy and
ensure that all schools have policies in
place by September 2002. 
Health Board s
44 To have immediate access for drug
misusers to professional assessment and
counselling by health board services,
followed by commencement of treatment
as deemed appropriate, not later than
one month after assessment.
45 To increase the number of treatment
places for opiate addiction to 6,000 by
the end of 2001 and to a minimum of
6,500 by end 2002. 
46 To develop and put in place by end 2002
a service-user charter specific to
treatment and rehabilitation facilities
which would lead to a greater balance in
the relationship between the service user
and the service provider. Such a charter
would be helpful to drug misusers
presenting for treatment with low levels
of educational attainment and/or low
levels of self-esteem. 
47 To base plans for treatment services on a
“continuum of care” model and a “key
worker” approach to provide a seamless
transition between each different phase
of treatment. This approach will enhance
movement through various treatment
and aftercare forms. In addition, the 
“key worker” can act a central person for
primary care providers (GPs and
Pharmacists) to contact in connection
with the drug misuser in their care.
48 To have in place, in each Health Board
area, a range of treatment and
rehabilitation options as part of a
planned programme of progression for
each drug misuser, by end 2002. This
approach will provide a series of options
for the drug misuser, appropriate to
his/her needs and circumstances and
should assist in their re-integration back
into society.
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49 To develop a protocol, where appro p r i a t e ,
for the treatment of under 18 year olds
presenting with serious drug problems
especially in light of the legal and other
dilemmas which are posed for pro f e s s i o n a l s
involved in the area. In this context, a
Working Group should be established to
develop the protocol. The Group should
also look at issues such as availability of
appropriate residential and day
treatment programmes, education and
training rehabilitative measures and harm
reduction responses for young people.
The Group should report by mid 2002.
50 To develop, in consultation with the
NACD, criteria to ensure that all State-
funded treatment and rehabilitation
programmes accord with quality
standards as set out by the Health
Boards.
51 To have a clearly co-ordinated and well
publicised plan in place for each Health
Board area by end 2002 for the provision
of a comprehensive and locally accessible
range of treatments for drug misusers,
particularly for young people, the
planning of such services to be linked to
the national profile of drug misuse
amongst young people and to the areas
where usage is most prevalent. These
plans to be implemented by end 2004.
52 To produce and widely distribute a well
publicised, short, easily read guide to the
drug treatment services available in each
Health Board area with contact numbers
for further information and assistance.
53 To require from 2002 that all Health
Boards, in considering the location and
establishment of treatment and
rehabilitation facilities, develop a
management plan in consultation with
local communities. Existing examples
whereby Health Boards have established
monitoring committees with the local
community to oversee the operation of
the treatment services have proven
successful and should be replicated,
where appropriate.
54 To consider, as a matter of priority, how
best to integrate child-care facilities with
treatment and rehabilitation centres and
how childcare can best be provided in a
residential treatment setting. This should
be done in conjunction with the
Department of Justice, Equality and Law
Reform.
55 To explore immediately the scope 
for introducing greater provision of
alternative medical and non-medical
treatment types, which allow greater
flexibility and choice. This may increase
the number of drug misusers presenting
for treatment as it is evident that a “one
size fits all” approach is not appropriate
to the characteristics of Irish drug misuse. 
56 To consider as a matter of priority, how
to increase the level of GP and pharmacy
involvement in the provision of
treatment programmes. Increased
capacity at the primary care level will
have the effect of alleviating the pressure
on the secondary care services which are
currently over-subscribed.
57 To oversee the development of
comprehensive residential treatment
models incorporating detoxification,
intervention, pre-treatment counselling,
motivational work, therapeutic treatment
and high quality rehabilitation for
misusers who wish to become drug-free.
Resources should continue to be targeted
at the most efficient and effective of
these services.
58 To report to the NACD on the efficacy of
different forms of treatment and detox
facilities and residential–drug free
regimes on an on-going basis.
59 To secure easy access to counselling
services for young people seeking
assistance with drug-related problems,
especially given the correlation between
suicide and drug misuse and the growing
incidence of suicide amongst young
people.
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60 To ensure that treatment for young
people includes family therapy and
community integration phases, in order
to encourage family involvement which is
a crucial component in the treatment of
young people. 
61 To consider developing drop-in centres,
respite facilities and half-way houses,
where a clear need has been identified,
as such facilities have been found to be
useful in the prevention of relapse. 
62 To review the existing network of needle-
exchange facilities with a view to
ensuring access for all injecting drug
misusers to sterile injecting equipment. 
63 To pursue with the relevant agencies, as a
matter of priority, the setting up of a
Pilot Community Pharmacy Needle and
Syringe Exchange Programme in the
ERHA area and in the event of a
successful evaluation, the programme to
be extended where required.
64 To continue to develop good-practice
outreach models, including mechanisms
to outreach drug misusers who are not in
contact with mainstream treatment or
support agencies. A reduction in the level
of drug-related deaths, particularly from
opiate abuse through targeted
information, educational and prevention
campaigns must be a key aspect of the
Strategy.
65 All treatment providers should co-operate
in returning information on problem
drug use to the DMRD of the HRB.
66 To consider the feasibility of new suitably
trained peer-support groups in the
context of expanded provision. Peer-
support groups are a component of the
existing strategy and are regarded as an
effective rehabilitative support. 
C o roners' Service and the Central
Statistics Off i c e
67 To develop an accurate mechanism for
recording the number of drug-related
deaths in Ireland.
Local Authorities and Health Board s
68 To achieve close liaison between
treatment providers, social workers,
probation and welfare officers and the
relevant local authorities as well as family
supports, so as to ensure that recovering
misusers should have access to housing.
This is very important in ensuring that
the effectiveness of treatment and the
goals of rehabilitation are not underm i n e d .
69 To develop and implement proposals for
the collection and safe disposal of injecting
equipment, in order to ensure that the
wider community is not exposed to the
dangers associated with unsafe disposal.
70 To consider how the design of housing
estates can contribute to the prevention
of drug dealing in the context of on-
going reviews of the Social Housing
Design Guidelines for Local Authority
Estates. In this regard, the lessons from
the ISP may be relevant.
City and County Development
B o a rd s
71 To consider the needs of those areas
experiencing high levels of drug misuse
when drawing up city/countywide
strategies for economic, social and
cultural development.
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P rofessional Bodies and
Training Institutes
72 To make available to individuals
interacting with groups most at risk of
drug misuse, such as youth workers,
teachers, student welfare officers, GPs,
pharmacists, nurses, counsellors, child
care workers, law enforcement agents,
members of the judiciary etc. specialist
drug prevention training as part of their
initial vocational training. The relevant
professional body or employer should
ensure that training, or up-skilling is
available on an on-going basis to ensure
that the approach taken reflects
changing attitudes and patterns of drug
misuse.
Public Media
73 To encourage the media to play a larger
role in creating a greater understanding
of drug misuse throughout society.
Informed coverage and analysis and
debate of drugs issues on an on-going
basis within the public sphere will
contribute to the successful
implementation of the Strategy. In this
regard, the role of the Department of
Tourism, Sport and Recreation, as the co-
ordinator of the National Drugs Strategy,
as a possible central source of
information should be considered. 
State Training Agencies
74 To increase the number of training and
employment opportunities for drug
misusers by 30% by end 2004, in line 
with the commitment to provide such
opportunities in the PPF
75
and taking on
board best practice from the special FÁS
Community Employment Programme and
the pilot Labour Inclusion Programme. 
75 To examine the potential to involve
recovering drug misusers in Social
Economy projects, and in other forms 
of vocational training. The ring-fencing
of places within the FÁS Community
Employment Programme has been an
important element of the existing
approach to rehabilitation. 
76 To monitor the participation of
recovering drug misusers on such
programmes and to review their overall
effectiveness. In this context, alternative
models should be developed where
appropriate.
O i reachtas Committee on Dru g s
77 To establish a dedicated drugs sub-
committee of the existing Select
Committee on Tourism, Sport and
Recreation, which would meet at least
three times a year. 6
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7 5 The commitment in the PPF states that “As the number of drug misusers taking treatment increases, the re q u i rement to provide training and employment
o p p o rtunities to assist them towards a full re c o v e ry will also incre a s e . ”
I n t e r- D e p a rtmental Group 
on Drugs (IDG)
78 To be chaired by the Minister of State at
the Department of Tourism, Sport and
Recreation. This will ensure greater co-
ordination between the IDG’s
constituents in the future and will help to
maintain high-level representation and
more effective communication between
the IDG and the Cabinet Sub-Committee. 
79 To consist, in future, of designated
officials, at Assistant Secretary level, from
the following Departments:
n Tourism, Sport & Recreation;
n Taoiseach;
n Finance;
n Health & Children;
n Education & Science; 
n Enterprise, Trade and Employment;
n Environment & Local Government;
n Justice, Equality & Law Reform; and
n Social, Community and Family Affairs.
The Chair of the NDST will also be a
member.
As has been the practice, regular joint
meetings to continue to be held between
the IDG and the NDST to contribute to
the effective and efficient development
and delivery of the National Drugs Strategy.
80 In conjunction with the NDST and the
Department of Health and Children, to
develop formal links at local, regional
and national levels with the National
Alcohol Policy, by end 2001 and ensure
complementarity between the different
measures being undertaken.
81 To seek reports from key service
providers, such as the Assistant
Commissioner of An Garda Síochána, the
Director General of the Prisons Service,
the Chief Executive of the relevant Health
Authorities, the Revenue Commissioner
with responsibility for Customs and 
Excise and the County/City Manager of
relevant Local Authorities on request 
and to attend meetings, as appropriate.
Representatives from the voluntary,
community and professional sectors
should also asked to attend, as
appropriate. 
82 The Terms of Reference of the IDG to
include the following:
n advising the Cabinet Committee on
critical matters of a public policy nature
relating to the National Drugs Strategy;
n ensuring the timely and effective input
of relevant Departments and agencies
into any emerging operational
difficulties or conflicts in relation to
implementation of national drugs
policy; and
n approving the plans and initiatives of
the LDTFs and the proposed RDTFs and
monitoring and evaluating the
outcomes of their implementation
through joint meetings with the NDST.
83 In conjunction with the NDST:
n to review the membership of the
Team, immediately and, every two
years subsequently, in order to ensure
that all relevant interests are
represented; and
n to review the workload of the NDST
and satisfy itself that the level of
support is adequate to carry out its
new terms of reference. In particular,
to examine, as a priority, the need for a
Director to oversee the day to day
management of the Office and
additional technical support workers.
The review should be completed by
end September 2001. 
84 Departments and Agencies participating
on the IDG and the NDST to commit
themselves in writing to the process and
the level and extent of representation
should be specified.
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National Drugs Strategy Te a m
85 The Terms of Reference of the NDST to
include :
n ensuring effective co-ordination
between officials from Government
Departments and State Agencies
represented on the Team and members
of the community and voluntary sectors
in delivering local and regional task
force plans;
n reviewing on an on-going basis the
need for LDTFs in disadvantaged urban
areas, particularly having regard to
evidence of localised heroin misuse;
n identifying and considering policy
issues and ensuring that policy is
informed by the work of and lessons
from the LDTFs and the proposed
RDTFs, through joint meetings with the
IDG;
n overseeing the establishment of RDTFs;
n drawing up guidelines for the
operation of Local and Regional Drugs
Task Forces and overseeing their work;
n evaluating the Local and Regional
Drugs Task Forces Action Plans, when
submitted and making
recommendations to the IDG regarding
the allocation of funding to support
their implementation;
n ensuring that monies allocated by the
Department of Tourism, Sport and
Recreation to projects overseen by the
NDST are properly accounted for; and 
n preparing an annual report and
presenting it to the Department of
Tourism, Sport and Recreation.
86 To meet regularly with the co-ordinator
of the National Alcohol Policy and,
similarly, a member of the Team should
be represented on the body charged with
the co-ordination of the National Alcohol
Policy.
87 To continue to be represented on the
YPFSF National Assessment Committee
and to ensure that the LDTFs continue to
be represented on the Development
Groups for the Fund.
88 The NDST to be kept informed by
Departments and Agencies of any
initiatives being taken which will affect
Task Force areas. In addition, membership
of NDST and of the Local and Regional
Drugs Task Forces to be acknowledged
and written into the business plans/work
programmes of all relevant Departments
and Agencies.
89 To consider funding on a pilot basis,
training initiatives to strengthen effective
community representation and
participation in Regional and Local Drugs
Task Forces.
90 To examine and advise the IDG on the
feasibility of introducing a standards and
accreditation framework for all
individuals, groups and agencies engaged
in drugs work. Such a framework should
address issues such as standards, training,
qualifications, etc.
91 To continue to identify best practice
models arising from the work of the
LDTFs and the proposed RDTFs and
disseminate them widely.
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Regional Drugs Task Forc e s
92 Regional Drugs Task Forces (RDTFs) to be
established in each of the current
Regional Health Board areas
76
including
each of the three Health Boards
77
that
comprise the ERHA, with the following
terms of reference: 
n to ensure the development of a co-
ordinated and integrated response to
tackling the drugs problem in their
region;
n to create and maintain an up-to-date
database on the nature and extent of
drug misuse and to provide
information on drug-related services
and resources in the region;
n to identify and address gaps in service
provision having regard to evidence
available on the extent and specific
location of drug misuse in the region; 
n to prepare a development plan to
respond to regional drugs issues for
assessment by the NDST and approval
by the IDG;
n to provide information and regular
reports to the NDST in the format and
frequency requested by the Team; and
n to develop regionally relevant policy
proposals, in consultation with the
NDST.
93 To consist of senior representatives so
that members are capable of decision
making and influencing budgets.
94 To include representation from the
following sectors:
n Chair;
n Regional Drug Co-ordinator of the
Health Board (providing
secretarial/administrative support);
n Local Authority;
n VEC; 
n Health Board; 
n Department of Education and Science;
n Department of Social, Community and
Family Affairs;
n Gardaí;
n Probation and Welfare Service;
n FÁS;
n Revenue Commissioners – Customs and
Excise Division;
n Voluntary Sector;
78
n Community Sector;
n Public Representatives (nominated by
Local Authority in accordance with
normal procedures); and
n Area Based Partnership.6
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7 6 Midland Regional Health Board, Mid-We s t e rn Regional Health Board, Southern Health Board, South-Eastern Health Board, Eastern Regional Health Authority,
N o rth Eastern Regional Health Board, North We s t e rn Regional Health Board, We s t e rn Regional Health Board. 
7 7 East Coast Area Health Board, South We s t e rn Area Health Board, Nort h e rn Area Health Board .
7 8 The Vo l u n t a ry and Community Sector re p resentatives could be nominees of the Community Development Fora of the relevant City and County Development
B o a rds. However, they should meet the criteria specified in the NDST Handbook for LDTFs and be re p resentative of areas where there are problems of emerg i n g
d rug misuse.
Local and Regional Drugs Ta s k
F o rc e s
95 RDTFs to consider the development and
implementation of community-based
initiatives to raise awareness. The goal of
such initiatives would be to develop best
practice models which send a clear and
consistent message and which ar e
capable of being mainstreamed. In the
communities where drug misuse is most
prevalent and where there is
considerable knowledge about all aspects
of the drugs issue, schools could tap into
and use this knowledge as a beneficial
aspect of their programmes. By contrast,
there are communities that have a very
limited knowledge of the nature or
manifestations of drug misuse. In these
areas, the school, the health promotion
officer, GPs, pharmacists, the Gardaí and
others must take the lead in creating a
greater awareness of drug misuse. 
96 To enable user groups in Task Force areas
to play a role in the generation of a
greater societal understanding of drug
misusers and drug misuse issues. For
those misusers who may not be in contact
with mainstream agencies, these groups
can help foster awareness about support
services available e.g. treatment options,
needle exchanges etc.
97 To include local publicity about the
nature of their work and the type of
measures/initiatives being put in place by
them as a key element of the work of
Task Forces and as part of their action
plans. This information should be
disseminated as widely as possible. 
National Advisory Committee on
D ru g s
To examine their current three year
research programme to establish if the
following actions could be
accommodated within it:
98 To carry out studies on drug misuse
amongst the at-risk groups identified in
this Report e.g. Travellers, prostitutes, the
homeless, early school leavers etc.
including de-segregation of data on
these groups. It is essential that the
individuals and groups most affected by
drug misuse and those involved in
working to reduce, treat and prevent
drug misuse have immediate access to
relevant statistical information.
99 To commission further outcome studies
within the Irish setting to establish the
current impact of methadone treatment
on both individual health and on
offending behaviour. Such studies should
be an important tool in determining the
long-term value of this treatment.
100 To conduct research into the effectiveness
of new mechanisms to minimise the
sharing of equipment e.g. non-reusable
syringes, mobile syringe exchange
facilities etc. to establish the potential
application of new options within
particular cohorts of the drug using
population i.e amongst younger drug
misusers, within prisons etc.
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P a rt III
Appendices
G L O S S A RY
CDP Community Development Programme
CE Community Employment
CNDT Customs National Drug Team
CPF Community Policing Forum
DLO Drugs Liaison Officer
DMRD Drug Misuse Research Division
EMCDDA European Monitoring Centre on
Drugs and Drug Addiction
ERHA Eastern Regional Health Authority
ESPAD European Schools Survey Project on Alcohol
and other Drugs
EU European Union
FÁS Foras Áiseanna Saothairi
HBSC Health Behaviour in Schools Aged
Children Survey
HRB Health Research Board
HPU Health Promotion Unit
IDG Inter-Departmental Group on Drugs
INCB International Narcotics Control Board
ISP Integrated Services Process
IV Intravenous
LAAM L-Alpha Acetyl Methadol
LDTF Local Drugs Task Force
LSD Lysergic Acid Diethylamide
NACD National Advisory Committee on Drugs
NAPS National Anti Poverty Strategy
NDP National Development Plan
NDS National Drugs Strategy
NDST National Drugs Strategy Team
NDTRS National Drug Treatment 
Reporting System
RDTF Regional Drugs Task Force
SMI Strategic Management Initiative
SAPP Substance Abuse Prevention Pro g r a m m e
SMPP Substance Misuse Prevention Pro g r a m m e
UN United Nations
UNDCP United Nations Drug Control Pro g r a m m e
UNGASS United Nations General Assembly 
Special Session on Drugs
USI Union of Students in Ireland
VEC Vocational Educational Committee
VFM Value for Money
YPFSF Young Peoples Facilities & Services Fund
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A P P E N D I X 1 – K E Y S T R U C T U R E S O F T H E N AT I O N A L D R U G S S T R AT E G Y
Membership of Inter- D e p a rtmental Committee on Drugs (IDG)
The review was conducted under the auspices of the Inter-departmental Committee on Drugs (IDG) which
consists of high level representatives of key Government departments with a role to play in addressing issues
related to illicit drug use. Membership of the IDG at the time of publication is:-
n Mr. Con Haugh (Chairperson) Department of Tourism, Sport & Recreation
n Mr. Eddie Arthurs (Secretary) Department of Tourism, Sport & Recreation
n Ms Eileen Kehoe Department of the Taoiseach
n Mr. Tom Corcoran Department of Environment & Local Government
n Mr. Jimmy Duggan Chair – National Drugs Strategy Team /
Department of Health & Children
n Mr. John Fitzpatrick Department of Finance
n Mr. Tom Mooney Department of Health & Children
n Vacancy Department of Education & Science
n Mr. Seamus O’Moráin Department of Enterprise & Employment
n Mr. Brian Purcell Department of Justice, Equality & Law Reform
n Ms. Kathleen Stack Chair – YPFSF National Assessment Committee/
Department of Tourism, Sport & Recreation
n Mr. John Kelly Department of Tourism, Sport & Recreation
Membership of the National Drugs Strategy Team (NDST)
Membership of the NDST at the time of publication is:-
n Mr. Jimmy Duggan (Chairperson) Department of Health and Children
n Mr. Ray Henry Department of the Taoiseach 
n Ms. Eileen Hughes Department of Environment & Local Government
n Superintendent Barry O'Brien Garda National Drugs Unit
n Mr. John Harkin FÁS
n Ms. Mary O'Sullivan D e p a rtment of Social, Community and Family Aff a i r s
n Mr. Stephen Falvey Department of Education & Science
n Ms. Lylia Crossan Department of Justice, Equality & Law Reform
n Fr. Sean Cassin Voluntary Representative
n Mr. Fergus Mc Cabe Community Representative
n Dr. Derval Howley ERHA
n Dr Joe Barry ERHA
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National Drugs Strategy Review Sub-Gro u p
The IDG were assisted in the preparation of the review by a sub-group, comprised of representatives from
Government Departments and the National Drugs Strategy Team (NDST) consisting of the following members;
n Mr Con Haugh (Chairperson) Assistant Secretary Department of Tourism,
Chair of the IDG Sport & Recreation
n Ms Kathleen Stack Principal Officer – Department of Tourism
Drugs Strategy Unit, Sport & Recreation
n Mr. Stephen Falvey Assistant Principal Officer – Department of Education
Social Inclusion Unit & Science
n Mr. Brian Purcell Principal Officer – Department of Justice,
Crime Division Equality & Law Reform
n Superintendent Barry O’Brien An Garda Síochána NDST Member
n Mr. Jimmy Duggan Principal Officer – Department of Health & 
Chairperson of the NDST Children
n Mr. Fergus McCabe Community Worker NDST Member
n Mr. John Kelly Secretary to the National Department of Tourism,
Drugs Strategy Review Sport & Recreation
The Secretariat to the review was supplied by the staff of the Drugs Strategy Unit of the Department of Tourism,
Sport & Recreation and consisted of Mr. John Kelly (Secretary); Mr Caoimhín Ó Ciaruáin, Ms. Sharon Gleeson; Ms.
Patricia Kenna and Mr. Anthony McCarthy. Mr. John Kelly succeeded Mr. Tony Bass as Secretary to the review in
November 2000.
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A P P E N D I X 2 – R E S P O N S E S T O T H E D R U G P R O B L E M I N I R E L A N D
Time Period Developments
1966-1979 Working Party on Drug Abuse established December 1968
Report of Working Party completed in 1971
Committee on Drug Education established in 1972
Report of the Committee on Drug Education in 1974
Health Education Bureau established in 1974
Health Education Bureau established in 1974
Misuse of Drugs Act 1977
1980-1985 Prevalence study conducted by Medico Social Research Board in 1983
Inter-Ministerial Task Force established in 1983
Report of the Inter-Ministerial Task Force in 1983
Misuse of Drugs Act 1984
National Coordinating Committee on Drug Abuse 1985
1986-1991 Health Research Board established in 1986
Health Promotion Unit established in 1987
National Coordinating Committee on Drug Abuse reconstituted in 1990
Government Strategy to Prevent Drug Misuse 1991
1992-Present Time Criminal Justice Act 1994
Criminal Justice (Drug Trafficking) Act 1996
Criminal Assets Bureau Act 1996
Proceeds of Crime Act 1996
Disclosure of Certain Information for Taxation and Other
Purposes Act 1996
Bail Act 1997
Housing Act 1997
Ministerial Task Force on Measures to Reduce the Demand
for Drugs established in 1996
First Report of the Ministerial Task Force 1996
Establishment of National Drugs Strategy Team 1996
Second Report of the Ministerial Task Force 1997
Establishment of Cabinet Drugs Committee
Establishment of Local Drugs Task Forces 1997
Cabinet Drugs Committee reconstituted into wider 
Committee on Social Inclusion and Drugs 1997
Young People’s Facilities and Services Fund 1998
Criminal Justice (Drug Trafficking) Act 1999
National Advisory Committee on Drugs 2000
A P P E N D I X 3 – S U B M I S S I O N S R E C E I V E D
I n d i v i d u a l s
O rg a n i s a t i o n s
Addiction Resource Centre, Rooskey
ADHD – The Irish National Council of Supports Gro u p s
A I S É I R Í
AISLING – Group Cavan Branch
Aisling Gro u p
AISLINN – Adolescent Addiction Treatment Centre Limited
An Garda Síochána
A rea Development Management (ADM) Ltd
Association of Secondary Teachers in Ireland (ASTI)
Athlone Drug Aw a reness Gro u p
Balbriggan Aw a reness of Dru g s
B a l l y f e rmot Local Drugs Task Forc e
Ballymun Youth Action Project (BYA P )
B a rn a rdos – Southern Region 
Beg Borrow and Steal Theatre Company
C A I R D E
Campaign against Bullying (CAB)
Canal Communities Local Drugs Task Forc e
Carlow Regional Youth Serv i c e
Carlow Urban District Council
Catholic Primary School Managers' Association
Catholic Youth Council (CYC)
Cavan County Council
Clonmel Community Based Drugs Initiative
We x f o rd Community Based Drug Initiative
C O A I M
Coalition of Communities Against Drugs (COCAD)
Combat Poverty Agency
Combined Tallaght Community Treatment Pro g r a m m e s
Community Aw a reness of Drugs (CAD)
Coolmine House
Cork Local Drugs Task Forc e
County Kilkenny VEC
County Louth VEC
C PA D
CREW Network
C ross Border Anti-Drugs Initiative Committee
C R S A
Cuan Mhuire
Cumann Lúthchleas Gael
D a rndale/Belcamp Resource Centre 
D e p a rtment of Education and Science
D e p a rtment of Health & Childre n
D e p a rtment of Justice, Equality & Law Reform
D e p a rtment of the Environment and Local Govern m e n t
D rug Prevention Alliance
D rug Treatment Centre Board
D rugs Education Workers Forum 
Dublin City University
Dublin City Wide Drugs Crisis Campaign
Dublin Corporation
Dún Laoghaire Business Association
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n Mr. Max Brohan
n Dr. Gerard Bury
n Dr. Fergus O'Kelly
n Mr. Adrian Carolan
n Cllr. Sheila Casey
n Fr. Sean Cassin
n Prof. Paul Connon
n Mr. Con Doherty
n Dr. Pat Fanning
n Dr. Michael Ffrench-O'Carroll
n Mr. John Fitzgibbon
n Mr. Michael Fox
n Mr. Hugh Greaves
n Mr. Paul Gregory
n Ms. Roslyn Hurley
n Mrs. R. Leech
n Mr. Fergus McCabe
n Ms. Maria McCully
n Ms. Nancy O’Flynn
n Ms. Siobhan O'Donnell
n Mr. Richard Parker
n Mr. Lorne Patterson
n Mr. Ciaran Perry
n Dep. Pat RabbitteT.D.
n Mr. Paul Sheehan
n Mr. C. Skelton
n Mr. Eamonn White
Dún Laoghaire/Rathdown Local Drugs Task Forc e
East Coast Area Health Board
East Wall Drugs Committee
E a s t e rn Regional Health Authority (ERHA) (form e r l y
E a s t e rn Health Board )
E U R A D
F Á S
Fatima Young Person Project Focus Ire l a n d
FORÓIGE – National Youth Development Org a n i s a t i o n
General Practitioners Specialising in Substance Abuse
( G P S S A )
Haddington Clinic
Health Research Board (HRB)
Institute of Technology Tr a l e e
Irish Association of Univeristy and College Counsellors
Irish Bishops' Drugs Initiative
Irish College of General Practitioners
Irish Congress of Trade Unions (ICTU)
Irish Medical Organisation (IMO)
Irish Prison Serv i c e
Irish Sports Council
K e rry County Council
K e rry Diocesan Youth Serv i c e
Kilkenny Drugs Initiative
K i l l a rney Urban District Council
Labour Part y
Lake Isle Relaxation Centre
L e i s u re Point
L I N K S
Local Bishops Network Committee
Local Drugs Task Forces Repre s e n t a t i v e s
Marist Rehabilitation Centre
Mater Dei Counselling Centre
Matt Talbot Community Tru s t
Mayo County Council
Meath County Council
M e rchants Quay Pro j e c t
Mid We s t e rn Health Board
Midland Health Board 
Midland Regional Youth Serv i c e
Mountview/Blakestown Community Drug Te a m
National Adult Literacy Agency (NALA)
National Council for Curriculum and Assessment (NCCA)
National Parents Council – Post Primary
National Parents Council – Primary
National Youth Council of Ire l a n d
Natural Law Part y
N o rth Clondalkin Community Development Association
N o rth Eastern Health Board
N o rth Inner City Drugs Task Forc e
N o rth We s t e rn Health Board
N o rt h e rn Area Health Board
Nurses Addiction Network
O ffice of the Revenue Commissioners 
One Parent Exchange and Network
PA C E
Pavee Point Travellers Centre
P h a rmaceutical Society of Ire l a n d
P o rtarlington Drug Aw a reness Group 
P revention Project Group, Department of Education, 
NUI Maynooth
Prison Officers' Association (POA)
P robation and We l f a re Service (PWS)
Ranelagh, Rathmines Drug Aw a reness Pro j e c t
Rathmines Drug Aw a reness Gro u p
Rialto Community Drugs Te a m
Ringsend Action Project Limited
Ringsend and District Response to Dru g s
Rinn Development Initiative Limited
Rutland Centre Limited
SAOL Pro j e c t
S e c retariat of Secondary Schools
Sligo County Council
Sligo Northside Community Resource Centre
South East Regional Drug Helpline
South Eastern Health Board
South Inner City Community Development Association
South Kerry Development Part n e r s h i p
S o u t h e rn Health Board
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Southhill Community Development Pro j e c t
Southill Young Men's Pro j e c t
St. Michael's CBS
Tallaght Community Drug Te a m
Teachers Union of Ire l a n d
Teen Challenge Ire l a n d
Thomas Mullins and Company
Ti p p e r a ry S.R. Vocational Education Committee
T R U S T
UISCE 
Union of Students in Ireland (USI)
University of Limerick
U R R U S
Vincentian Partnership for Justice
Wa t e rf o rd Community Drugs Network
We s t e rn Health Board
We x f o rd Area Part n e r s h i p
Wicklow County Council
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Oral Hearings
During July and August 2000, the Minister of State, the Chairperson of the IDG, members of the Review Group,
representatives of the consultants and the Secretary to the review met the following 34 groups. Each session
consisted of a short presentation by the group concerned and then a lengthy discussion around issues raised.
ADM Ltd.
An Garda Síochána
Citywide
COCAD
Combat Poverty Agency
County & City Managers Association
Custom and Excise Division, Revenue Commissioners
Dept. of Education & Science 
Dept. of Enterprise, Trade & Employment
Dept. of Health & Children
Dept. of Justice, Equality & Law Reform
Dept. of Social, Community & Family Affairs
Dept. of the Environment & Local Government 
Dept. of the Taoiseach
Eastern Regional Health Authority
FÁS
Health Research Board (Drug Misuse Research Division) 
Irish Bishops Conference on Drugs
Irish College of General Practitioners
Irish Courts Service
Irish Prisons Service
LDTF Reps
Merchant Quay Project
National Council for Curriculum & Assessment
National Parents Council (Post-primary)
National Youth Council of Ireland
Pharmaceutical Society of Ireland
Policy Research Centre, National College of Ireland
Prison Officers Association
Probation & Welfare Service
Regional Drugs Co-ordinators (excl. ERHA)
UISCE
Union of Students in Ireland
Voluntary Drug Treatment Network
A P P E N D I X 4 – D R U G T R E AT M E N T T Y P E S
The following is a sample of drug treatment types,
some of which are mentioned throughout the
Report. 
Needle/Syringe Exchange Schemes
Needle/syringe exchange schemes provide injectors
with clean injecting equipment to prevent them
from using needles more than once or sharing
with other people. Moreover, they facilitate the
safe disposal of injecting equipment reducing the
harm associated with unsafe drug using behaviour.
The overall concept of needle/syringe exchange
facilities is to reduce needle sharing and
unhygienic practices so that the threat of
transmission of disease, in particular hepatitis and
HIV, is reduced. Exchange schemes may make
contact with injectors who are not in contact with
other services and the international literature
consistently reports evidence of reduced sharing
frequency amongst those attending exchange
schemes. Although it is argued that the presence
of such a service encourages injecting, research
indicates lower HIV rates among drug injectors,
where there are good services available.
Needle/syringe facilities are now recognised
internationally as a central part of a harm
reduction strategy.
Detoxification Pro g r a m m e s
The aim of detoxification is to eliminate opiate
and other drugs from the body. Detoxification is
carried out for a range of drugs, particularly
opiate drugs or substitutes to opiate drugs
(opioids) and is conducted by either gradually
reducing the dosage or abruptly stopping the
dosage until the individual is drug free. Treatment
generally continues until all withdrawal symptoms
have subsided. Detox programmes can be accessed
in hospitals (in-patient) or on a community basis. 
Methadone Reduction Pro g r a m m e s
Methadone maintenance programmes apply to
individuals who are using prescribed methadone
as a means of reducing withdrawal symptoms
from coming off opiate drugs. The aim is to
prescribe a gradually tapering dose over time,
with the ultimate aim of the individual achieving
abstinence in the medium term. The time in which
abstinence is reached can vary significantly
between different individuals. Such interventions
provide immediate benefit in reducing in drug
misuse and injecting behaviour.
Methadone Maintenance
P ro g r a m m e s
The aim of methadone maintenance programmes
is to stabilise the user by prescribing methadone as
a substitute for heroin and other opiate drugs.
Methadone maintenance is the most evaluated
form of treatment in the treatment of heroin
addiction and is the most common substitute of
choice for those treating opiate addiction. In some
cases, individuals can be prescribed methadone for
a number of years. International evidence
surrounding methadone indicates that methadone
maintenance significantly reduces heroin use, drug
related crime and the spread of drug-related
diseases through injecting drug misuse 
H e roin Pre s c r i p t i o n
Experiments involving the prescription of heroin,
under strict medical supervision are in place in the
Netherlands and Switzerland. Only those serious
misusers whom it is considered can no longer be
helped by the regular care system are allowed
participate in the experiments. The INCB opposes
such experiments. 
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In-Patient Treatment Serv i c e s
In-patient treatment services generally provide
detoxification and early rehabilitation, on a short-
term basis (2 –12 weeks). On completion of in-
patient detoxification a significant number of
patients generally go on to residential
rehabilitation facilities. 
Residential Serv i c e s
Residential treatment services provide a managed
environment for heavily dependent drug misusers
who are trying to become drug-free.
Internationally, residential treatment programmes
are generally divided into three broad categories:
1. Therapeutic Communities, where residents attend
intense therapy sessions. 
2. Twelve step models based on Alcoholics/Narcotics
Anonymous. The aim is for long-term abstinence
and the approach is based on spiritual, as well as
practical guidance. 
3. More general houses, some of which have a
religious-based philosophy. The approach used is
based on group and individual therapy.
R e h a b i l i t a t i o n
Rehabilitation involves assisting a drug misuser in
achieving a drug-free lifestyle, as well as enabling
the individual to cope with all aspects of daily life.
Individuals availing of rehabilitation can either be
stabilised on medication, detoxing or already drug
free. 
C o u n s e l l i n g
Counselling plays a central role in drug treatment
therapy and can include psychological therapy,
group therapy, as well as advice on how to deal
with issues such as housing and social problems,
criminal justice problems and health problems etc.
A l t e rnative Forms of Tre a t m e n t
Self-Help Networks
Narcotics Anonymous (NA), which is an
international self-help organisation, co-ordinates
local support groups for drug misusers and is
similar to Alcoholics Anonymous. Similar groups
are run which place specific emphasis on the
family of the drug misuser (Family Anonymous).
Both groups are based on the 12-step abstinence
model. 
NeuroElectric Therapy (NET)
79
NET is a form of electro-medicine used in
detoxification. Special adhesive electrodes are
placed behind the ear and continuous stimulation
is applied for between 6 to 10 days (significantly
less for nicotine addiction). NET is used for both
drug and alcohol addiction. It utilises minute
amounts of electricity transcranially to re-establish
or stabilise the natural levels of neuropeptides
intractably disrupted by chronic substance use and
misuse. 
Transcendental Meditation (TM)
Transcendental Meditation is a simple form of
meditation which has documented benefits for
health and well being.
80
It is taught using a shor t
programme based on a standard seven-step course
and is practiced for 15-20 minutes twice daily.
Transcendental Meditation settles mental activity
while maintaining (and enhancing) alertness. The
health and personal benefits arising from this
practice has been researched worldwide, in over
27 countries. 
3 4
7 9 Patterson et al. (1996) Electrostimulation: Addiction Treatment for the Coming Millennium. The Journal of Alternative and Complementary Medicine, 
Volume 2, No. 4.  
8 0 Transcendental Meditation, Introduction and Overview of Researc h – January 1998. Scientific Research on Maharishi’s Vedic Approach to Health: Part 1.  
A P P E N D I X 5–D R U G T Y P E S
Types of Dru g s
The following is a sample of drug types mentioned
throughout the course of this Report. 
There are four main categories of drugs:
n Depressants, such as alcohol and cannabis,
depress or slow down mental and physical
activity.
n Stimulants, such as amphetamine and cocaine,
stimulate mental and physical activity.
n Hallucinogens, such as LSD and magic
mushrooms, create hallucinations and delusions
and may alter sense of smell, taste, time etc
n Opiates, such as heroin and methadone, have
pain killing properties and produce feelings of
well-being. Opiates are derived from the opium
poppy. Opium is the dried milk of the opium
poppy and it contains morphine and codeine,
which are both effective pain-killers. 
Amphetamines are stimulant drugs, also called
speed, whiz or base. They come in the form of a
white powder, and can be snorted up the nose,
mixed in drink or prepared for injection. 
Benzodiazepines are synthetic drugs manufactured
for medical use and are a form of tranquilliser.
Benzodiazepines can be used in the same way as
street drugs. 
Buprenorphine is a semi synthetic opiate
possessing both narcotic agonist and antagonist
activity, which is being studied as another
alternative form of medication as a treatment for
heroin and other opiate addiction. Buprenorphine
produces less euphoria than morphine and heroin.
Cannabis is usually smoked when rolled into a
cigarette or joint, often with tobacco, or can also
be smoked using a pipe. Other common names for
cannabis include hash, weed, dope, etc. Smoking
cannabis generally has a number of physical
effects, including decreased blood pressure,
bloodshot eyes, increased appetite and occasional
dizziness. 
Cocaine is made from the leaves of the coca shrub
and is a white crystalline powder in its most
common form. It is generally sniffed up the nose,
but it can also be made into a solution and
injected. 
Crack is a smokeable form of cocaine made into
small lumps or “rocks”. It is usually smoked. Crack
can also be prepared for injection. 
Ecstasy often known as E is both a stimulant and
an hallucinogen. Sold in tablet or capsule form, it
can be any shape or colour. Tablets are often
referred to after the image printed on it, for e.g.
doves, apples etc.
Heroin is an opiate drug from the opium poppy. It
is made from morphine and is a white powder in
its pure form. Heroin is a sedative drug which
depresses the nervous system.
LAAM (L-Alpha Acetyl Methadol Hydrochloride) is
a substitute drug similar to methadone in
composition and pharmacological effects. It has a
much longer duration of action than methadone
(up to 72 hours). 
Lofexidine is a non-opioid and can be used to
detoxify people who are dependent on opiates. It
may be particularly useful in treating young
people who are at an early stage in addiction. 
LSD (Lysergic Acid Diethylamide) is a powerful
hallucinogenic drug also known as acid, trips or
tabs. It comes on small squares of coloured
blotting paper or tiny pills (‘microdots’). A tiny
dose produces a non-stop ‘trip’ which can last 8-12
hours. 
Methadone is one of a number of synthetic
opiates (called opioids) which is manufactured for
medical use and has a similar effect to heroin. It is
mostly prescribed as a substitute drug in the
treatment of heroin addiction. 
Morphine is an opiate drug derived from the
opium poppy. It is one of the most powerful
analgesics known and it acts as an anesthetic
without decreasing consciousness.
Tricyclics, otherwise known as antidepressants, are
generally used in the treatment of depression and
depressive conditions.
1 3
A P P E N D I X 6–R E F E R E N C E S
Action Programme for the Millennium Review,
November 1999
Ali, R. et al. (1999) 
Report of the External Panel on the Evaluation of
the Swiss Scientific Studies of Medically Prescribed
Narcotics to Drug Addicts. 
Allwright, S., Barry, J., Bradley, F., Long, J. and
Thornton, L. (1999) 
Hepatitis B, Hepatitis C and HIV in Irish Prisoners:
P revalence and Risk. 
Prepared for the Minister for Justice, Equality and
Law Reform by the Department of Community
Health and General Practice, Trinity College, Dublin.  
An Garda Síochána Annual Reports 1996 -1999.
Aware (1998). 
Suicide in Ireland: A Global Perspective and A
National Strategy.
Brinkley, A., Fitzgerald and Green (1999) 
Substance use in early adolescents. A study of the
rates and patterns of substance use among pupils in
Dublin. 
Bryan, A., Moran, R., Farrell, E. and O’ Brien, M.
(2000) 
Drug-Related Knowledge, Attitudes and Beliefs in
Ireland. A Report of a Nation-Wide Survey. Drug
Misuse Research Division. 
Caulkins, J.P., et al. (1999) 
An Ounce of Prevention, a Pound of Uncertainty:
The Cost-Effectiveness of School-Based 
Prevention Programmes, 
Rand Corporation p.85.
Comiskey, C. (1998) 
Prevalence estimate of opiate use in Dublin 
Ireland during 1996. 
Dublin: Institute of Technology Tallaght, 28.
Coombs, R.H. and Ziedonis, D. (eds) (1995). 
Handbook on Drug Abuse Prevention: A
Comprehensive Strategy to Prevent the Abuse of
Alcohol and Other Drugs.
Cox, G. and Lawless, M. (1999) 
Wherever I Lay My Hat: A Study of Out of 
Home Drug Users. 
Merchants Quay Project: Dublin.   
Department of Health (1993) 
Report of the Expert Group on the Establishment of
a Protocol for the Prescribing of Methadone.
Dublin: Department of Health.
Department of Justice, Equality and Law Reform. 
Drug misuse and drug treatment in the prison
system – draft action plan.  
Dublin: Department of Justice, Equality and Law
Reform, 1999.  
Department of Tourism, Sport and Recreation (2000) 
Report of the Interim Advisory Committee on Drugs, 
February 2000.
Eastern Health Board/Gay Men's Health Project,
1997, 
Report on Men in Prostitution.
ESPAD Study: Implications for Prevention. 
Drugs: education, prevention and policy,
Vol. 6, No. 2, 1999. 
European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA) (1999) 
Annual Report on the State of the Drugs Problem in
the European Union, 1999. 
European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA) (1999) 
Extended Annual Report on the State of the Drugs
Problem in the European Union. 
European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA) (2000) 
Annual Report on the State of the Drugs Problem in
the European Union, 2000.  
European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA) (1999) 
Evaluating Drug Prevention in the European Union. 
Scientific Monograph Series No 2.
European Union Action Plan on Drugs, 1999.
Farrell, Dr M., Buning, E., (1996) 
Review of Drug Services in the Eastern Board.
3 6
Farrell, M., Gerada, C. and Marsden, J. (2000) 
External Review of Drug Services for 
The Eastern Health Board. 
National Addiction Centre, Institute of 
Psychiatry, London. 
Faughan, Pauline, 
Refugees and asylum seekers in Ireland: 
social policy dimensions, 
Social Science Research Centre, University College
Dublin, 1999.
First Report of the Drug Court Planning 
Committee, Pilot Project,
August 1999. 
Freeman, K., Lawrence, R., Karski and Doak, P.,
(April 2000) 
New South Wales Drug Court Evaluation: 
Program and Participant Profiles 
Turning Point Alcohol and Drug Centre Inc.
Friel, S., Nic Gabhainn, S. and Kelliher C. (1999) 
National Health & Lifestyle Surveys.
Gleeson, M., Kelliher, K., Haughton, F., Feeney, A.
and Dempsey, H. (1989). 
Teenage smoking, drug and alcohol abuse 
in the Mid West. 
Department of Public Health, 
Mid Western Health Board.  
Hibell, B., Anderson, B., Bjarnason, T., Kokkevi, A.,
Morgan, M. and Narusk, A. (1997) 
The 1995 ESPAD Report: Alcohol and Other Drug
Use Among Students in 26 European Countries.
Stockholm: The Swedish Council for Information on
Alcohol and other Drugs (CAN), Council of Europe
and the Pompidou Group. 
Hibell, B., Anderson, B., Ahlstrom, S., Bjarnason, T. ,
B a l a k i reva, O., Kokkevi, A., and Morgan, M. (2001) 
The 1999 ESPAD Report: Alcohol and Other Drug
Use Among Students in 30 European Countries. 
Stockholm: The Swedish Council for Information on
Alcohol and other Drugs (CAN), Council of Europe
and the Pompidou Group. 
International Narcotics Control Board Report 1999.
Jackson, T.M.R. (1997). 
Smoking, Alcohol and Drug Use in Cork and Kerry.
Southern Health Board, Department of Public
Health.
Kiernan, R. (1995). 
Thesis on substance use among adolescents in the
Western Health Board Area.
Unpublished Thesis. Faculty of Public Health
Medicine, Royal College of Physicians of Ireland.  
Long, J., Allwright, S., Barry, J., Reaper-Reynolds, S.,
Thornton, L. and Bradley, F. (2000). 
Hepatitis B, Hepatitis C and HIV in Irish Prisoners, Part
1 1 : Prevalence and Risk in Committal Prisoners 1999. 
Prepared for the Minister for Justice, Equality and
Law Reform by the Department of Community
Health and General Practice, Trinity College, Dublin.  
Marsch, L.A. (1998) 
The efficacy of methadone maintenance
interventions in reducing illicit opiate use, HIV risk
behaviour and criminality: a meta-analysis. 
Addiction, 93.
Memery, C. and Kerrins, L. (2000). 
Estate Management and Anti-Social Behaviour in
Dublin. A Study of the Impact of the 
Housing Act 1997.
Threshold Publication.  
Ministry of Health and Social Affairs, Sweden. 
A Preventative Strategy – 
Swedish Drug Policy in the 1990s, 
The Swedish National Institute for Public Health
1998:21 & Fact Sheet No 4 March 1999.
Monitoring Poverty Trends
(1999) Data from the 1997 Living in Ireland Survey.
Conducted by ERSI for Combat Poverty Agency and
D e p t a rtment of Social, Community and Family Aff a i r s .
Moran, R., O’ Brien, M. and Duff, P. (1997). 
Treated Drug Misuse in Ireland. 
National Report 1996.  
Dublin: The Health Research Board.  
Nadelman, E (1998). 
“Challenging the global prohibition régime”, The
International Journal of Drug Policy.
National College of Ireland, (PRC) 
Evaluation of Local Drugs Task Force Projects, 
September 2000
1 3
National Drug Treatment Reporting System (2000) 
Statistical Bulletin 1997 and 1998. 
Drug Misuse Research Division, 
The Health Research Board. 
National Institute of Justice, Washington, DC, (1993). 
Miami’s Drug Court: A different Approach:
National Youth Council of Ireland. (1998). 
Youth and drugs – The NYCI drugs policy.
Dublin: NYCI.
Nexus Research Co-operative, June 2000. 
Poverty, Drug Use and Policy Grants Scheme –
Evaluation Report. 
Nurses Addiction Network (2000). 
Conference “Cocaine, an emerging problem”.
Clontarf Castle, May 2000.
O’ Higgins, K. (1996). 
Treated drug misuse in the greater Dublin area. 
A review of five years 1990 – 1994.  
The Health Research Board, 
Baggot St., Dublin, Ireland.  
O’ Higgins (1998). 
Review of Literature and Policy on the links
between Poverty and Drug Abuse. 
Combat Poverty Agency/ESRI. 
O’ Mahony, P. (1993). 
Crime and Punishment in Ireland.  
Dublin: The Round Hall Press.
O’ Mahony, P. (1997) 
Mountjoy Prisoners. A Sociological and
Criminological Profile.  
Dublin: Department of Justice, Equality and Law Reform. 
Paterson, M.A., Patterson, L. and Patterson, S. (1996) 
Electrostimulation: Addiction Treatment 
for the Coming Millennium. 
The Journal of Alternative and Complementary
Medicine, Volume 2, No. 4. 
Pavee Point Youthstart 1998-9 (1999). 
Drugs and the Traveller Community Project, 
Pavee Point Travellers’ Resource Centre, Dublin,
August 1999.  
Programme for Prosperity and Fairness, 1999.
Reuter, P. and Culkins, J.P. (1995) 
Redefining the Goals of National Drug Policy
Recommendations from a Working Group. 
American Journal of Public Health; 85. 
Ruddle, H., Prizeman, G. and Jaffro, G. (2000) 
Evaluation of Local Drugs Task Force Projects.
National College of Ireland, 
Policy Research Centre. 
Steering Group for Prison-Based Drug Treatment
Services Report (July 2000) 
Prison-Based Drug Treatment Services in the Eastern
Regional Health Authority Area. 
Transcendental Meditation, Introduction and
Overview of Research – January 1998. 
Scientific Research on Maharishi’s Vedic Approach 
to Health: Part 1
Uchtenhagen, A., et al. (1999) 
Prescription of Narcotics for Heroin Addicts: Main
Results of the Swiss National Cohort Study.
Executive Summary.
Uhl, Dr. Alfred Ludwig-Boltzman Institute for
Addiction Research at the Anton-Proksh Institute,
The Prevalence of Problematic Opiate Use in Austria
Based on a Capture Recapture Estimation
Vienna, 2000.
Union of Students in Ireland (USI) (1998). 
USI National Drugs Survey of Third Level Colleges
1997/98. 
Women’s Health Project, Eastern Health Board,
Dublin, Ireland and European Intervention Project
Drug Using Women Working In Prostitution. Dublin:
1999.
3 8
